var title_f30_18_31008="Hidradenitis suppurativa wound healed";
var content_f30_18_31008=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F81667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F81667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa wound healed",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the healed wound following unroofing of an inflamed nodule and multiple sinus tracts in a patient with extensive hidradenitis suppurativa of the groin. The wound healed in four weeks, dressed with petrolatum only. In order to avoid damage to the reepithelialization process, no gauze or other dressings were used.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31008=[""].join("\n");
var outline_f30_18_31008=null;
var title_f30_18_31009="Type 1 reaction in leprosy";
var content_f30_18_31009=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 489px\">",
"   <div class=\"ttl\">",
"    Type 1 reaction (RR) in leprosy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 469px; height: 279px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEXAdUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6B+IPjSx8DaVaX2o2l9dpdXQtI47NUL7yjvk73UYxG3f0rh/+F9aKf+Zc8S/98Wv/AMfo/aa/5Ffw5/2Gl/8ASW5rzj4ffD+98Z6Zq2oR69Z6Xb2N4bUpNYNNwIYpC5fzkA/1hHTt1rOUpc1ojPSR8d9Hx/yLfiX/AL5tP/kilHx10cjjw34k/wC+bT/5IrhPBPw+tfGunz33hfx/p1/bQS+RIw0KaMq+AcbXnB6Ec4wfwNcNo1w95pVldSBQ88CSNtzgEqCcfnUynKO4WR7sPjnpJ6eGvEv/AHzaf/JFKPjlpR/5lrxJ/wB82n/yRXjIWpFFR7aQ7HsY+OGlnp4Z8S/laf8AyRTv+F3aYf8AmWfEv5Wn/wAkV4+i1KgxR7aQWPXP+F16b/0LHiX8rP8A+SKX/hdWnf8AQr+Jfys//kivNtM0e91EgWlu7j+9jC/nXX6b8PJ3Aa+ulj77Y13H86aqyY1Bs2v+F06f/wBCv4k/Kz/+SKenxmsnICeFfEzE9gLM/wDtxUtj4K0a1IMkbzuP+ejf0GK6GzsrW1G21tooh/sKBQqrKVPuULb4hXNyAYvBHikg9C32Jf53NWf+E01D/oR/Ev8A390//wCSq1AgyOlSYHY5qvaMPZoyB4y1E/8AMj+Jf+/2n/8AyVTv+Ew1L/oRvEn/AH+0/wD+Sq2Uwe2ad0/GnzsPZoxP+Ew1L/oRvEn/AH+0/wD+SqB4w1Lt4G8Sf9/tP/8AkqtpjzxQhIbpmjnY/Zoxv+Et1T/oRvEn/f7T/wD5KpD4v1IdfA3iT/v9p/8A8lV0WFbBNDIuKOdkcqOaPjTUB18D+Jf+/un/APyVWdP8TmgLCfwZ4oiwcfvPsS/lm55/CuvkTnJxiqV3bxTxmOaJZo24KsoYH6g0vaMr2aexy3/C2bf/AKFXxD/38sf/AJJpD8W7YdfC3iAf9tLH/wCSah1b4b+GNRJZ9OEDn+KByn6dP0rmrz4MaQwJtbm4X0Eh3fqMVPtJd0L2bNDVv2g/D+ktt1DQPEcR3bOFtWyfwnNP0n9oDQNWExsNA8RS+UAXyLRcZ6feuBn8K8v8f/Bq9XSt+kwtdzo+7ETZYDvgNjPauc8M+CI7K3Fvqkc41CQb2WRDGV46YPpzVub5bkOLT1Pd9O+PWh6jPNDa6B4gMsJw6ObOMj8GuBke4rQ/4XDY9f8AhGtf/wC/tj/8k1896z4GhCSSwcGJSxIkAZR61U0TTrDyFTWBFBMVDxv9oUCVD0bGcis/ay3VhH0JqXxx0jTbOW6vPD2vxwR43MGsmI5x0FwT3rr9T8c6fp/w9tvGD2t9Lp9xBazxwRqnnkXDIqDBYLnMi5+bHXk18oeK/C0I0e4NhG4u0AdQWzuAOcV7d4o5/Zc0D3sdE/8AR1rWtOTkrsDQ/wCF6aR/0LXiT/vm0/8Akig/HTSP+ha8Sf8AfNp/8kV5V4S8O3nizxVHo1lqFvp/+hTXjTS2rXGdjwoFCiRMZ80nOT06VY0Xw/pGt3tja6f8QLZpL6V4LV5fDF3DFPIn3kSR5QjMPQHNNOTHoemn466R/wBC14k/75tP/kij/heukf8AQt+Jf++bT/5Irx/WtLuND8S6xot5dQ3kmnzpGJ4oDCHDQRS/cLNjHmEde1VscVLm0NRR7R/wvbR/+hb8S/8AfNp/8kUH476OP+Zb8S/982n/AMkV4wkTOcIpb6CnLZXMjBI7eVmJwAEJJpe0ZXIz2X/he2j/APQt+Jf++bT/AOSK0tI+LUesSbNM8G+K7g9ykdptH1P2jArmPA3w4t9sd74lkjXPKWfmAH/gZ/oK9etbOKO2SKzEUNuowqwqAoHtitE+5LVjEbxhqSj5vBHiMfWfTv8A5Kpv/CZ6h/0JPiL/AMCNO/8Akqt02CHrvb6nFV59OtgCXLL9GouxWRk/8Jrf5x/whPiPP/XfT/8A5Kpf+E0v/wDoSfEX/f8A07/5KpLuHTIsh7t0P+/WJdXWnRE7dVZcepBqHUt2K5WzeXxfqTdPA/iQ/wDbfT//AJKpw8Waof8AmRvEn/f/AE7/AOSq5F9aii5i1uE+m7/9dV38X3EJ+XUoJMe5pe2XUfs2zt/+Es1X/oRfEn/f/T//AJKpG8W6ooyfAviX8JtPP/t1XFp4+uF+88Mn0Yf1q1bfEGNmAk+Q/mKftoi9nI6NvG98pw3gjxKD7y2H/wAlU9PGWouMr4I8SH/ttp//AMlVVtvFljeptk2P+NSF7W4+azvPKfsrtx+dUpp7EtNE0njLUY13P4G8TY9pbA/yuqiTx1eP93wX4j/7/af/APJVV5tUv9OwbnLRf3jyPzpn/CR2cpzLEob+8OKOdLcVmaI8Y6iRx4H8Sf8Af7T/AP5KqG98c31nbtNP4G8UmNevltYyH8luSap/21GGzbzL9GqaPxKYz++AP0pqaDUwH+OWlIxV/DPiVWHBBW04/wDJik/4XrpH/Qt+JP8Avm0/+SK0dYs/DfiUH7fCsVwek8fyuPx7/jXn+v8Aw6vrNXn0iVNRtQM4T/WKPde/4UNv7I1Y6/8A4XrpH/Qt+JP++bT/AOSKQ/HbR/8AoW/En/fNp/8AJFeMyxNE5SRSrjghhgioyvNRzsdj2r/he2j/APQt+JP++bT/AOSKjufj7odtbyzz+HfEixRIXdtlqcADJPE9eMbeazfEo/4p3Vf+vWX/ANANCmwsfbVFFFaknkH7THPhnw3/ANhpf/SW5rjPBdrr+ofBXx1pvhK0+06rfasbVR5qRCON7W2EjksR0Xd05yRXaftLf8iz4c/7DI/9JLmvFLKS7szN9g1TV7FZ38yRLPUZ4EZ9oXcVRwM4VRnHYVlKSjO7Glc9g+FHw+1/4d/EC6hiS0u/DOo6bCs1xaxi3WG5hGxcxNK7EsoJZhwWbOBivFfDAz4b0r/r0i/9AFayX+rd/EXiT/wdXf8A8cqGyt47W2it4F2QxIERck4UDAGTWc6ikhpEyDmpVAHPemoOau2NpJeXUcEIyzHH096xs2Naj9Osbi+nEVtEZHPp0H19K77QfB0EGJL/ABPKOdg+6P8AGtrQdLg06zSOBRk/eY9WPrW/Em1QD3qloaqKjuJZ26QIoVQoHAAGAKuFwBjOTUDE9uAaeoCr17U0XvuKoHBxg1ZQZBzxUCkZ45qzHwRnpQgbHpjH0qZAOM1FlV+7im+YSfYVRO5b4zwRQyg4ANVg5UhiODUpkPrzVCEkwpOKdGPm70x3GamiYD5simht6EsagL14pJJMelRmQZNRSPkk5zSZKjdiu3bJqIk5xmms1AYHioNbWGPyeuKRN47ZFWEUMwBpZFKjpx60mhXKU2V5x9ar3VpbXkYFxCki/wC0Mkf4VZm9OtCocUktdAdmeT678L0gk1W80G6uDJdQyKbSZ9ylyDgqx6fQ1494o8Ja6b+2jXS2YR20MTMzAFCq4IxmvrJlOSKo6ppdtfxlZ1Bb+Fx1FO5hUpJnyZ8VdSuLTxHDDbyzxmO3XcEJAJyfSvoLxRn/AIZe0DPX7Fon/o62rxT40eHrvTvF2+WMm3lhHlSgcMB1/EV7b4rGP2Y9BH/Tnon/AKPtq2pbWM7WOe+Bwx8U0/7A13/6Ptao+BPht4s01/CCNod7YajpmsyXd3e3eoRT2gtWZiyRQiV9sjKQNyop9W71zAjkjvEuba6vrS5RGjEtndy277GKllLRspIJRTg+gqY3mrf9DD4k/wDB3d//AByqjJJWKtc1fiQM/FLxf/19wf8ApFb1N4e8Om9dWnHXpH/jWbotkGuZ7u5mubiWVw8kt1O88kjBVUEu5JOFVQOewrutK1GO2QbAAT371jUlrod+Gw948zRvaZ4Yt4EXcEBHO1RitSHTLSNwSgY+4rITW2MQAXLkcZpkF5K8q8nax55rJps6uSb3Z1HkxEYAGB2FOjUxn92zJ/unFIikwKB1xTlUgDcct61LZztDZC55LsT7mondtpAJP40kiybjzuBpVGF2kUhpIge2VxuKqT7ioJLON1KvGrD0YZFaSD1/KkdASDkVLBM4/VPB+k3wPm2USN2aP5P5Vyl/8OYlctaXVxGvoZG/xr1V3XkkdO9Vy8TNwRz2NF2i/keVL4DnXAa4ldf+urVIPh+jdSwPqJCD+delyOvTbz7UAFgMA4pXY1bseYt4Iv4ebLUpUI6BmLfz5/WnrY+MLAgQyW96AMkNlD+dek+VkjYR74pVgKsMA+maakyJRi+hxmnat4sRdr6PLt7gTIVP5mp54prtS15oVzBJ1LwMAfyBruIFAHtUzJ8ucCrU2jF049jyq6ge3b9zfXkB/uXMBYfnVdr+8ixia2lP++UJ/Aj+tepzIDklQQOuRVa4sbWdCskKMD1G2q5ifZo8yXXW80xTK0coGSp5IHrx2rTstbmRgYZj/wABar+qeAtLuLkXMUbW9wpyskR2kfiKjHhuWIEbbe595FIP5gj+VUpImVPsTXclh4gj26rCPPxhbmMYkH1/vD61xviDw7daQ3mHE1o33JkHH0I7H2ro/wDRbG6WK+jvbRmOFZf30Z+h4P511ukxQXsDwQyx3sLjDRvGUJH48VvFqW5zyTieJYxWd4mH/FOar/16S/8AoBrvPGvhptFuRLbhjZyE7dw5Q/3TXDeJh/xTerf9ekv/AKAaVrMD7Tooorcg8i/aT58OeG/+wyP/AEkua8VQcV7X+0l/yLvhr/sND/0kua8XHbrXNW+IaHryelTIBmo1HIqdR09ayuUPRRmvQfAuj+VCb2Zfnk4QH0rmvCmjtql+oIIt4yDIf6V6zbwhAEUYVRgAdqroaQj1J7eLoT07CrMR3Lz2qFWKqcEcUCbEeOBmgbTJM7ulNJP3R0qJG45PFDuAeO/f0pFlyE9OauE4UHGayYZQJAN3OM1cWbcODxTTE0ywJCc5pPM5qB5Bj6VWef5sbuaLjSuaTSh1Az0pTL3z2xWWkpA4YmpVlY5zwafM2Fi4ZeeanWQAYHSsoTA84J96kSfCndQpDcTR35Geg6U0MCBVL7T2Xt1JqJpS3RsChyDlL0h6Ypit82CarLMMYJyaXeSeBj61Nw2NCJxkYNWXIKcEE1mKxGKnSQnr0qkyGhJOTnGKVTxQxz0qPOKaDclkTK5AqrKpXFT7zkc8VHN3PpQ0I5zxp4ct/EuhT2UwAlwTFJjJRqw/Fylf2Z9DVuotdFB/7/21d0mTzXE+Nf8Ak2/R/wDr30b/ANKLatKT0ZlNHlBHSkxlsDrTzUtrEXmGAcL8xPoKQ4q7sXYZBHGIx0BxVyGXaB9Ohqk0Y8sMDznNERG4c5FYtnu0tFZG/p0jSTBFOc9xXeaPZrGqu2S3piuJ0RfLljbGWPau7tZ0WMGRgvqc9KlyM67eyNXjbjOKawyMdqYkqFNyMCPWo2uosld/Ss7HKkxs0/lnaFqWL5l3MKhlYbgQMntRdS+XCAnDEdaaRSV7BcTYGEOR61UuJyo68exqCS4xEMnOOKzby7AB2ngdKbSOiFMuHU0G9T1+tUzdiaUqhGevpWXdsCwKt1IJaoYGCy+ZySO1JxNfZo66zJkizx15rRUAJyuBVHSmR7MSKDg8471aimMxYFCB71NrHG07jSQAwIPPQikjYFBvBPNRtDIrfeOzOSD1odiAxI4AyKAfkWC+0YHTrml8zC4rNN0FfPY96mdlY8mgnlZYkyc56GoGfywqqeelNimZmK5BFNYjc3Xr39adxWtuNlmPIxzis9bzLlWGOamnfaTWNdXA5PcmjcNLF68kSWMggZByD711GgXn9o2bfZ2WO7iGJUXjd/tVwHnh0JDe1Eeqz6LLHqNopd4f9YgP+sT+If1/Ct6U3FmNWClG3U9E1/SF1nSpra5ALsvyvjoexr5t8a2k1jout29yhSWO1mVgf9w19T6Vqlrqtik8Iyrjp0IPoa8l/aC0dJPC+qalBEUeOzlWQ/3l2HB/CutrmV0cSdtD3yiiimB5J+0j/wAi74a/7DI/9JLmvGFHt0r2f9pD/kXvDX/YaH/pJc140oI+tc9X4holQZq9p1nLe3UcEC5dz+XvVOMdPyr0bwfpq2MCyyL+/lGTnsPSs7dWaQjzOx0ehaZFpdgkMQGQMlv7x7mtmPGPqKqNKqIQD0qa0l3n2pXuzdqyGs5jOPWmBwD83SmXZ3TA4yB1qvLKoXOaVwepYmnVMAnoaat0HTBI9qx559x3Z6cYqP7SFJJai4zeR8uDVyFwOM8+lczFfFu5z6Zq5bXJL5JOTU3G1c3HcYIXj2qjMdpPWpBN8vCg55qKY5IPOfagS0EjlO8DOM9auLcKmADms5JtrHcy491przg5YnC0XK5bmg9wwf5cYPOMVGZsn5mBPoKorMMkIuR1zmntMzLwAB9KDRRsWBd5yoHy+opPtBA6cD1qqxbdwyj6CmxyEn375pXbHyovR3BY9KvRSBwFJOayywIUDj2FXrUsADIcCrRlJaF37iZAYkDgDrSh8Y5NRmRTzuFQTThTxmpcrGRfEnOAaY8wzzisr7YAx5wfel+1ggcjPpSUw5WaYkBHFOJLKM1lR3J3YznmrkEmV61akDjbUtQ8bh61w/jX/k2/R/8Ar30b/wBKLau4j5+tcP41/wCTcNH/AOvfRv8A0otq3pdTGZ5X2rV0uLGm305HdIQfqSf/AGWsvHauoeMW/hmzVVwZJPMdvU4OP0o6NlQ+JGMFbkHoFq5aWG6NXPao1V5JTHEMkDvVq4laC3EYIyByfWuds9qL0SRpaXJ5cquW6cAVr6jcmdliVsY+Y4ri7K5kMmcDg1vhxJMPmwT1FQynH3uY6rRM+WVLFlHHWrq2y+fuZsrjgY71l6UyxgKre5NX5BM8qEMFQc5z1oTOWTvJ6l9XUH5iRjmqmpXICAZGDzmllBki25z9OKiaJDBsx+JouKFlqzLuJSVJXms6ds8+vtzVueGQTGMZIPTFVZYmhYKefbqadzsi10Ks3zADPA9aYB83cfX0qWeN9oLjHtUIQ7vlB56mmUjptAmIzGQAgXOa3rYo4JjYHHXmuX00yo8Rj3GJ+DtFdNbQpGp2DGeTSZyVkrj5mJB4zVHBGd64Gexqe8kaOJjGhc+gNZM+oAfej+fvz0qGRGDa0Ib3UFgnVJY8oehFTi4MoUiNgCe/pVQT2lxzIgDr0BqyblRG3kgMwHy8UGjVtLGiEWNcKOcVnz3bo2JIyRuwCO1Rxaqh+WQYcdx3rM1u9ljQNb9DySOaCFB3sy3eTfLweT61gXchJJz+FLb3/wBojJm+8vOfasz7WZbkKeh4qooTg1cuRLsjJHc5+lSbgxKsOMcinIQy4xUkEYZwMdOtWYM6vwpei70WO5s4sXEOYriMcElTjOPwzVH4nXAvvhr4oVs749NuSQfTymOa2/BscMlvPDCVS7hO9T6q3r7ZyKy/iaYp/h14pniUJINLu0lT0IieuyDukzgmrSPW6KKKsR5J+0f/AMi94a/7DQ/9JLmvG1HPNeyftIf8i94a/wCwyP8A0kua8bU84rnqvUaNvw3aLc36tKP3UfzH3PpXoFtcEn5RiuX0CDybEcYZ/mNbdq3PQg44rFu2h20oWjcu6tfGC2Z8/dHP0qbR9YSa3G1gfesbWPmt2G7qOlcl4Vvngu7i1Zv9W3GfQ9KhS1sEldHq8k4KDJHPpWbNLuB3ngGqcV4Sntiq0tzuLc5p3IiLPNy2CcVTa7HTdUN3NsUkdeetYcl2TIQTxUttmm5vfa9zgg4I6mtS1vgQADz3FchBPtPXPNaVpKNwJPNT1GdxY3asgy1W3mDRkpwfWuUivBtIUY9TV2zu8qct19aoLFx5Dlh6Dv3qpPdMCBu47g0PIGHB5HvVC4YKCc/hTKT1LIumV+GIBPUVfjvR5eDz7iueWR9wAPHfFXbZm43Zz1FC2KbNJJt+S2QPSgz5YhQQO9UJpz1PX1p8Ll/kHQ9/SgdzYhnVV5yT9asrP3LEVkKuB8jZI5JqQTuq5Vce5OM0NkM02u1HTc3v0qnNeYJweCOhrPuJju+8STVCSbJOTzUslI0muSxODweMUC62r71lLOC33s+9OLHA5qE7oUtDYt7k7gSePWti1nDOQp+lcnFLkjPB962LS424wRkVaYPU6SCfGQ31rk/Gv/Jt2j/9e+jf+lFtW1HMWUZxu9KxPGf/ACbbo3/Xto3/AKPtq6aDvc5qqseWnk11muOF8P6GiZywLn8AB/jXJDrXS6ifl0aLduRbYn6c/wCOa0fwsdH40yWxgWISyMMccVi3kzSuDt4zWhqdwyWgRPvMcE+1UbWJrmL5OVB5JrkZ69J2XMyzYtHEysV3EdAK2NPkDy8r7/SsyONYdobp04rRglWBB37/AEqWVJ3WhvW8gVgOhHr2p41MxXSo2CncmsuO53J5gz9O9SvbrchXwykjkVK0MUkn7xvG5jwNjZBHXNCXIz6YrGkl+ywrwSV45ptrctOjyKuMcY9aVxcml+hpJfLLdbUA+tW5IkkYMUXcfUVhWmLdjJKMOeRVltQO5WTJ9RVovku/dKeogxyMMdRiobSFyvz5AbpnvVue4Ekm5wDIf0rU06yBAllIbOCB6CruaufIrsu6TA0FuiyDtn6VpbgybuhxjFZ738a53Zx61RutQeeNliyvPUVLOfklJ3ZFe3riZkRjj0rJupydxBBJ7moLq4IckscmqTXAbI5+tI7IxsTyyb26kGtfTbrMG1vvLwPeufVldsk1oWUbtIjJ2PNJkVUmtS41mxnZuNh9P5UlzABbNEACCOea0A25CWz7VWn2jJ6Y6c1Nzkc2zmpYRbK4wdzVRfakgOOa23ImYq5B7hhUM0CFssufQ1omW5W3JIUDRgZ54PFWdmCCOpFV4TtPHAHFWI5BkZ9KZzM2fCrtDrUUq53bWRh/eHX+hp3xfjNr4H8T3MXMNxplysg9zC2D+f8AOqWj3q2+q20nGBIufpnB/QmtL4lqT8L/ABbBKM+Vp11tPt5bEf0rroO6scdde8es0UUVsZHkf7SP/Iu+Gv8AsND/ANJLmvI9LhNxexpjIJyfpXsP7Q1vJc6J4ZhgXdI2s8D1xZ3R/pXmXhy3YSSSSKVb7vPGPWuervc0px5nY6cKIkA4JNXoCHABwR2qsjALgqSfrTxIUXBIArBnpRWg6+iLQkDnivPcG016Unjcv8jXftP8pzyDXC+IWCahHL05wawbtImUTpLe9PlDJ5NLHc4Bz0rmbS9z8uTVx7rYvLcmr9DFK2havp9x+U1nhT948DtUMl1lxnofSpHl5UZBHbmg08ixEmevBPQ1Mk0iPtbg1CASo5pzEOMOTuHQ0XFc0oZztAB61p2zZXIzkdq5yOUxtliAfStO3u+RtP45podjYRuDuyAPeopsFATnFVzKSRzjPY0Syo2NzfhQwsRNIgYKpJPr6VetrwKMEZArDllVJGJO0Zq3DeQPGPmGV6ii5dtDVa4VvvAL7VMkm4/LwKxJbgHaQcnpViK7REALYJHencTRrCUo3yk49PSpBOWGG59KyPtgZsKTTxO2MheemelDYNFq6Y4DL27VWZSV3OMZ9KRpSQeefrSqXdeuWFQyHoMEWBkdc1MOwGcn1poyrYHGaFJ7kUmS3cN2CTnkVchmIwT/ACrPeXqGH4VELlgBg8A07iOlgusOMmovGf8AybZo3/Xtov8A6PtqxVvQuCPWtnxif+MadFP/AE66L/6Ptq6cP1MK3Q8tzWibwym0yeUQxn6Zz/Ws0niljzuVhjg4q3sKnua16TKAM4q5Yp5VrhTxVSFg0a5PTvSG6LS+WMgDjINc7PRpu6sTN8xHJABrQtIwyfN931PaqVuwL7VGT9K2AnmDYOFIHI4qGbylZWJVkWCAFRuJ6VetZfMRTI+wkcDPWqqRCODanboKzlEkt6rnOR1HYVG5EbSubc0YlULI3IJOKsWCRmVVTb8o+7nrWfcXAUAA5bHUVUtxJ9oVw2Tnn2pxdndjUOZas3ryPzrhGjb5R8uKwixRipGMGtO8u2ijG3hz0rGeRmyXIyxqk+bU1op2LBkULuU8/Wuo02UR2kYncBmHAriedwY4x1xV+K5LkMXOR6VVh1Ic6sat7tS4K7889qsW0cTAgHDY5GaxWlBfzOcmmWt60U4JBAPrQ0Dg3GyE1O2ZHOM4zwaynHXu1dU08NxHgsvuD2rLu4YyjFflIHFRcUattJGVFIV4RRx61sabLvHIx9KyrW3Ej7iSADWnFtTAQd+w60mTWmnoabPuxzxVe5mVUGRkGmK3HB69qr3LAp14HvUo50tRhVAuUVVB7CowxbPTFV5nxGVDc44qv5+w9QfpWiCUS4xwpAaqtxcFcANhgMimCcsD9ao3UoLEA4Yd6q5nexfluysqMpwK734jOtz8KfElyh/1mj3LH8YGNeWGYMT14rt9ZvfO+CviBGPP9i3H6QsK6cO9zjxHQ9xoooroMDzz4wdfB+cY/tluv/Xjd15wQZbiSVAFVmJAFd58d5Gi07wsycN/bBGfTNldj+tef2EjMAoAwPaues9Ujqw0dXI0kjYKG3fhUrsXUhuQO/em2s2zCyYA9KtsYzkg/pWF7o7ldGTKF2naSO9cP4udkQsD05HFd/d+WuSvJxXE+J4i8Eny9jisJbhLYw7O53BZByCAatPdl+O1c1otz+7mgb70TY/DtWlHISfer2djB9zVR8nk1ftyrD5to+tY0UhOOhIrQhcsAM4oYjYQ4wFki/75pzcn/XKcenFZ0cm3AJb04qZXUkZUN9TSuBc3cjeysuO61NH9mADZA9QBVCM5JOMD2pksgzg8iqTKi7s3oZLdjhWPNWRbQs6kPzXO2pjwS3UVbgkiD4+fHc5pXNGkti3qCw7yGAxjqKhtjCDwMetVb4RsmQJOPeqkIGSU3D8aLkxehtny8bk6fnUUkwA3IP0rPVyoPzgEc8intJkDcVwaNykXhcEj0P1qaK7ORyufWslG5OSv1zTdzhjyOtDK0N5ZATlm5q2rttyDxjmsG0chvmq/HNweSPr3pGE9zSilDLgnmk8xMgAVQRjuJ7U/zQx65IpWJHXkgT5j0rLkutshAPHYVcv/AN7EV/Kucmdlb5s8cUykjZ+0bl+Xiu08X/8AJs+if9emi/8Ao+2rzi3kGwsTgAZNei+LTn9mTQyOhs9FP/ke2rpw3U5q/Q8rzxWndx2aafbSWkjtKwJlVj91vasgmprU5Drn0rTpYiO5YguQMjPSrFu4ZznlieDWVKGV8gcCtXT/AJ48kYx0rBo7oOyua8SEHeh6DvVy0nGZMn7vJ5qihYJgdasBQ8foT14rJmykrFn7WZJAsecetWC4dsHAY96oW9u0eSSD+NThtjgYPTOamwNq+hMF2uTJgg8Zq1bxop3oNy46elVVcLycY96cjryycH9DQHM2TXcLT4KHkdqp3tm0dvvPOO1Xkf8Adlp/lbrnNRS3ubeRQAVIwDmhGkZSWiMncSucZPaiG5CjBzuqs9xliuBjsaYsi55wK0TOg0jOTwPxAqOWYVDHIiA+9QyuNxwQR6elA0x63TQ3C/OTz1rY84PhgcjFc9IAU6Ensa0LUPFEokOQf0qGjKsk1csqQrHAxnsKmV8DnnFVmIUZIOB6Ukrg49qTOZlxbhSMMOpqGdwdw6VTLHPB4qRsFQe59aEK6RUmDluW+X1NU2mAyM/MP1q3dEADvnjisiVhHLjnpmmgcrlj7VhghyGNQTSZJzwc9KqyTfvBkgHtTWbJzmqsYyJi2ATWtq1+yfC7W4jxu0u4X842rEc8Zp3iicp4H1aJe9hMPw8s100TlrH1vRRRXSYHl3x9JXTPCxAyf7a/9s7quI0tX3b3yFIzg8V33xvjEtt4SQqHB1roT/05XVc3HEqJkxRD2zmuWu7SR10HaNhFs0YB/NGafLaMFG0qc96YdQETBVt1HrnjNLeXhkt1kTcg9jmsGdK5lYpXVnIuARhe9c34htf9GYZ7V1sd350OCd5/lWHrgDRMOg9xUO3QmUpbM8O837B4gZGP7ub5T9R0roY34GOtc148xb329OqkMDWjp12JoY2znIzVON0mKPY6C2YEjNakXQY/nWLZyLu6cVrxtkcVAmiyuCcjjBqTdg496qISmATnNWFUBelMVhxkIwcgDvzUJk3OdppzIWAJHFRyAg+lMuLLUEgxjrWhbNuAwBg+1ZNryemc1uxssdv0Hue9BUmPuVDQkfmBWRGrozbe/Aq016rOVGB/Wq0k6HIGR36Ur3Faw5wx5wcnrio3yODkA9BUsM4A2lTnqalcLKgKjB96ZSZRL7eCfpzSrOd3Wo542DYHIFRrwPQ0+g7m3bOJUAbqKsI2G5OTWXaHjnrVoSYAyeh71NrGMtzQSUsMhcH+dNYkSbl49qptMShIPFHnEhTniiw0i27bhn1rHvVG4noav+Z1HtVC7cF8UAjC129+z6W8cZ/eTHy1/Hr+lew+K+P2X9B/68tE/wDR1tXz7q90bjxA0Kn93Bhf+BHk/wBK+gvF3H7MGh/9eWi/+jraunDq10YYjoeSPJinWU2Zynqpqu5yaLU7buM++K0MYvU1xEJUAIP1q3ARCAOfSo0IX5cVFOxByD2/GsJHUrmolxnjj2q3FcBcDIyK5+BizYYk49OK2LKMswOBj35rNmkTVgYk8qeasSIMAsR9KjhUKoJJz2qx5SvgtUmpTf8AeR8dDSKpXAzkCrRiXBA4FZzOrXOM4VTgc9aLlxVy9IC8BXcV4rMmJQGNWJHoat3shWPcOg71lSkM2d3X1oRtSWlxDES2VK47imGJcFgxxnnvTWQfd8zJ9jU5iCAFeR6E9K0NCpIpVs+YdvvTUjkDblcEdatq8W4AjnHPrTQUBOPu0hl61DSw8AbgOuKbHLMhMcq9/Wk0518wheM1bMJmlIK4HXdUmLVm77C+Uzxsh+6wxSNG0MQUqWx371chC7duRxU2xWCnI9elTcwehkujBqrzuyHnHFa00S85OayrxFANIzloZs07HPI/rWfcEFsnnPap5zknr71n3Tfu2C8EjqKtEdSME5BboDUyNnHpVRNxTA5PerCt0AGOOvrVCkSO3yn2qj4huDP4T1cj5Y/scwHq3yH9KnnbbGfWqOthv+EX1gyHLfY5sD0+Q100Tmqn2lRRRXQYHnHxoXfH4QXAP/E6PB/68rusS1icnISPA9FAroPjAu8+D1BwTrR74/5cbushYnReFz+f+Nclf4jqofCT/ZoyhaRI8DndjNUJ3gL+WkakdMgVOzAoe49BWA135Vyy+U2CfQ1g3Y6Iq9y5cRxxK2wKPpxXHeJLhgrbeOK3L68ZYyccfWuJ16/JR+eMVLeuhKTZ5n4jt5dT1SO2j+/K23nt71Dp++ykNtJndESh/Cui0CPztamumHyxLtBP94//AFqqeIbXytYeQD5ZMMPr3rW2iRHP+8sXtOcsvvW5Ax2gHg1g6ZwMZrZj5QAckCsmtTZ6lyBG3M2ck96txnPy9CKrQl1jGBknvVlTgcYBxTtYVrljjAx3qF49z+gFIGPTPApJCzNyc+9MLWJ4nSNsKBn1olueSACcdKrdAcnnvxSiQMvy444zU2F5j1ZXJx07jGMVWvCwddp6HHXrRI5GQOvUiqdy7FtynB96QNmhHI23pjHrViKRyc8471lWxcnBIP0NaMBJcAnr3qh81i1MNxBx/wDXqBQpcqwNWlBfsCOnFIyDOcU2IYB2AA54p5Y7PmGffNO4xuxQw3ZwM1KEQRs2/ah+XvVgYKAdGHWoWjIwyd+tMMm3J7ih3K3LBkArN1W4ESs2eMZp8kuSz54Paud8T3EkkSW9v80sxEagdyTimtWD0OV0G4+16rdSt1eZm/DNfTPjH/k2DRP+vLRf/R1tXzJpdjNo+s3Nlc4MsUhBI6HuDX014xP/ABi9op/6ctF/9HW1ddL4pHNWd4xPG2aow4WRT6EGo5H5xUDvVGFzqzIMZPtVq3i85ScZAqC0jWW3jdupUGtKzXZEdo9qwmd0WnEZHaBD0rRgXaB/Wq9sCWJZsnHT0q4pVTnAyKyZaVi1DnjjNTSu8EbOOQOetVRPhcKSp9aVpvkwTk461JomMtbp595I7/lUUkQ80uAMZoD4UhQPc03zCRk/lQU3roMvGPlEHp3rE3MDt3Z78VsytleeeKxJImeZggOKC6c7aCbwrZB571Mkzuh8vqKhFpIZNvGCfWtO3txGCAnbk+tUW6iWxRV1OF3/ADd+aa0U5+44I9+KhvQIiXVGJNJaebNgjdigvm0uXLMTiUN6HpWvb30jyFXXp0x3qC1j8tdpOTT0t9k4ZTgDmpMnOMr3NJTwCDg04ycYL8VVDc/Mc5PBqJyV5xnHvQY3LEsy4ILE/hWZdOpzgsajurt1Hyng8Yqr9pHQ/jSsKUXYikTIPGf1qlKm5TjFaJGVYoQf6VWlUAEZ5qkYFBUKL6k0wsQKnkHGfSqkxwM1aE2RzyZKrmsrxPqSwaBqNvEN0j20isf7oKEVl6tqzm/kggkCBPlLe9UtQDHRr88EfZ5OhyPumt4vlVjGSvqfoHRRRXSc5wHxZ5m8G46/203/AKQ3dZ7OSnDAHvxVn4zyrDH4Rkf7o1o/+kV3XN/2ogQbCBXNWXvHVQV4l54WAPz81nXVqzHLKfrxVoXqNCCzdfWq1zertwDwa52mbrUwNVtsIfmxXnniPEcT85I716Dqk5KsB1PevNvFreXbyEn5jxzWdrMtbEWjhIbVQGDFvmbB7ml11POtFccsh6+1cUjyocqxBHoauwX9zlY5JXMZOCDzxWntLnJ7N83Nc2bBgWCj72a3IsAANkHuao2Fj5ZEpjJxWotsxcsQeeuaJLU6o6k6yAABasxKrLuJ59KriMIPmG0UiyRhsk4/GkinYuNsPQULInA4GfaqRuo1YgHr71G8+AQpz64oexDZdkuEQkKwPvioPtCSSZGeOgrPYM+Aflz71etYYggZiSR60iSeOPfuJXlvSqWoRNAykDgVsrPHHGMAAj0rL1O7iYDpk9aEMZBhgCuAPapxMc7TgiscO0b/ACAMp7Zq1HMG7EN79aZNjXScgY3DI7VIsucH1PNZibiMkZx1q1bFXBGTn06ULsUmaSglR6U1lYcrSKzI2Mkj3FS+aMc4pCIRIVYqVH402VPMUlRxirJ8uQjGPepURSdvQYoZaOfuQVUgGqXha2F54gmmnXctqoKezH/6wNb2tWQFs0iMAeo96reDIwthNIR+8eVtzeuOlUjGtL3TmfHNt5HipLhRxcRKc+44/livcvGf/Jrei/8AXjov/o62ryvx1aiaGzuMZMUm0n2I/wARXqXjdtn7LGkMegsNGP8A5Gtq6aTvcwm7wieIOagkNMWcOSMEfWmyNxVJpq6MmraHe6V8+nW+e8a/yrSjwp46GsXQJd2mW/P8GK0zJjO2sZ7nVB6F2HaucDGabu8sHnOTmqf2nBwePamST4XGfpWLNVIuedhsMaQXO5yBwP51lGcluoINMFzuk2/3e9SWmbfm9VHQ96iaURjJbj3qkkpOc8ikn2TLtLc00Wi35u5d2eKjkuERCx5wKqySCCLB6AcCobppJbcLEAQeTRYLdSL7c5nL/d9BWja6ooXbIMtn06Vz/mfZplMwwQc4q3JcRMwmUn5ug9Kuxu0n0NWa8glTEqjPpTjIEMbxr+7Irnp5iZMhSQe4Fb2nyKLWMMMN2BpMmSUVdFm5u1gUc4I9aSDUdx55rG1G4DTMGwR6Go4JQzbVJFKxaiuU6gXCyfcxxVea4CyYYg5rMtbkRE7/ANKsG5VmU7cgc571JhJcrJJo/l3HkDnBrPlh8xiQcA9qvNMGQE96hdlXJGOaEZ87QwttjA/lUMjqVB4+tI7fOelRuBtBxzVJGbGTMMHFZepTiC0llboiFj+Aq7LICCgPNYHiyby9HlGcF8LWsVqSzzu2u2lnZ5T+8ZiT71q3cmdIvNrHBgfj/gJrCliO7cvBzSy3ci2c8b942Gfwre1zM/S6iiitjmPMfjwQLDwoWzj+2u3/AF53VcKZoxjBbP1rtP2gX8vSPC7emtf+2d1XnlvIXPU++K56vxHXh/hNH7ZtQjGT2qJp3fjH51JDbhhkdPcU8221sjAJrFnXFozLpsBi2cD2qloek22qXty95AksCrtCOOMk9f0rVvIJMHbhgOcYqx4ctrq0D/a1VVnbKgdjTpL39TDEtqDsZF98PNEuSTEk1sx/55vx+RzWBc/DGSKQS2l8kiqd2yRME49xXqoSs7W702cSpGR58nA9h61rOlC17HnwqTbsmeTRaosZKNkMpwRSza302qBiuhuPB+mXzM0sJEzkksjEHPrVKT4awtzHf3Sj03dK5mmz1ItW1Oen1aaXOTj0qs14WOWPIrq7f4bQFsSX10fbditK2+HWmRg73lkP+1IaXL2G7HBLqAAKjBJ4rRsLa5mO7y5EU9yMflmu/g8LaXYAGKBAcdep/Oi5tbaLlX4HuKLGbZz1tYRhfmOT78mpJwIV+X/Cpru4hVfvHI7CsmaZZMnnj1NIRHcSys2McetY2oM6Hgk98etaskoHQfpWNqbMWyvHORT6lDra8QgKyZrSiUSj7shUjsKybcqRkrz3zW1YzmNl2K2Pah7iJ4YJ0wY2Zhn7rdalkuCjfNGwIrVs7yPA3rjP94ZrRRbaccwgk914p2Yjl/7VaMbSAT2zStqCSITyn4V1iafFgAR5Ho6ZFX4NNjCjbDCue4QCjluUeeHUjHgqDx6CnDXZd2Nrf98mvRzpyLk7Ex6AUkenqzDagANHLY0Vjz+41oSWzJLuUkcZBFavh8CPSbfHAYFvzJNddqGi29xaMkqLyO/NcwkYtSLbOfK+UfTtTtY5sRqtBusQi502aIjORx9R0rufHADfsraSG4B0/Rgf+/ttXFSkGNs8V2vjv/k1fS8HB+waP/6Otq6aG7ORvQ+dBclWBY5I4JFWRIHGRWBLLIlzNFIMHdn8DVyynyuD2pQjytxKbulI7zw3c5shGT90kVuiYFeDXEaBc7ZJEzwea6W2lBjGO3FTUWpvB3iXpWyMn8RVYuxGc8U1pGD/AOzjrTHYY+U1gy0DP145FJGxI/nURYljkZpwlAyCDmpKQ+8uzEgVe/WqKXTs+ATxznNV7590m4njpUMcwXIFWkdtNWib4aO4RQ7YbuPWrjsYoSI8ZA4Fc3FcP5imNc1uKXkUYHUdKTVjKroZOobmmBl6kflTo95ixjCdeKh1dJFnAIPSmo0/2UqVbGapbGql7qZcGI9pZgR2qaSYsuQ1ZEbs5+Y8D1qdW3JhjQWSTZkzkjNEL7CMEEiqkhI4B4qMsU/+tQM11mGfm61agmLDHX3rmXeR3AQ5rbsQyQDf97vUtGFWyRqGQA49BUTOCMVAZcDJFRB+vWkcxOXGTntSM1QmShn4qkIZIo3ZHeuS8amV44EjR2QEsxVSQPrXVs3BNbHhyPFnI7D7z8fQVtTV2Z1JcqueFsiFvmcqfQjioryBBZzkc/u2P6V9AX+k2OoLtu7SGQepXn8+tcL418D20GjX95pkrRCGCSR4nOQQFJOD17VtytGPtEz7jooorQyPJP2j3Efh7w056DWh/wCklzXmNjdZX5gAMce9ek/tMHb4Y8OH01pf/SW5ryHT5Q8YDGuer8R2Yf4TstNnyoySfrWnuA4bqOuK5yxYgqT0J6k1swvGTudt/PArO5uSKQ9wuB8ucn3q/cjenX5hz9OaorKd4Y4BPQDtVl3Ee1uu71pBJXLyzotm08hwqKWb2x1rkDMt7dm7um5Y4Vf7o7Cr/iWeWDR7hYxlXI3Edhnn9K5hJWfbs5FVOpc56FDlm7nVeYq4aNQx6ZpJpXMeRxzyKyrW4lhGQPwNSNdk5LA/hWd0dLXLsPa8kHTim/bZSM5/WqksgkH3aI7dioOMe9CYucsfbGPBY/TdVW6eN+GiYn+8ScVZjt+29tx+gpXs5pE4l2n86TM2zAuIYxn5fwAql9mkYnYmF9zzXRnSyH3PIzn6Cm/YfmGVHtk5NJrqCMAWgx8/FZ91YCQ/KDj6V2oslxiRefTtTX0/f9xGAx9AKEM4iPT3iGU3AercirlvACcPGee611UWnbeC233I6/jSjRrhm+XypPTsaBMyLSyLY8sk/Vv8a17fTpSAynH0qyml3sGN9ujr2OCf1xVyBZI8ExsmOy0IVxbe3lQDcxH41pwJsXO4t7VAsxGOv4ipBeKo6ZPtVopMs+em3AB/GpYWMg2oMD1NU47lHOHBx7VbS9hiBAzTZd+hNLE2MHn1rjPFFqbV/tSc7eSPUV1Z1BXyMEetYnihg9lJgZYjAHqTSQnG+jOdH+khRHyhwxI9K734gHb+yxppHaw0fj/ttbVymkaf9mtUixnjbk9e1dZ4+AP7LemA9PsOj5/7/W1bYfdnJXhyRSPljU2IvkLcMynIos3be2BkCl8QMrTRtnLK+M+gNVoblrZw3VCeRV1rxndGVJc0bM6bSJ9l0M/xAiustn4yP/11w0Lq4SeA55ziunsLncqkHqOKyclNXRvBOOjNiV3CgR4x39qFbgDvUKMcjbjB5NTYQsF6OegrFo2HE+nWo5Imfvj6VKsTA5bgDrVlVXjAz7UrFK6OfvYmDN1wKqQAsxNb1/atMfkXB74qrb6VIHGWAqkzeNRW1H6bbGVCxDYB6Ct+ECNMsQvsahgItoCqgZArGur6RpT1x6elS9RJe0fkXNdw6oqfM2etVohNFbbSuD396W2uSWUEZHU1auXBQMIy7dMUeQ2+W0TGkTnIHWmlmHynA/rVyR1DFChUH9KfeWyPAkkZ3Y4PtTua8xmk56moZGG33p8+EYqc5qBkwM1Q7lrS2RpCGHPXmtdOB0yKxbNXE6bQdp6mtsAgVLOarqxeuP7tLx1HAFG4A+3vUbMCvGMUrGYMccnio3cAdeaYCzocrjHvTM8DNUkJiu5x1rqdLQRWEKkjO3J/HmuXto/tF1HEOjHn6V2AjXGAOBXTSXU5Kz6D91ZHjD/kUtb/AOvGf/0W1a3ljsayvGEePCOtnPSxn/8ARbVuYH1jRRRSKPGf2pm2+DvD5H/QaT/0lua8X0e5xtDAH1r2D9rMlfAuhFeo1pP/AEmuK8A0a5JIy3XqDXNWV5HVQelj0O1uCRx93OKuLOVGFyT29q5/T5sqpPSugsdjITjLdqyudi1RbtnfzAvLMeMHtWzJD+7Q9WzjrxVO2tTHgp948s3p7VeQszMccfdFMmWo66t1ntzG/OeCMcHiuEkt207UWtXLbfvRn1Hp+FegR7g4DDkZJ+lcx41snltRPbgmaIlxjuO4/LNZyeo13KQmySM/jTd+4cDP0rHtL1JogVk5rTt7uPbiQ0XFInBJ4USA+wz/AEqBmmVsN5uAc1p2t9BnjDegNasFyjABQqE9wopoyu0Y1k8knS2mfHftWlAk8gwYWUeprViZyc+YzflU7uQwBbB+vNPUm7uZ6Wc5XIRAP7zH+lNNmwP752Y+ijFaDTBCPmXGPXNV5rqE8KQ7Hp9aLDQtusa8LGFPqTzTJ7QSnqef9rGKpTXUsZ+UDjtVBr+6OQAoxzxzSvYa0L8mmSAExSsMc4zmkhhuoeSquPbrTrTU5NmJSjZ6Yqdb8g8cd8UJXETQX7Ip8xXX9ae88UmGKnp1pwvomiB2hSOvFRrLHJ2AOMZFNoLFSSJJHO2UqR/eNQlzHkExkdiK0pYlVTuRWGOxrOuIrdSfm2j0phchMyD7rY+gqL7QF53k1UvWiT7hA9xWZLcKnRyaTZtHU3F1Ahwd3GahF3/aerJGv+rhG9vTPQf1rnbi/WONmZgAOa0vBZL2kly2N85L8+nQfoKNLFysjpnIRwvQAnBH0B/pWv8AEVtn7K1g/pp+kH/yLbVhTODbbiPmA3jHscGtf4nSbP2S7WQ87dM0lv8AyLb1vh2cOJ6Hy3qrLMqn7shOf/rVSuZkWMbjjJxWPNeySyqR2PFW70b7RT6YNbVbSaOel7qZoWN29q+V5Q9R613vhySC8tQ4OADtz6d680gJCiu5+H88RFxbyHGWVxWDhZ3N4SvoddZmLd+8IJBxuq+00AcdM44ao5tOz80JLA84FMELIRuyuP71Zs7oKMtSWSQvmNlx+HaiMuJCQDxSJK/zBkHy9GB60kE7ysdygYqbGjSsT+cWYgDr6Uxid2T+VWEeIrwqhqilIyecVJzS30IGlJz3zxWbcKUcDaWBPGKuS/LnJG3HGKrTMyru656AdaZUZW2JVZIwOACKePM2sUP4ZqgMgDdVuJj5fDFR344osTfUkm3SQdAzg9aqRGaE9CVz0xkVZgV0LZbOTnipsjfjP1JoNFUtoNnt4pSCygMaga2hYjK4xx0q6nzP0GPWpPLQ4B496DNSZXhgVRhVwKspDkH0qxDGuNoIxVgYQAY/KkIy54Dt4UfhVQ25znOF9K3GljboMfhVadk2kHFNDRllSowMY96pXTj7pHetCd1OQrcjtmqEwDOMAFiatITsjX0KA7DclTz8qnH51tpIe9O0zZbwJDsAIHOBjPvV8fZpDhwob34rtjGysefJ8zuU1k4rD8ZXo/4RfWY/71lMP/HDXWT2CGLMXDnpk8Vwvja3kj8PaqWwf9Em4HYbDVPQk+yKKKKko8K/bCmMHw70WQdV1qL/ANJ56+bbK6GFeNvlbnivon9tNivwu0ph1GtRf+iJ6+T/AA5fM6tA5yfvL/UVlUjdXRpTlZnqOn37Er6V1ulXW/G1fSvONJmCEBuc9M11ml3gR12cGuVo7ozuj0C3un+UMfmJ4rUQiNkZifUVyVleMI/m5bPf0rWt7uSZjluAOD6UDfc1mlZmGw4P8RqK9ZZoyoIPUccdqg88ghVcZ4LEd6ReQ7H6j/69FhJnk2vBtG8QSQbtkExLx57HPI/z61ctbmJwN0mfxrY+Jnh3+2dJcRDbcLh0YdQa8Di1PUrCdofOfKHBDHNFOHN6kTqcjs1oe9214icKTir6assZHP414RF4pvlGGAb8cVL/AMJbMSd6OB+da+yZm6sbn0BFrSkDLtnNPk1ETZKyKp9Sc18/xeLJScAuOOOKu2/iyRWDeW0vszEfyIpqjJidaK6Ht5uh3maQj0qX7YEQs5Cr0+leT6H40vb/AFixsg1tZxTOELmFT+pBNenareajYaRdTXVxYRxCKVjKkeSpUjac9euPzraOEbV0znnjOV2sF1fgqDCpPHUjrWQZ72WY84QnnrXM2fxC1G6t18vfuAxkADNW4fGGqyKMtKDn0q3gf7xH1x/ynW2scyjBk56jPSo7m5e2bcJF9wa5qHxhqzeZhtwX0GcGqNx4t1Vw2+GGUHrviT/CpeDt1KjjPI6xfERUhZJAF9jmrC+IoF4Mo9+OleV3+sl2YyWYDdzEdv6Cst9Wfny4rg8duay9g11N1iU+h7rb+JrUKf3uT79Kin163lJXepBrxTQri51bWrawDPD5jAkStsLjPQH1Oa6nxV4f1PQNHF8bZwoK7iLjzMAkg59Odv50ewk1cn6xC9ranYXt3EwPlOPXlq5281DZuJZcj3rzuTWLo8rFj6sazNQ1S+ZCC6qP9leaz9nrudCqyir2O5fU/wC09Sh06Bt5kbMhHZR1/wAPxr1XQ0W3txHgAbDj8s15p8IdAdme8vATPL0z1Ar1xIAuFyOg5+uRWcrc1lsXGTkrsaZAEi3fcBdW9D1rc+KADfsj2y9jpelD/wAiW9cjcuEiIViGjkz9eldf8TPm/ZKtMd9L0n/0Zb1vQ6mGJ6Hx35SquAKsSDdasPY1ahsGk5kIRO5NJewLBhU3FCOpGM1UpJvQwStuVLT5lA717d4K8HwwaCDcr/pdwod27p6AV5v8NNG/tPVHldd0Vsu/B6Fv4R/X8K95sGaKCIN1IwfrTqM1ow6s4W5fUNEufLcFkz8pPQ1N/bH2qLZcR8+orvZ9Pt7pWEyh1YchuRXO3nhCNmL2srxe33h/jXPfudPK1qjGjuAG+U5X3OKlD5YnAH4g0s3hy+iHDI4HcHH6VUNjqMRKiM49cgUiueXUttMq8LhqqySs3Q805bKdeXQZ9QQalNu7IA+8fhRYkpIszHeRx781MIWbO79ak8oxc7mOeuRVeacJ1fn3oAe64B3Y9sVXSRomO0nae2KqTXbHOMZqul2S/wAxwT2zinYGzbEynHPWkMh6A8e9UYxk5VyB9cipAZNp43D2FKxNy6k2FI3c9sUyOUo2W5qkriPjBGfY08y7SDuGKdilKxswXSbfmG0j1qb7QrDqPYiuekvQBjBIqubsnIjDk+wosSzpXnj4yaq3E8Z6EGsNvtsmdqFR6ucVC1pdvzJcKi/7I5/WixSTexo3VzHGmVxu9SaLXfIRLggDlfeqdlp4MoJDysOdznNbvlhFVSMe1UtAlFrc6O1mElsko6EdPf0q9ax8YIBJ5Nc3olxtuBDIfkY5X2auvtUGB6niuyD5lc86ceV2FuX8m34+8/ArD8aWKf8ACD6zK2fN+wzsPoI2raXF1elif3MQwD9Ky/Htwi+DNedyFU2MyKPqhAH61W5J9PUUUVBR4D+2mpb4XaUFGT/bMX/oievjK0eS2nSQArg5zX2z+14u/wCH2iL/ANRqP/0nuK+UzaKQdyqfrWcp8rsBcsr9ZY43XGD156V0Gn35R02jt61ykMAhyFACnnirlu54ye+M1g/I6qcz07SrxpUBc8g8DNdFbTbQAGw45Nea6NdGJwGYk4xiussrlnxhgoPUms3udCZ2FvIpX1JHBq9EihSSfvc1zltcnhUJJI6+lbtrNHdRqqZJ746YFC7hYju4nljkJG7ggDHtXhPxK8KyWUralCnyOf3nt719CopQgE/M56deTWV4i0uK+0uaF41dCpHI4NF2tUKUVJWZ8sW6ZPIqZ4VwTgZrW17SJNE1NoZAfLPzIxGOPSqahSAeSD6c1Tk9xRjFqzKQiH92rMCvFyjOh9mIqYKpPGKceFapc2aKlHqLYXs6X9sXnlZVkU8tnvXeanqEs3h2aIyZUxSj5uSSHU/0rzpBhweuOa7pYRJZyqpHzGRQD/tKcfriu7DybhJHm4uCUoyOVXUbmPG2QKP9mNB/SnDUrth/r3APoqj+lQeUQo+lKEIUcflXE60ujPRVGPYl+2z/ADDz5RnrjAz+lRmeVsgzzn/gY/woWPk5FPEZBPy1Mqz7leyj2GbWYf6yY/WQ1WlX5sHJA9WJ/rWgkfKjAyajntxuYlgPrUKq7jdKPRGWpNvqVvLD8skbq6keoOa9s8TX0l54fv4nVjt8xfyw3/steLzhTdJg7j7c16jrOrIdOu4sjcQ49yfLI/rXpYeX7uSfY8vExSqwku/+R51MAQeOferXhjQpNZ1ZDIh+zxkM2f4j6U+z0m+vZ4IhBJHFI2PMKHGPXmvX/COjW+nqixEblGOfX/Oa87WOj3PRnOM9tje0PT1tEDRxquOgA7dakaQF5UJJ+XgjsQRVtXEaEM53Lw2O1VpYx5uQeSOopXEc7qZJkJXI3Dg+v+cV6D4/Xf8Asp6ap/i07Rx/5Ftq47UYkjOGGVBPPXBzXaePAT+yzpe04Y2Gj4/7/W1dWG1umc2JeiPnCO0QBnYFdvAz/hVHULNJYzvYkY+XPGK2WDudrOAO/XJFLKvmOU2qVAycmvR5Fax5vM73NL4bINM0K4lcfPJMTn26Cu+s9SjmtwygFh1A61wmjM32WS3b5cnK1paYt1BOjY4B5OeorimrOx69DllBM7K41EpatJACx6c9qqW+tEFfN4PoD1pguUk3ADb2INZ9xZ8sYmBXrg1k0dEJxWjOmi1OCUAMCOOtEwhmjymG+uK5WMvGejD2xmrUUsgOQSF+lTyocuXoaNxbQEc5BrLnjjBxv+nQ1NLcNt+dNw+lZd1KrdFH5UWMbkV1Ps+XfGfwNZU77ic7fyqS4Iz8oJNV/Ldj90fnTsSV5mG05IHt1qlnD4Zfl+mcVqtbZ4PX6Un9nhs5BoGlcbarDxh8fnWtbxwY5cg+u/FUUs9gBIyPWrlug9Rx6ikxWL8NvEwxuz7Zqx/Z9qeqZ9gKhgToBn8qvIr4+XOaVhkC6ZEMbYiPqKeumr/u+1XI1cKCzHPvUm8DljzTsWrIzf7NRgQRiqraconwcFRWrcXDKPkAx61RUSy7iSRzzRY0T0GrGiMFjWkdM9RxVnb5SnJ/Oq0ko55GOtUkYSdyCT92VZeoORXXNef6GjJ/rJQAvtkcmuH1C7WGPdnk9Peuj00uYomkGGRAoHpxW9LRHJXWxsxv5UQiX6sfU+lcF8StWivNH1OytZ4HaCGQyp5oDA7T2PX8K3PEmsLo+kyz5Hmn5Yl9WP8AnNeOalY3E2mXl3JGjsY3dmLAN0JJNa3sjFI/RSiiipGeH/tcHHgHQz/1Go//AEmuK+XshgAefwr6e/a+yfh7om3r/bcX/pPcV8woM4HesKu4CFM1XuHEDoN2A/er+04rO13Edosm0HDdxnsayitdRp2LtjdskgOc4xXc6NdJJErHgdCM15Lp9+M7WfHof6V1Oiak8T44YMfrj3qpQsdNOdz1rT2Rzvj6EdG9K1bG4e2wsZ5kwCB2Fc54fukukXLADHzV0A2ONqHtye9ZHRujaSRXjDRnLdFP9ae8gni8mMjI7n0rDsbrbK8W4bVGRz0FXVbZmTlQ3Y80vJhujB8T6cBbS3YRX8peARkMB2rk4LPw/q0KtNp0QkI5MfyE/lXpWrtF/Y8zOQQEOQB0FeN27x2GpG2nBjjkYlWzgKT2+ld2DmleE1dHm46GqlF2Ztt4H0a4iBhuLq2bHTzA4B/EVm3nw9UD/RtTy5GcSQj+hrYgnjZdhcqVOOvXFaIDRQ74pDkjvXpLDUZr4TzfrNaGikzzy+8DaraoZYvKuEGc7QVIq5pOVEaTRTtN+6bYqEkkYBwfwNdx9ouBE0kUnz4BKseG9q5O/wBSv7XUZYLe9vIVI+WCKFWIxk4z9aiWGjT1gaRxM6mkzCh8Pane317Bp9uk62srREmQqTj2NXrbwTr8pw1lHFnvJMRW5aa3aaZqHmx+aruxZg/O9X+YH9a7q01SG/gSSBjn+7nH4URy+jIqWPrx9Dyq68D+IrblrOF165WYmrFp4D1y5j3gWa4/hMjE17DbPztcbSRnJ7iqep2TpJ59u7Ybqq0/7OpLUh5lX2ueex/De/IU3GoWiA8fLCWx+ZqcfDsRn99qjkf9MolH866ee7MZUeVknPXJOami1hZbbypFPmAHB5ParjgaC+yRLG4h/aOCl8HWFhObiWR7qRcBI5pdoLZ4yemP8RTNAhlhnmvLxLdjHkkLIHwzHJPH0rsprbz8ARgxsOpGa5PU1VrpNNtJk8yRvmSLoF75qKlONL31okVSnKr7r1bOi8PK2oxtfSkhWfMa4/h7V01nHlgVAUqfyqno9obfSdgAGwdMVpxOH2sg5I+bt+NeBUqOpJzZ9BCmoRUV0JIxiVnYk5OOP51WvrkLF83yt3x3xU8ksaxkhgAv61j30nmZI4BOM1C1KuQTTMVkEh5/nzXofjs4/ZX0o+lho5/8jW1eUXsjxZQMDtNer+OMn9lfScdfsGjf+jrauzDbs5cS9EfPahWVpXBXPTnnFPR4okZlJG71OTTXErjC4x0zmnynDKFj3Z4+lekeYhbaRodshLYPPNdRp10hgUhgF6c1yspYqECEqSBkjAFOtbprSfyiSUJypNc1aPU7cNU+yzug4b2NKVbrmsmzvvMwCavxyMw4bH61y2OwlIUdZADTSwAJWXcPY0yeBpo+m7PoKrR2cyEKikj3FIqNupOSzYGTj2NQvZmQ8yNj6VcSGdU+6KeImAzyDQF10M7+z1XHGfrR9kVOCAvvitBo3JGXIB4yBT4YPLOfLDP/AHm60hXKAtnK/u4/l9TxmnR2IPDsoPoK1WkUL+8qJXjYjlSp7YqS1IiWxGwgPg/nTBprk/LsY+vQ1eEKkqUOB7HFSEvEMnBX1osQzPW1mhfDRn+VTxs69Vbj0q2t0mMEmmuy7sjinYCMyKcYBB9aimuYkIBPJ7U2fDE/OM/lVGUgclh061QJlg3Sg/dyfc1Wn1Iqp2qAazLicKmSxNZ814AML1oLtcuX98ZcmSRgMY2rUKahCluDk46CsG5uGZjuYYHYVQln7A8DqTVpXCTVjorTzNX1SGCMHYG3N7AdSa9DVVijCg8DvXnXhrxDpWjwTi4kaO9/iDplWXsFIrp9RvP7a0OeLS7pIZpk2rIfmAz16dOK3hE8+q3J36HAeLPEMesa66W0uYLUFU9C2eTWOt9c3Gl6iWELK0D5+YggbT0FQ3vhLXNIl85rVp4f+etufMH6c/pWHemaBZNoby3UjjtxyDQ1dgnofpzRRRQSeCftmMy/DLSChw39tRYP/bCevkBNQvIzw7HHvn+dfYX7ZC7/AIbaOvrrUf8A6T3FfIQt+eKiVgJY9bul+8ob6r/hUk2sJcxGO4jXaeuCRVf7OcZo8gjHGahqIAqWTEFd6/kavWciQyALKWA6Z4qh9mB6xg/hSrbAE4Vl+hpbjTtqjvdJ1t0CruII444z7muz03VQ6AM2eMtz+leQ2E+0qjnkcZrqdL1BYYgWwc8gE/qaylHsdkKiaO6kvDGwYEFpW/HArrNMkkuLZN8TiY8DeNob6E8V5Rbx6lfz/aoTLFEqjao+VmXsQfT6dc1oJreo2sgX7RLIin7jMXXn2NJRi9ZGcq7TtE77X7q3gs4IJojJHKWSRsjhuhAH3gykfjzzXFXfh46lKls5jkSZc+bH/d7EHsc/lViPUrK4864lQ/aSNssQA2TMeN/+ywznockdq7Lw7bp9mM82N5UFuw6YFDbjdIinD2r5pHl95o+qaJ8t8GkgQ4E6rke270q5Z3cz26iN4pQByoIyfpXqdzF5yP5q/K/JXGcDtXnPinwfOB9q0T7oxviHbBzkV1YfGOGkycRg1JXiR2uqMsjLcRNGVXoyZHrWbdrA1xBcqs8537iFJU7c4x+ormb24vLN5YLhpIJSwZd5ZRjuOeD9a0b7WQqwkyZjEJQ5kQ89a9WGJjKJ5csM4y0E8TQPbGJ1hZNhaIo/JAHzL/6Fj8KraHql0kgS0mHzf8s24J9hWt4m1WyvrG2liyTG8bHDAMVIIOT+XX1rl4ZY9zqmAFZgHMgAIPI59RUuf2kVGDtZnqGi63OE/eRSuAfmjP3h64rsrPUUkiRlBKsMASdj6HNeVWWpwH7EQzEAYc+evcfWrcur232R4Xlg37sh/PMhyOnC59K1jXutTGVC7PQ9SvbGIDzHhUs23aPmwewwOa5m/wBUtjLPJDbFSi7mZm2hhnGcHmubv9ZEqTJCJHR3V/3aCMKQOxPP6VjXmoyGZioUStk7VG9jn3PTn2FROvZFQw+p0+q639nDM9xmEMCAvyhlxnGep5qfwZoEhRtTuFw8hCoMcoo/rWZofhO9vZ47/WMxQCQFYyclvdvXmvSdJgMalWHQ9O3TFePi8V7V8kT18LhvZ+8yeyjMUmGBIYYNJP5UMm2LJ9fpVi5fDIFwT93isvWroRQmBNqzPxvJ6CuF9jtv1M69vt8pWEgqnGfWs9rvceJDuPb1qoWyTHGwYqMk+v8AnmqOoEqgJwmPzqoktkl/d7FPmL26ivZvG5x+ytpB7f2fox/8i21eBwgzuWc5CjIzXvnjjH/DK2k5GR/Z+jf+jbauyhBw1fU4qtRT26Hz7HlmdgzFCcDjipoUCuTJIH4wBTXkjSPZxjsBS/ZwI0GWTIyef6V6BwIN0gdgNpRccZxVW8SWSF2CbdqlgT6gVegVY43XO5mPU9aqyysscxcEKMjIFJq+hSdncztK8QR7/Kkba445rqrXVvlA3ZHvXm2m2IuWnEi5JYIPb3rKh1a9tJnaGUvFuOFbkYrklS0ud0autj3S21Rcc1eivVkwV4rxiz8XuuBPEQfUGti18YxjGGIPvWfIzZVInqyzk8Zp+9WBG8fnXnEXi5D1lpW8VRn/AJakD60uV9h88e56PvjjHzOpzTZbvj5Aqgd64CDxIryqkKtLK33VU7mOOegqW61+5g2te209vEWC75UIGT05o9nJ9BOrFdTpby5Y5XcRz6ZqGBsyAtP1rn5dXtnXP26AEjHU8fpSWeoafHjzb+E556nr+VP2M+wvbR7nZw3DRgYct3Bq99tBADYIrj213T40IS6icjtk1Sm8TCFvlMbL/vj/ABo9lNdBqrDud49xCeiDB9age4QAhT+FcDL4tDcfKO/3hVeTxOFJZnUAdfmFLkl2Hzx7ndzTJzvWqE1xAA3zfhXJP4gmZGfybkqP4vKOAOvWsuTxTE6k7iR9P8aapSfQj2sV1OuurtCMfLisG+v1JZU2+5Fcte+JHckRKCPzrKlu7i4Yl2IB7VXs7bsFW7I6G61GGM/M+5vReaoNevO7ZACf3fWstRt9z60NKFkKscKyn86cdXoKUna7LV1KXt4mblo2MefUDBH86ns9SkgkDxSSQv8A3kOKoXEnyxoTlh8zfU//AFsVFuxRNakU5uKO+03xlf24U3KrcRno4+RvzHX8aua3rWiazoWofaYEW8FtIY2ddrbwpx8w689q6Dw7pFv/AMIvYW93AkmYw7Bl6Fuf61g+LPB0EOlX13ZSNGIoXkMbcjAUng1XvLzHzU5bqx940UUUzIwPGfhDQ/GmmQ6f4lsjeWkMwuEQTSRFZArKDlGU9HYYzjmuO/4UL8N/+hfk/wDBld//AB2iigBf+FDfDj/oX5f/AAZXf/x2j/hQvw47eH5f/Bld/wDx2iiiwB/wob4cf9ACX/wZXf8A8do/4UN8OP8AoAS/+DK7/wDjtFFKwB/woX4cf9C/L/4Mrv8A+O07/hRPw6Gf+JFNz/1E7v8A+O0UUWQFmH4M+BoIxHDpt9HGOAqaveAfl5tN/wCFK+BN7P8A2Ve7m6n+1rzJ/wDItFFFkA1fgj4BVyy6PdhjjJGq3mTj/trVtfhJ4QRdqWuqKvoNbvgP/R1FFFkNNj/+FU+E+f3Gr89f+J5ff/HqQ/CbwkQQbbViD1/4nd9z/wCRqKKLIOZ9yrdfBfwLdpsutLvZ067ZNXvGH6y1SPwC+Gh6+HH/APBjdf8Ax2iimtNhPXcd/wAKF+G+AP8AhH5cDoP7Su+P/ItP/wCFFfDvGP7Cnx6f2nd//HaKKd2KyG/8KG+HAOf+Eflz6/2ld/8Ax2pB8DPh6P8AmCXH/g0u/wD47RRSuOw9fgj4BXO3R7sZ641W8/8AjtJF8EPAETl4tGukY9Suq3gJ/wDItFFD13BabFz/AIVH4P2hfsmqbR2/tq+x/wCjqX/hUvhDOTa6rn/sN33/AMeoopcq7D5n3AfCXwgDkWuqg+v9t33/AMeqGT4O+CpW3S6fqLt6trF6T/6Oooo5V2C7GD4L+BQ2Rpl8Ce/9r3n/AMdpH+CvgR/v6Vet/vateH/2rRRRZBdiD4J+Ah00m8/8G15/8drqdQ8JaLqHhGPwxd2bPokcUMKW4nkUqkRUxjeGD8FF53ZOOc0UU7itY5U/BHwAxy2j3RPvqt5/8dpW+CfgJhhtJvD9dWvP/jtFFO7FZCD4JeAQcjSLvPr/AGref/HaD8EfAJUqdHu9p6j+1bzB/wDItFFF2FkRr8C/h4n3NDnX6andj/2rUP8AwoD4af8AQtt/4MLr/wCO0UUhiH4AfDM9fDbf+DC6/wDjtA/Z/wDhkOnhoj/uIXX/AMdoooAd/wAKC+Gv/Quv/wCDG6/+O0f8KD+Gv/Quv/4Mbr/47RRTuA+L4D/DmGQSQ6BNG4yAy6ldgjPHXzafN8Dfh7OpE+iXEikgkPql2eR0PMtFFF2BF/woT4bf9C9J/wCDG6/+O0f8KF+G+Mf8I/Jj/sJXf/x2iii7Cwv/AAob4cA8aBLn/sJXf/x2j/hQ/wAOf+gBL/4Mrv8A+O0UUXYWQH4C/Dc9fD8h/wC4ld//AB2mH4A/DRuvhxz9dRuv/jtFFF2Bak+CPgGRNkmj3bp6Nqt4R/6Nqn/wz98Mv+haP/gwuv8A47RRSuA7/hQHw0/6Ftv/AAYXX/x2j/hQXw0/6Fx//Bjdf/HaKKAuL/woL4a/9C6//gxuv/jtNPwA+GhOT4bY/wDcQuv/AI7RRQAp+AXw1Y5PhxyfU6jdf/HaP+FA/DT/AKFxv/Bhdf8Ax2iigDQHwd8FKoC6fqAA4AGsXvH/AJGpJfg14ImieKXTr943UqyNrF6QwPUEebyKKKAPQ6KKKAP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The initial lesions (panel A) became highly erythematous and indurated during a Type 1 reaction (panel B) that occurred after 12 months of multi-drug treatment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31009=[""].join("\n");
var outline_f30_18_31009=null;
var title_f30_18_31010="Allergic conjunctivitis with chemosis";
var content_f30_18_31010=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Allergic conjunctivitis with chemosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the swollen conjunctiva extending up to the border of the cornea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baskin MN. Ophthalmic and otolaryngologic emergencies. In: Atlas of Pediatric Emergency Medicine, Fleisher GR, Ludwig S, Baskin MN (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31010=[""].join("\n");
var outline_f30_18_31010=null;
var title_f30_18_31011="Indirect immunofluorescence on basement membrane zone-split skin";
var content_f30_18_31011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Serum IgG basement membrane zone antibodies showing combined epidermal-dermal staining on split skin substrate in bullous pemphigoid by indirect immunofluorescence microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Linear IgG antibody staining in a combined pattern, epidermal-dermal, on basement membrane zone-split skin substrate characteristic of bullous pemphigoid and, rarely, bullous lupus erythematosus. This pattern also is referred to as staining the roof and floor of the blister.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kristin M Leiferman, MD, Immunodermatology Laboratory, Department of Dermatology, University of Utah, Salt Lake City, Utah.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31011=[""].join("\n");
var outline_f30_18_31011=null;
var title_f30_18_31012="Ganciclovir (systemic): Patient drug information";
var content_f30_18_31012=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ganciclovir (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/3/24630?source=see_link\">",
"     see \"Ganciclovir (systemic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/42/13990?source=see_link\">",
"     see \"Ganciclovir (systemic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8106925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cytovene&reg;-IV",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8106926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cytovene&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700847",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have anemia, low platelet counts, or low white blood cell counts. Change in dose or even stopping the drug may be needed if you have any of these side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug can cause cancer and infertility in animals. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691682",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a viral infection of the eyes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702188",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ganciclovir or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug and for 3 months after getting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697015",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy during care and for 3 months after care ends. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever and chills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store the shot closely. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11692 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-67CE5B8581-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31012=[""].join("\n");
var outline_f30_18_31012=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8106925\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8106926\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031215\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031217\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031216\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031221\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031222\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031224\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031219\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031220\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031225\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031226\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/5/6228?source=related_link\">",
"      Ganciclovir (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/53/41811?source=related_link\">",
"      Ganciclovir (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/58/6052?source=related_link\">",
"      Ganciclovir (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/3/24630?source=related_link\">",
"      Ganciclovir (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/42/13990?source=related_link\">",
"      Ganciclovir (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_18_31013="Soft tissue infections due to human bites";
var content_f30_18_31013=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Soft tissue infections due to human bites",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31013/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31013/contributors\">",
"     Larry M Baddour, MD, FIDSA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31013/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31013/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31013/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31013/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/18/31013/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 16, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human bite wounds can occur as a result of incidental or purposeful injury and are more prone to infection than animal bites. This topic will review the microbiology, clinical evaluation and management of soft tissue infections due to human bites. Soft tissue infections due to dog and cat bites and animal and human bites in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28038?source=see_link\">",
"     \"Soft tissue infections due to dog and cat bites\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/57/20377?source=see_link\">",
"     \"Initial management of animal and human bites\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human bite wound pathogens include aerobic bacteria (such as streptococci and S. aureus) and anaerobic bacteria (such as Eikenella, Fusobacterium, Peptostreptococcus, Prevotella, and Porphyromonas spp) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. In a study of 50 patients with infected human bites, the median number of isolates per wound culture was four [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/3\">",
"     3",
"    </a>",
"    ]. Both aerobes and anaerobes were isolated from 54 percent of wounds, aerobes alone were isolated from 44 percent and anaerobes alone were isolated from 2 percent.",
"   </p>",
"   <p>",
"    Viral pathogens, including hepatitis, human immunodeficiency virus, and herpes simplex virus, are transmissible by human bites; clinical descriptions are limited to case reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/4-9\">",
"     4-9",
"    </a>",
"    ]. Human bite transmission of syphilis has also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human bite wounds can occur as a result of incidental or purposeful injury. Incidental injury may include self-inflicted wounds (such as paronychia due to nail-biting or thumb-sucking) or \"love nips\" to the face, breasts, or genital areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/61/37846?source=see_link\">",
"     \"Paronychia and ingrown toenails\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Purposeful injury to one individual by another may result in occlusional bites or clenched fist injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/13\">",
"     13",
"    </a>",
"    ]. Occlusional bites are frank bites by human teeth, most often to the fingers, hands, or arms. Involvement of the hand portends high risk for osteomyelitis and septic arthritis.",
"   </p>",
"   <p>",
"    Clenched fist injuries are the most serious of human bite wounds; they present as traumatic lacerations that occur when the clenched fist of one person strikes the teeth of another. The lacerations typically occur over the third and fourth metacarpophalangeal or proximal interphalangeal joints of the dominant hand. Although they are usually quite small (up to 15 mm), they are highly prone to infection given the proximity of the skin over the knuckles to the joint capsule. Relaxation of the fist may carry organisms into the deep compartments and the deep tendon spaces of the hand. Thus, patients with such injuries are at risk for deep soft tissue infection, septic arthritis and osteomyelitis. Many patients ignore these wounds until the onset of pain, swelling or purulent discharge; as a result, these injuries are often complicated by established infection at the time patients seek medical attention.",
"   </p>",
"   <p>",
"    Clinical manifestations of bite wound infections may include tenderness, erythema, swelling, purulent drainage, lymphangitis, and fever. Pain near a bone or joint that is out of proportion to injury severity should suggest periosteal penetration with risk for osteomyelitis.",
"   </p>",
"   <p>",
"    Cultures should be obtained at surgical debridement as discussed in the next section. In addition, radiographic imaging should be performed if the bite injury is in close proximity to a bone to evaluate for osteomyelitis, septic arthritis, tendonitis or fractures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/50/12071?source=see_link\">",
"     \"Approach to imaging modalities in the setting of suspected osteomyelitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of human bites includes wound care, antibiotic therapy and vaccination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Wound care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bite wounds should be irrigated copiously with sterile saline, and grossly visible debris should be removed. Surgical evaluation of bite wounds is critical to evaluate nerve and muscular function and the extent of injury to tendons, bones and joints. If debridement is needed, it should be performed cautiously to avoid enlarging the wound and impairing skin closure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1\">",
"     1",
"    </a>",
"    ]. Debrided material should be sent for aerobic and anaerobic culture.",
"   </p>",
"   <p>",
"    In general, wounds should be left open, with approximation of wound edges to facilitate closure by secondary intention. On reevaluation within a few days, delayed primary closure can be performed if needed. Facial bite wounds are a special exception for which primary closure by a plastic surgeon is preferable to avoid scarring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1,14,15\">",
"     1,14,15",
"    </a>",
"    ]. Large lacerations and disfiguring wounds may also be appropriate for primary closure. Subcutaneous sutures should be used sparingly, since foreign material in a contaminated wound increases the risk of infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/57/20377?source=see_link\">",
"     \"Initial management of animal and human bites\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Elevation of the injured area is useful to reduce swelling and pain. Clenched fist injuries require immobilization with splinting from the fingers to the elbow in a position that maintains the maximal length of ligaments and intrinsic muscles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no comparative antibiotic trials for treatment of human bite infections. Antibiotic agents should be selected based on their activity against potential flora including S. aureus, E. corrodens, H. influenzae and beta-lactamase producing oral anaerobic bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Microbiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Agents lacking activity against Eikenella corrodens should be avoided; these include first-generation cephalosporins (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    ), penicillinase-resistant penicillins (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/11/3253?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    ), macrolides (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    ),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    and aminoglycosides. However, clindamycin may be used for anaerobic coverage if it is administered in conjunction with an additional agent that is active against E. corrodens.",
"   </p>",
"   <p>",
"    When available, culture and susceptibility results should subsequently be used to tailor antibiotic therapy. With the increasing prevalence of methicillin resistant S. aureus (MRSA), including community-acquired strains, consideration of this organism may be important for patients with appropriate risk factors (",
"    <a class=\"graphic graphic_table graphicRef53504 \" href=\"mobipreview.htm?5/9/5275\">",
"     table 1",
"    </a>",
"    ). The approach to the treatment of MRSA is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/7/4216?source=see_link\">",
"     \"Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/48/21258?source=see_link\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic prophylaxis should be administered to all patients regardless of the appearance of the wound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1,16-18\">",
"     1,16-18",
"    </a>",
"    ]. This is particularly important in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Occlusional bite wounds and bite wounds involving the hand",
"     </li>",
"     <li>",
"      Wounds in close proximity to a bone or joint (particularly prosthetic joints)",
"     </li>",
"     <li>",
"      Deep puncture wounds",
"     </li>",
"     <li>",
"      Moderate to severe wounds with associated crush injury",
"     </li>",
"     <li>",
"      Wounds in areas of underlying venous",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      lymphatic compromise",
"     </li>",
"     <li>",
"      Wounds requiring surgical repair",
"     </li>",
"     <li>",
"      Wounds in immunocompromised hosts",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Appropriate antibiotic agents are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef69328 \" href=\"mobipreview.htm?6/17/6429\">",
"     table 2",
"    </a>",
"    ). Prophylactic oral antibiotics should be administered for three to five days, with close followup [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1\">",
"     1",
"    </a>",
"    ]. On followup evaluation, signs of infection should prompt further evaluation (with radiographic imaging",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgical consultation, if needed) and an extension of the antibiotic course.",
"   </p>",
"   <p>",
"    Routine HIV testing following human bites is not necessary. However, in special bite injury circumstances (such as intentional bites of law enforcement personnel), rapid HIV testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    empiric postexposure prophylaxis pending results of testing may be warranted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/47/7930?source=see_link\">",
"     \"Management of healthcare personnel exposed to HIV\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals whose wounds are clinically infected at initial evaluation should be admitted to the hospital for further evaluation and intravenous antimicrobial therapy. Reasonable parenteral agents for treatment of human bite wounds are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef80019 \" href=\"mobipreview.htm?43/40/44684\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients with complicated infections require prolonged therapy tailored to individual circumstances. For example, tenosynovitis should be treated for up to four weeks, and osteomyelitis usually requires at least six weeks of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/34/4649?source=see_link\">",
"     \"Overview of osteomyelitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of such complications, the duration of antibiotic therapy should be tailored to clinical improvement. In the setting of bacteremia, 14 days of parenteral therapy should be administered. Otherwise, cellulitis and skin abscess usually respond to 5 to 10 days of therapy. Intravenous therapy may be switched to outpatient oral therapy with evidence of clinical improvement (",
"    <a class=\"graphic graphic_table graphicRef69328 \" href=\"mobipreview.htm?6/17/6429\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/293?source=see_link\">",
"     Tetanus immune globulin",
"    </a>",
"    and tetanus toxoid should be administered to patients who have had two or fewer primary immunizations. Tetanus toxoid alone can be given to those who have completed a primary immunization series but who have not received a booster for more than five years. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7014?source=see_link\">",
"     \"Tetanus-diphtheria toxoid vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=see_link\">",
"       \"Patient information: Animal bites (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The predominant organisms in human bite wounds include aerobic bacteria (such as streptococci, S. aureus, and Eikenella corrodens) and anaerobic bacteria (such as Fusobacterium, Peptostreptococcus, Prevotella, and Porphyromonas spp). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations of bite wound infections may include fever, erythema, swelling, tenderness, purulent drainage and lymphangitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31013/abstract/10\">",
"       10",
"      </a>",
"      ]. Complications include subcutaneous abscesses osteomyelitis, septic arthritis, tendonitis and bacteremia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clenched fist injuries are the most serious of human bite wounds; they present as traumatic lacerations that occur when the clenched fist of one person strikes the teeth of another. They may result in simple cellulitis, although given the proximity of the skin over the knuckles to the joint capsule, more often they are complicated by deep soft tissue infection, septic arthritis and osteomyelitis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Those with deep or severe wound infections and should have radiographic imaging to evaluate for subcutaneous abscess, osteomyelitis, septic arthritis or tendonitis. Blood cultures should be obtained. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bite wounds should be irrigated copiously with sterile saline, and grossly visible debris should be removed. Surgical evaluation is critical, especially for wounds involving the hand. Debrided material should be sent for aerobic and anaerobic culture (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Wound care'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Infected wounds should be left open following debridement, with approximation of wound edges to facilitate closure by secondary intention. However, primary closure is appropriate for facial bite wounds, large lacerations and disfiguring wounds. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Wound care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend prophylaxis with oral antibiotics for patient circumstances as outlined above (",
"      <a class=\"graphic graphic_table graphicRef69328 \" href=\"mobipreview.htm?6/17/6429\">",
"       table 2",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that patients with deep or severe wound infections receive intravenous antibiotics (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Appropriate regimens are outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef80019 \" href=\"mobipreview.htm?43/40/44684\">",
"       table 3",
"      </a>",
"      ). Intravenous therapy may be switched to outpatient oral therapy with evidence of clinical improvement, and the duration of antibiotic therapy should be tailored to clinical resolution of infection. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vaccination status for tetanus should be considered. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Vaccination'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/1\">",
"      Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/2\">",
"      Brook I. Bacteriologic study of paronychia in children. Am J Surg 1981; 141:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/3\">",
"      Talan DA, Abrahamian FM, Moran GJ, et al. Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Clin Infect Dis 2003; 37:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/4\">",
"      Figueiredo JF, Borges AS, Mart&iacute;nez R, et al. Transmission of hepatitis C virus but not human immunodeficiency virus type 1 by a human bite. Clin Infect Dis 1994; 19:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/5\">",
"      Bartholomew CF, Jones AM. Human bites: a rare risk factor for HIV transmission. AIDS 2006; 20:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/6\">",
"      Shapiro CN. Transmission of hepatitis viruses. Ann Intern Med 1994; 120:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/7\">",
"      Vidmar L, Poljak M, Tomazic J, et al. Transmission of HIV-1 by human bite. Lancet 1996; 347:1762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/8\">",
"      Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990; 336:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/9\">",
"      Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989; 1:889.",
"     </a>",
"    </li>",
"    <li>",
"     Oh, Y, Ahn, SY, Hong, SP, et al. A case of extragenital chancre on a nipple from a human bite during sexual intercourse. Int J Dermatol 2008; Mar 3 [Epub ahead of print].",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/11\">",
"      Fallouji MA. Traumatic love bites. Br J Surg 1990; 77:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/12\">",
"      Wolf JS Jr, Gomez R, McAninch JW. Human bites to the penis. J Urol 1992; 147:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/13\">",
"      Henry FP, Purcell EM, Eadie PA. The human bite injury: a clinical audit and discussion regarding the management of this alcohol fuelled phenomenon. Emerg Med J 2007; 24:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/14\">",
"      Stierman KL, Lloyd KM, De Luca-Pytell DM, et al. Treatment and outcome of human bites in the head and neck. Otolaryngol Head Neck Surg 2003; 128:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/15\">",
"      Stucker FJ, Shaw GY, Boyd S, Shockley WW. Management of animal and human bites in the head and neck. Arch Otolaryngol Head Neck Surg 1990; 116:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/16\">",
"      Goldstein EJ. Bite wounds and infection. Clin Infect Dis 1992; 14:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/17\">",
"      Zubowicz VN, Gravier M. Management of early human bites of the hand: a prospective randomized study. Plast Reconstr Surg 1991; 88:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31013/abstract/18\">",
"      Medeiros I, Saconato H. Antibiotic prophylaxis for mammalian bites. Cochrane Database Syst Rev 2001; :CD001738.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7674 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-219.243.220.100-C5CC09C3EA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31013=[""].join("\n");
var outline_f30_18_31013=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Wound care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7674\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7674|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/9/5275\" title=\"table 1\">",
"      Risk factors for MRSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/17/6429\" title=\"table 2\">",
"      Oral antibiotics human bites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/40/44684\" title=\"table 3\">",
"      Empiric intravenous antibiotic therapy for human bite wounds",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/50/12071?source=related_link\">",
"      Approach to imaging modalities in the setting of suspected osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/57/20377?source=related_link\">",
"      Initial management of animal and human bites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/47/7930?source=related_link\">",
"      Management of healthcare personnel exposed to HIV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/34/4649?source=related_link\">",
"      Overview of osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/61/37846?source=related_link\">",
"      Paronychia and ingrown toenails",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=related_link\">",
"      Patient information: Animal bites (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28038?source=related_link\">",
"      Soft tissue infections due to dog and cat bites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7014?source=related_link\">",
"      Tetanus-diphtheria toxoid vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/48/21258?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/7/4216?source=related_link\">",
"      Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_18_31014="Delivery of inhaled medication in children";
var content_f30_18_31014=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Delivery of inhaled medication in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Robert H Moore, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31014/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/18/31014/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The delivery of aerosolized medication is an important component of treatment for many respiratory disorders, and is a critical aspect of asthma management in children. Glucocorticoids, bronchodilators, antibiotics, and mucolytic agents can be administered via aerosol using a range of aerosol generating devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In addition, indications for aerosol therapy will broaden as novel macromolecular medications are delivered via the respiratory tract for the treatment of both pulmonary and systemic disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/20/18762?source=see_link\">",
"     \"Delivery of inhaled medication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The delivery of aerosolized medication to infants and children is complicated by anatomic and physiologic differences in their respiratory systems compared with adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Thus, a basic knowledge of the uses and limitations of aerosol delivery systems, the properties of effective aerosols, and the anatomic considerations affecting aerosol delivery in infants and children is essential to the optimal use of this therapeutic modality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. An overview of the delivery of inhaled medication in children will be presented here; specific aspects of medication delivery using nebulizers, pressurized metered dose inhalers, and dry powder inhalers are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30376?source=see_link\">",
"     \"Use of medication nebulizers in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36760?source=see_link\">",
"     \"The use of inhaler devices in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5426205\">",
"    <span class=\"h1\">",
"     ADVANTAGES OF AEROSOLIZED DRUG DELIVERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several advantages to delivering drugs by aerosol rather than systemically:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delivery of agents directly to their sites of action decreases the dose required for therapeutic effect.",
"     </li>",
"     <li>",
"      Faster onset of action (compared to intravenous delivery) of bronchodilating medications allows more rapid reversal of acute bronchoconstriction.",
"     </li>",
"     <li>",
"      Reduced systemic bioavailability minimizes side effects.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5426212\">",
"    <span class=\"h1\">",
"     TYPES OF AEROSOL DELIVERY DEVICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three types of aerosol delivery devices are widely employed in the management of children with respiratory disease (",
"    <a class=\"graphic graphic_table graphicRef52016 graphicRef71527 \" href=\"mobipreview.htm?14/57/15262\">",
"     table 1A-B",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nebulizers, which use a jet flow of driving gas, ultrasound, or vibrating membrane to aerosolize medications",
"     </li>",
"     <li>",
"      Pressurized metered dose inhalers (MDI)",
"     </li>",
"     <li>",
"      Dry powder inhalers (DPI)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific issues related to the use of these devices are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30376?source=see_link\">",
"     \"Use of medication nebulizers in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36760?source=see_link\">",
"     \"The use of inhaler devices in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LUNG DISEASES MANAGED USING AEROSOL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide range of pediatric disorders can be treated effectively using aerosol therapy as a central component of management. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstructive airway diseases, including asthma, congenital emphysema, bronchiectasis, and bronchiolitis",
"     </li>",
"     <li>",
"      Processes that result in acute upper airway obstruction, usually croup or postextubation upper airway edema",
"     </li>",
"     <li>",
"      Chronic lung diseases, including bronchopulmonary dysplasia and cystic fibrosis",
"     </li>",
"     <li>",
"      Infectious diseases, including Pneumocystis jirovecii (previously carinii) pneumonia (treatment and prophylaxis), respiratory syncytial virus infection, and some pulmonary fungal infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/12-15\">",
"       12-15",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less common indications for aerosol therapy include intractable cough, which may respond to inhaled",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/57/37776?source=see_link\">",
"     lidocaine",
"    </a>",
"    , and administration of analgesia in the setting of palliative care, using inhaled",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. In the future, aerosol delivery of gene constructs could be an important component of therapy for genetic diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PROPERTIES OF AN IDEAL AEROSOL THERAPY DEVICE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal aerosol delivery device varies depending upon the medication to be administered and the clinical situation. To maximize the advantages of inhaled medications described above, the device selected should:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Deliver an adequate dose of medication to the lungs",
"     </li>",
"     <li>",
"      Minimize oropharyngeal deposition",
"     </li>",
"     <li>",
"      Minimize systemic side effects",
"     </li>",
"     <li>",
"      Match the needs of the patient",
"     </li>",
"     <li>",
"      Be simple for the patient to use",
"     </li>",
"     <li>",
"      Be cost effective",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     FACTORS AFFECTING DRUG DEPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of factors influence the ultimate amount of medication delivered to the appropriate anatomic region within the lung.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Properties of the device",
"    </span>",
"    &nbsp;&mdash;&nbsp;Devices vary greatly in their efficiencies in delivering particles to the lungs. From 6 to 60 percent of the total dose of medication is delivered to the peripheral airways when these devices are used optimally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/20/18762?source=see_link\">",
"     \"Delivery of inhaled medication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Aerosol properties",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aerosol particles are characterized by their mass median aerodynamic diameter (MMAD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Particles with MMAD less than 0.8 micrometers generally are exhaled.",
"     </li>",
"     <li>",
"      Particles with MMAD of 0.8 to 2 micrometers are optimal for alveolar deposition, which occurs largely as a result of gravitational sedimentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/7,21\">",
"       7,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Particles with a MMAD between 2 and 5 micrometers are optimal for deposition in the lower airway, and are deposited largely by inertial impaction with airway structures.",
"     </li>",
"     <li>",
"      Particles with a MMAD greater than 5 micrometers are deposited largely in the oropharynx.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Properties of medication to be delivered",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ultimate effect of the dose is dependent upon the site of deposition of the drug within the lung, the rate of drug clearance from the airway, and the site of action of the medication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/18\">",
"     18",
"    </a>",
"    ]. To be effective, drugs must be able to withstand the shear forces required to generate the aerosol, and often must penetrate the mucus layer and airway mucosa to reach their target receptors or cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Disease state and ventilatory pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomic and pathologic factors, as well as ventilatory patterns, alter the efficiency of aerosolized drug delivery. Aerosol particles may be deposited in the central, rather than lower, airways in diseases that are associated with decreased airway caliber such as asthma. In a study of infants with acute bronchiolitis, only 1.5 percent of aerosolized drug released from the nebulizer was deposited in the lung and 0.6 percent penetrated to the peripheral airways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/22\">",
"     22",
"    </a>",
"    ]. However, most of this information is based upon studies of inhalers containing chlorofluorocarbon (CFC) propellants. Penetration into peripheral airways appears to be better with the hydrofluoroalkane propellants (HFAs) that have replaced CFCs, even in patients with significant obstructive airway disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diseases causing mucus plugging or atelectasis, such as cystic fibrosis, may lead to reduction and marked heterogeneity in the distribution of particle deposition. Other factors such as tidal volume, breath-holding time, respiratory rate, and nose versus mouth breathing can dramatically alter the deposition of aerosolized particles in the lungs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/7,24\">",
"     7,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Patient technique, acceptance, and preference",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improper technique is a common cause for a suboptimal response to aerosolized medication, and poor understanding or acceptance may lead to noncompliance. Rapid inspiration from MDIs may increase inertial impaction of droplets in the central airways and decrease lung delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/24\">",
"     24",
"    </a>",
"    ]. Patient education is essential for the effective use of any aerosol delivery device [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, patient factors such as weakness, severe arthritis or contractures, and altered mental status may mandate the use of specific delivery devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SPECIAL CONSIDERATIONS IN INFANTS AND YOUNG CHILDREN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The deposition of medication in peripheral airways and alveoli is reduced in infants and young children, presumably due to their smaller airways, faster respiratory rates, and lower tidal volumes, which combine to lower the resident time of small particles in the airway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/7-9,25,26\">",
"     7-9,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, aerosol doses do not need to be decreased except possibly in very young children.",
"   </p>",
"   <p>",
"    Data suggest that drug deposition in children older than five to six years of age is similar to that observed in adults and identical doses in children and adults result in similar plasma concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/18,27\">",
"     18,27",
"    </a>",
"    ]. However, it is probable that variability exists based upon the specific medication used, drug delivery technique (tidal volume breathing compared with inspiratory breath hold), and delivery device employed.",
"   </p>",
"   <p>",
"    The output of the aerosol generating device may exceed inspiratory flow rate in children younger than six months of age, resulting in the loss of air entrainment (mixing of inspired air with nebulizer output) and a higher concentration of drug delivered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/26\">",
"     26",
"    </a>",
"    ]. Overall, this effect can lead to a higher inhaled dose per kilogram of body weight in the infant younger than six months of age, increasing the possibility of side effects, although increased side effects have not been reported in this age group nor are there recommendations to decrease any drug dose because of this effect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Respiratory pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal tidal breathing results in the most efficient delivery to the airways. Crying markedly reduces aerosol delivery to the lungs, therefore, in general, aerosols should not be administered to crying children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. An alternative in these infants and children is to administer aerosols while they are sleeping [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/30\">",
"     30",
"    </a>",
"    ]. However, lung deposition of aerosolized drugs may be reduced in a nose-breathing sleeping infant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/31\">",
"     31",
"    </a>",
"    ]. Furthermore, a &ldquo;real-life&rdquo; feasibility study of aerosol delivery via MDI and masked holding chamber to sleeping infants and young children found that aerosol delivery during sleep offered no advantage for most children due to frequent awakenings associated with poor cooperation and difficulty with the proper placement of the mask due to sleep position [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/32\">",
"     32",
"    </a>",
"    ]. Thus, aerosol administration during sleep may be tried for uncooperative infants and children, but parents should be informed that the success rate may be low.",
"   </p>",
"   <p>",
"    Breath-actuated devices and dry powder inhalers should be avoided in infants and toddlers, due to their inability to generate an adequate inspiratory flow rate to reliably aerosolize the medication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36760?source=see_link\">",
"     \"The use of inhaler devices in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Interface",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interface between the aerosol generating device and the patient is an important, and often overlooked, component of effective therapy. Administration of aerosols by a mouthpiece rather than a facemask is generally preferred due to improved drug delivery to the lungs by as much as twofold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/33\">",
"     33",
"    </a>",
"    ]. However, most children will not be able to reliably breathe through a mouthpiece until about four years of age and patient technique with a mouthpiece must be assessed prior to switching from a facemask [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, delivery by facemasks or mouthpieces has been shown to provide similar clinical responses when administering bronchodilators in children with acute asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/35\">",
"     35",
"    </a>",
"    ] or nebulized",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/48/35584?source=see_link\">",
"     budesonide",
"    </a>",
"    in chronic asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Poor patient cooperation leads many parents to use blow-by techniques for aerosol delivery. However, removing the facemask just 1 cm from the face may reduce the inspired dose by approximately 50 percent, and a 2 cm distance results in an 80 percent reduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/24\">",
"     24",
"    </a>",
"    ]. When a facemask is used either with a spacer or nebulizer, it should be placed snugly and tightly fitted over the face, as even a small leak may reduce the inhaled mass of drug to &lt;0.5 percent of the total dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nose is an efficient filter for particles in aerosol. Thus, when using a facemask, any nose breathing is associated with increased deposition in the upper airway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/24,38\">",
"     24,38",
"    </a>",
"    ]. This may lead to more systemic side effects, due to greater drug absorption from the upper airway. In addition, this can reduce drug efficacy because of decreased deposition in the lower respiratory tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31014/abstract/1,35\">",
"     1,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific aspects of aerosolized medication delivery using nebulizers, metered dose inhalers, and dry powder inhalers are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30376?source=see_link\">",
"     \"Use of medication nebulizers in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36760?source=see_link\">",
"     \"The use of inhaler devices in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/52/13122?source=see_link\">",
"       \"Patient information: How to use your child&rsquo;s dry powder inhaler (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/4/33858?source=see_link\">",
"       \"Patient information: How to use your child&rsquo;s metered dose inhaler (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/43/30386?source=see_link\">",
"       \"Patient information: Inhalers (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/3/44083?source=see_link\">",
"       \"Patient information: Asthma inhaler techniques in children (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/0/37892?source=see_link\">",
"       \"Patient information: Asthma symptoms and diagnosis in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5426330\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are three main types of aerosol delivery devices used in the management of children with respiratory disease: nebulizers, pressurized metered dose inhalers, and dry powder inhalers. (See",
"      <a class=\"local\" href=\"#H5426212\">",
"       'Types of aerosol delivery devices'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that affect drug deposition include properties of the device, aerosol particle, and medication, and patient factors such as disease state, ventilatory pattern, and administration technique. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Factors affecting drug deposition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In general, aerosol doses do not need to be decreased except possibly in very young children. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dose'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Normal tidal breathing results in the most efficient delivery to the airways. Crying markedly reduces aerosol delivery to the lungs. A better option in children who tend to cry with administration is to give the aerosolized drug while they are sleeping. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Respiratory pattern'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Administration of aerosols by a mouthpiece rather than a facemask is generally preferred due to improved drug delivery to the lungs. Blow-by techniques significantly decrease the inspired dose. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Interface'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/1\">",
"      Fink JB. Aerosol device selection: evidence to practice. Respir Care 2000; 45:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/2\">",
"      Dolovich MA, MacIntyre NR, Anderson PJ, et al. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. Respir Care 2000; 45:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/3\">",
"      Hess D. Aerosol therapy. Respir Care Clin N Am 1995; 1:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/4\">",
"      Roche N, Huchon GJ. Rationale for the choice of an aerosol delivery system. J Aerosol Med 2000; 13:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/5\">",
"      Rubin BK. Experimental macromolecular aerosol therapy. Respir Care 2000; 45:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/6\">",
"      Newhouse MT, Corkery KJ. Aerosols for systemic delivery of macromolecules. Respir Care Clin N Am 2001; 7:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/7\">",
"      Rubin BK, Fink JB. Aerosol therapy for children. Respir Care Clin N Am 2001; 7:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/8\">",
"      Everard ML. Aerosol delivery in infants and young children. J Aerosol Med 1996; 9:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/9\">",
"      Cole CH. Special problems in aerosol delivery: neonatal and pediatric considerations. Respir Care 2000; 45:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/10\">",
"      O'Callaghan C, Barry PW. Asthma drug delivery devices for children. BMJ 2000; 320:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/11\">",
"      Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001; 5:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/12\">",
"      Diot P, Dequin PF, Rivoire B, et al. Aerosols and anti-infectious agents. J Aerosol Med 2001; 14:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/13\">",
"      Gilbert BE. Liposomal aerosols in the management of pulmonary infections. J Aerosol Med 1996; 9:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/14\">",
"      Roth C, Gebhart J, Just-N&uuml;bling G, et al. Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis. Infection 1996; 24:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/15\">",
"      Simonds AK, Newman SP, Johnson MA, et al. Alveolar targeting of aerosol pentamidine. Toward a rational delivery system. Am Rev Respir Dis 1990; 141:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/16\">",
"      Sherman JM. Breaking the cycle: lidocaine therapy for habit cough. J Fla Med Assoc 1997; 84:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/17\">",
"      Cohen SP, Dawson TC. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis. Pediatrics 2002; 110:e38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/18\">",
"      Le Sou&euml;f P. The meaning of lung dose. Allergy 1999; 54 Suppl 49:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/19\">",
"      Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 1979; 120:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/20\">",
"      Dolovich M, Smaldone GC. Estimating the particle size characteristics of therapeutic aerosols. J Aerosol Med 1999; 12:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/21\">",
"      Newhouse MT, Ruffin RE. Deposition and fate of aerosolized drugs. Chest 1978; 73:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/22\">",
"      Amirav I, Balanov I, Gorenberg M, et al. Beta-agonist aerosol distribution in respiratory syncytial virus bronchiolitis in infants. J Nucl Med 2002; 43:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/23\">",
"      Zeidler M, Corren J. Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma. Treat Respir Med 2004; 3:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/24\">",
"      O'Callaghan C. Delivery systems: the science. Pediatr Pulmonol Suppl 1997; 15:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/25\">",
"      Barry PW, O'Callaghan C. Nebuliser therapy in childhood. Thorax 1997; 52 Suppl 2:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/26\">",
"      Collis GG, Cole CH, Le Sou&euml;f PN. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990; 336:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/27\">",
"      Onh&oslash;j J, Thorsson L, Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 2000; 162:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/28\">",
"      Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 1999; 81:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/29\">",
"      Wildhaber JH, Dore ND, Wilson JM, et al. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999; 135:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/30\">",
"      Janssens HM, van der Wiel EC, Verbraak AF, et al. Aerosol therapy and the fighting toddler: is administration during sleep an alternative? J Aerosol Med 2003; 16:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/31\">",
"      Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child 1993; 69:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/32\">",
"      Esposito-Festen J, Ijsselstijn H, Hop W, et al. Aerosol therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do? Chest 2006; 130:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/33\">",
"      Nikander K. Drug delivery systems. J Aerosol Med 1994; 7:S19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/34\">",
"      Amirav I, Newhouse MT. Review of optimal characteristics of face-masks for valved-holding chambers (VHCs). Pediatr Pulmonol 2008; 43:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/35\">",
"      Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 1992; 14:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/36\">",
"      Mellon M, Leflein J, Walton-Bowen K, et al. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med 2000; 162:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/37\">",
"      Erzinger S, Schueepp KG, Brooks-Wildhaber J, et al. Facemasks and aerosol delivery in vivo. J Aerosol Med 2007; 20 Suppl 1:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31014/abstract/38\">",
"      O'Callaghan C, Barry PW. The science of nebulised drug delivery. Thorax 1997; 52 Suppl 2:S31.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5737 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-FE77A46CF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31014=[""].join("\n");
var outline_f30_18_31014=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5426330\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5426205\">",
"      ADVANTAGES OF AEROSOLIZED DRUG DELIVERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5426212\">",
"      TYPES OF AEROSOL DELIVERY DEVICES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LUNG DISEASES MANAGED USING AEROSOL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PROPERTIES OF AN IDEAL AEROSOL THERAPY DEVICE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      FACTORS AFFECTING DRUG DEPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Properties of the device",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Aerosol properties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Properties of medication to be delivered",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Disease state and ventilatory pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Patient technique, acceptance, and preference",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SPECIAL CONSIDERATIONS IN INFANTS AND YOUNG CHILDREN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Respiratory pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Interface",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5426330\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/5737\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5737|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/51/38716\" title=\"table 1A\">",
"      Comparison of aerosol devices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/10/17581\" title=\"table 1B\">",
"      Aerosol device comparison",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/20/18762?source=related_link\">",
"      Delivery of inhaled medication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/3/44083?source=related_link\">",
"      Patient information: Asthma inhaler techniques in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/0/37892?source=related_link\">",
"      Patient information: Asthma symptoms and diagnosis in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/52/13122?source=related_link\">",
"      Patient information: How to use your child&rsquo;s dry powder inhaler (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/4/33858?source=related_link\">",
"      Patient information: How to use your child&rsquo;s metered dose inhaler (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/43/30386?source=related_link\">",
"      Patient information: Inhalers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36760?source=related_link\">",
"      The use of inhaler devices in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30376?source=related_link\">",
"      Use of medication nebulizers in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_18_31015="Light microscopy Sertoli tumor";
var content_f30_18_31015=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sertoli cell tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 260px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEEAYUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwC5BItnYiWz0+3tISAY7i5QvsI6q3saty+bay/b9HkjtdQhKyywMSA2Rxt3dUYHpUF2JrxLqy1nULVZLUGRRCwxIg6hxjk/TBqjqx0zVbrSf7R1SfE0RjEqxtIiIOnT5vbgcenFerbyPVT6X0LF7CZbaC403QrGxNyGN0kLFm3E53p1YA+gOBU3kXId5J5ZCWH7wFvnY+hPG7+dZGh6vp9hdKkM0oj3NBFDIS2/jG5Djlc9jzV2+1holJ0iZJ7u2tRI8Lx71lycZHuPbmsZqcvdWh1UHRgubctQySxRILiydbfJV3XK7s+47+/NW7N7dYJAsappxcI5uXxGT/tMcce+f0qPV4lhFrcLcSO2oQGRbcN+9t5lTLxAdueQTxWDqVrFqtrFqWtwXenWMccQIEistwgwrOUH3T0JI4PJApQpaa6BUxS6avz6Gra+IL+KW90m1gutPukAjBJ2QspbADDGVByCpBwc4PrUWg6bqN9qs661q17pjLbyxyNbt8sMwOzAXjduU549M5rrJ7aO2ijhjKiO2gCQB5M+YuNwwD1HOfxHFZq+IdNk0ldQS7RreNCzpDGBdcHaeCRnqBnIGK1u9oowcU9ZyM+x+HGm3MjTa5q+r6k+Pmhht/Kd3zw249Rgc/qe9beq+FdNvdRa4uo4t2z95a28rTcLwC+zhXwBn5+v6xweL9DkghmnubiSR4vMMJ5MY5wp3HG4cE4yPSqEvj3zNXgg8N6dctZxnZdoYMu5ORldpO0FcNzzkUuWV9dBfu4/DqdQ8SW2hXI04W1vAI9ggX5VlcZZFJJyctn5QRknJzXC3XiCS50qCPVpJAZ4BLdQ28hDLOrEgBD8oB7jPcdxil1HQNb1Ge5g125ttO05ipWaaVGZWXOAkaksxIY8Y98itSy8M6dFJpl7fvfRPFtEc0iri42kHzGQZIXg+v1oTjEdpTvZEOtzarf6Ob+aCe30yB/Ms7aOHDvGx27eeTgYYsc9/XNYl9Lq1lptq02ltIriRHntFJZo8AgSgZBbqc8N15wK0P7J1iztrjURJDrNys8RgjS7eTMe7rwy7V+7x/dzxXW2Xi2xv7+306O+Ec5lKRo0n7hwuASuRgc9M9QePSm11RCbsottHE23hi0PiOXTLm61OQ26Rz208Me1GhfBOXOcDnGMHkGu1j0Ff7Y26ToMAtI2DQyWyNv8wHGS3ZcfWt6GO2g1BrfX3CBBv2xRsFIJzzgHgdvrWvqHxD0bS7+102zhmn3RO/yqUCpGuTjI5wPXHTrWMpybslcqV6fwq9/uE0PwhPJHFJqwiSFTuWzQLhiCSN7Ae+cDpXnXi/Wpzpl9qC38sM0blIY4pPKjVugQLjJG0H+vpXeWnjq71GFL22Gnw6bIu9HeQ7sc5yTgdumPxrCvotO1RWuo1tprJpPMuSy7vKB/5apjnyzzz2JOcUoKUXeQU+eV3P5HlWlXGpavdvI2pW8lydkiLcTeVJFIv3cEgKAcbcg8g81pao+tuEu/EF9eQTKUnjDNmSPBOVOMBB3Az29KSHS7nw/Peteo0Fg7sIXcGWMj72846DBHUZ5xis+8vLzUNJFn5qzLLA8pltCyJCFPBk9upIPYjvxXRd9CeWKXvbmh4TtL2XU59NkS8t2kieYmSMyRTgrlGcZ2hcFSBznpio013+zpNOGpaVBc3Plttuhp3lT28nzKqxogCnBA4YHqemBXXeA7V49OtdQW43W7x+QI2kMkTxx7Rv2kbgN3b8cVz/ijw1rkb3N/Bqc81jG+4W8cjvNEjADdtxjGep68jgZ4V1e0hWaSkjr7AzXNtKZ0hnW7cTO9xOfMVedxwTlSMEE5HTkdqWFNJaTT7jTr1o4jhbcNIFMuTjYDnDEnPA59q5l9UubyxS90u0+1TW5Vb/Tp5R/pPmRlJMS8FC48zGekg75ArjtStNKutSs4dDupLmymlgtZLbUiDcRySMAAVUbcgkZ256e9ZKDejZ0vEqLTUen9fcdh41v47W4vIbNYxqOoqmmsJw2ww/KWbjjk7QG7bSeuSOh0fT7rwzolppE0rJOHMtw6yNsErfxI3ptxg8HrXC293Beg+FtdMmm24fzIbtIyRa3A+RwU6MCflx2JBHQk7fhe7eKSPQ7ya9n1a2G9zt+S0ROBHk8nt1qlG0bIyUlOrzS6mj4/sodR00XUOtTzvY2oL2dkw3xc8uYweFGRljjgVh6My3mr2eqnV4EhjhMcqXt0IJJmZdoxzg9AcZ/h966zxQ1hfacLrWZ5oYbOJ7d57RwvmEqF2zjGXXtjOeTXmE9raTeFXgBWCOCdZy8n79grfLvhcgZTGMgkEHGaqHwileMmjuvEsNtJpxvWkK+RD5iXcZLJHk8yYPHPA2nuccVn6Dq+g6NoA1GG1e9u2mS3nk8zymwQzFwjFlPIUfKMeuM89R4YuU0/Q7DUNDtiLJI/3QunTfMw4+XJ6k5yffiuKntRp1nPeQaRLeFJjsOtSxytbfLl2IwMruKnnrwcZpLS6ZU3dpokurbUkvo7C3SHRXvD9sF0bgs8kJyUYg/Mo4J2jnIPBwKuWVrHb2gtDN9qmKNDHcLOpdmcgkRJnJHU8+5706G61e/u7U+IbPSpb+3cR2ckwNq0meeecNgYAGMcioU15NO06a41bTYkvBNuT7Kqhl4IzkZUfQckAdKHe1hU1Z3YeJdWkn8KRTaRYXsc1rcET6vFApa2jC4Kh+TGSSOVIOO/Na2h6YL3QrW90qfUbEpHst55H+cZ+8zdyT656dKrXczWVzfR6DD5Ok6hp6Xiz3V6EAjk5/doCFUBhtw2W4OTzSaVfW9j4ssbSbV2kvWby51QNMkSsBlMg4ySeMcCqUdLLQlSTblLW5eXQLmxvodY1TV2ubqFFt5HvTiPYBhTjlmPPTjJrAtNQW58QPd6RPdRw2s0q+XMABIoUhiqjqCcgrk9R61H491K/ngvbfUpra1RZdtpaxtvcFCDmRhnLYIOemTT3ge28P6TqOqI0SRIsu/ymgJ3ykeYiEA49SQC2QfTOcnypPc2pKMpcm3Unl8SaeNalubK2dXtrcpHpsMQjiTIwVdk68Hp68V1+laPpOo6Rob6kBa6hJ8wt3cwsGiO4KuMbW28gdxgmuV1LXtT0Y6verGJLNHS4yV24gc4Eh4Hysw+8c9cGoPD/iW2bXbuz1K5nuo5r0XcN1cRrIUDRAlEJ5X5cdOD7CtLX02/r/gmMtHoy3eeJ4I/Ej6pJbi3FnAEWW4RvOwW5cR5CIDjG5voOtZt1aHVILG+0975rOWaRoVYndckHnb32jPLcAV0es6Npd5fX2reHtdv5tQuVPmRNESzPkHbucbQigdOTgDFZss8+p6KIdPF1E4Tbe6rdjCFM4IjkUAL6bacXpoidXfm2ZianeatJfobKLUn03KlrC1R445iud2SOeuBn+VdfDAkOm2ula5CJ9VkjW4lsbeQRxqu7IjJ6gYIGP4sH61lPc3lholj/YV7FDpME8kUmpT7tqAjAkbuSW7YIGFx61f8OSyXES3Ms/n6cWcXVzM375mwBuJByq4HQ+vam+q7FQ+K/cxdPhh1TxNdRiwTT7uKV7hYHvdsUhGPlY4+UDpxyegIrWg0RtdF3dzaoI4Zk8vy7WIywrIOCVGMnHT8+aiv71LfS7ryrOwj04nfax2aebPJ6SzOBgL145OcDA61H4du3h+zxNpF1YoT51u8zCN2XJzKRkYGenFS9dBxj0fUq+F/DFz9rNtea5aLYR3OZkFqX3AdF3NjacfgPeqPiaFYNU3aTeXdnZMWS6vEQiGND/CrjJ5HYdeldzr6NBpF7HIk+oxNsKw+ZsDpzkk4yPTGOe/FefarrE97BdWsMC2schUiILwgXoAp/njmhXnr1CUY004o1bXUYLLSIILe+1Ozt2dltmCosQDfxk9cn05+tZsjX+lbnubi3voJ/livFwGUfTp36+veuzsoDpumWumalC+oXTwgSxqoLW4YcAnoD9OBXMvp0l3dyJaQ6dZQQtgxSvmQAdMqT0xzzirsruxKT0uU4fEj6bGLTSBZwLGSZJdRma4lmY98AqqD/ZGfcmirc19pFrMwa1tJGbq8sQTdj0yCSPfiip+oRrfvJUuZvra/42E5Ri+XmOkfwvpaSRwx2wkIAR5CcFwRgZ7H610Gm6Bb20qadafYlYIhjieTqwPY469uDXG6T4h/sW8h0nXdOvYSsnlR3TRH5mJ5JyOeo5HrVRPEOo6hq+o2cE8drayq3lyXeU2FTyqkDOeMj9abjfqXzxt7ujOl8YTxxvPDPc2C6qsw2ozJIy9tm7GVOOM8fnXOQXfh/SxY3mq2622oXKut35B8xWifoDn7rD2weKxblrS2k0+O3sZNVe+fzDJLGGndA2HwQeCD3rffRfEAM8pu9HkDQARW0kSuGBOQ+NuAwA6nmlJK1kEJa6q5k+Kkim0qJvDc0j6U0gRlcbXct0AfOWUkcjgjirA0fxLcW40+Swj0nS4ohbumqSBYFf8AuwlhuZeONoPWjTNf0ufR5rfWbVvtUc22B9PQQKXx/wAtAO27HIGcVVfw/Z3mpQ3kuq6guuo3723W6Z2t5QM7Q57DjGD1+lNuSRDjzy90c3hmGPRbpNV1zfqUbSBY4I3kXYygAFn24IxkAA9McVa0aHw6bIyRaBeXrCNrZjqErRxM3ViqALkkH+9xUGteItS1ma3Mk2k3+rJJsFneJ++bbyVTgISwH3Q27PA5OK5Rn0jXnaXTtZ1LSY5Y/Mjtr9fOhZsgmKORCMAZyCy/Xnrm1J7sTnTj7ttf69DtTrMdtPb2Y8P6Ppl1Ig+ypFaK8xwCUVi5O3d0GfXPSnWeseKtYmiM1peT6YIS89sZhH8y/eA24yOmAR06VZ8PeCbW4FzquvXGoSakrrKsLlRu2jLbyCd4BwcjGOld9pNsktkJdOtfsqhWJRBhZMgAuM9RwenQjHtTfKtkUrvfQ8f11otae+uruzGnFLcG0VBtico2JFIA2jGGKkYJPByea1I9Tn12LSn0jSkkmsAHtrS9vNoa0RcMBOduOQT3wOeQK6bXSjeGDf3M8USWiCJ3ktxJIsLnYEUnGOSQOcfSvPLJNt3Ha6TqD+enzQSIpzboBuwx6ADj1HPU1S1Vws1Jx6m7qOlJ5eoP4Yn0ttNedBDqtxeGaac85R+8fXpsGQoOSKpyaBqMU2oQXulPCEOYblYmAf5huCyD5ef4c9fxqzDHHB/aM1npaTaZfqsEdpaIBcLcqAQyJzgplmycqQRjHZkVrLq0y+HILfWDcPLHGbyRHkjPlttkd42JCKucnDHB784o0XUlNxVmRWuq+IdI0ae7ubebU0uLo7Jpi0o2jbwWGSoOSNuRjBGK0m1CTxNeTyaXp8mnXVijW8k6sZQ0UpAaEjHBJBwc9yDV3V9dm0vVvI0t1itZ5cPfHMKyjI+4qcnvjg9c96Zea3evZRXHiC/kQ3Tb7WznlZnuEzgMI1AXAOcM7DJ6e8czb2NXBJb6djHXw5q+rJawL9nstBjdnhinu4o2YqW2jaxDZySA3pzW5oeo6lpt/DZeKrOCxabMsN/HOgRI+hVXBKsD06kjng9uIu08OyvLd21tfb2kC280aqXMmedwJ+UDjGDmtTUJb6Hwm9tNqtqLA3O9pZoVuI5GA2sAApKygsoPT5SO3NEnK6TWgoxsm09fzPStX0+xu4ponEs1s4WQx7CEOTwcEfNkjkjHasO+0C0u9MutNs/M0+C5kWWZrY7GfYe/Xj/9dafgLWYtb0qG0SOabbGw+2sgBLKcEMg4QYPy8n86uTxpHvWWTYrFgrK235RjOc9OvUjqKhqzN4SU1qUrQadaefJawxq8SiNjayqNmASFcE4QAFieM881lWvinTpL+VLaYPPZwGdpHkzFKoODtbrkEj2NT6zC2nWc39neHrq7k1GUtM8EYnjUE8PJuA3LtOOAR1PA68pFb6jpviC40nV/D9glrNCVMmnW4gQxkA7lk44OOuT8wA9quKRnOf2VodVY6bZ3up32uJdIba8tpIUhb5YZ2MbcSAcYJAbA5BGevI47wp4S1O10VPtqxwyahcokK2k0c0iNjruyQjcDHOareHYGbxNcWULXg0aSRmxJL5bTICeeOAOpJxz7Zr0yCx1CfUtThtptLvNHgMaWkFuu028bnBdi2Pn+8MbiSTnilLR6MhW3a/yOW8d2JgsrhPEzhp1iDbFBO1y3AJQEBhgEnJ+9+J5Gz1mDWLa1t/FNrfzCM+VHe2BCTNEFwqPkYbaehJyASK7eaXU73Tpg+kPJPYztBAl42wpERgyA/wAYBwAD27mue0GxfxJdGKWZJtKgjZ/3Z8qd3cbY9g/hOVJOcZA9cVUVpdk1Pea7iweFf7RuYojrckegPGZvMuWC3SjYW3eV0ZsjOQTkZPHSn6rZahoeixx6ZbLFZRhD/acsq7WYdJFi5UOcnK/N1rGnsFtYYUNrqGlD7YVjnbc7MehLHHPy4GBwRn8eqW6s9Atbmx+wRyaUpRJ4A4liWI52llJyrBiwyCOtN3uOMVy3RiJF4p12GwvrvV7J3mUiG3fylZowDiRYwoxzn7vPGelalld6tKdY0efTUv7EQ7/NnUqTIoBBjOSdx54zye1VdEtJG1oattsL/T7eXzU824BaFRnARhgrgAdRjAxir3jOOGXS01W1vZtRtra+3pFF+7EZ+8uTjjG0YI5we1OXZ7fkKKXL5/mc+95dX11YX1uIZ7EZit/OTD2+B/qwc/dz3OfwxV+LTNQ1I3WlxGKKIEzyQRABLZuVQgknrk9Tz19Kn1HwtDOLeGwh0628+JbuODzCJZWk+YhT0O05XBI+7xyaqaKde0prt4rWaFvtsIZY4Syvwy8KMkxgAZLEncR0qb9C16Gz4V0Max4BaJLMarqml3MkdvbiZoXXL/NG46FcnePU9wM1a+G1xYJcazpmq6XCl7Zq8suyEo8L5ACMScHvgj25PWsbQ79L3xdqmjia502y1WJluopAQ8DL80U8a5zsY4+TqVfHTGOn8M30dzBfanPqltrC3kbqiyQ+XcB4gu5WyM5AYc5I5HrSbdn5mdvfsji9ci1HVrsXmo2dnb6Vb3BJAuwk7qSAYgIyX545wMYJzW94kik1DVlbTrw3ej3UUqrHEFdo4AgXYE6swGRjkjqfWludeGo4Xwva6XaXMTmTUbZ7dI5/LAx5m85zkgLkYwSOOc1yUGsxwaPfalC9vY6pFcqlnHDPHLLErDLOiZyOhznn0qtdh3SvKRt+FU1e+1phZyazoSeSy2FxK7KUIA/dMkg2yISp+U9Cc9ql8R2sGswnXNavbyeUJsuLa2YIsKIwVJOgwT3AyARyR0ra0Sz/AOEm0u80fWb65k1G6hRriTzf9IKDnBTkBugC9cnBqtqZ1AWMFq8BtLu3YyXIgvraLUYbXaPmMRc7gVPIPPTg0PfUj3Vr1f8AVjJkWUeG5Gs2eey1S8NolwSsbrb+UNx2k8u3AJHAAx/FSarptnpWlaVb6Zr0d9AW2rpczBY5nDZYEAkbskcflTfGCRaXrVvbX5UCKNRJDeIZoDJjcwBiI2sAQDgAEqexp9taxWutx3zm3ufLImkgUL5c3GU2xkFjgY44PbIqo2tcpvmu9zFcXV1eaibGKOwW+t2+2W13cRocKciOOMnPUDHGe1dimnWdt4bu7GPRI4tQuLeFLgLKUQv97d6oAuMnoa4qC8N1fXWo22j2N65aWWS3ishkZbO/cpzF1xg8ZrauBH4a1GLVr6K8hsL0BJI2Y5aTaGCvnBAUMOD17U7X0Jg+5p6jcLJZWtrpgaS2j22ssKzukYKJucvIuCw25OQfxPSucgsLW7I1aO/i06+mkCWc0FtM/mR52bQGPyY4x1z7Vr634ii02R9P0sQx2KzuskU1tvaaY8llPTaUwB3AHSqmn70128mjisklWTzBYX5LxmLbuI+bgNxjsfbFEd7/ANf1+gTfNt0Nuz1jUdBv79FttUup4oBAqXdxHGxQHBkK8kZwehP1qvp/9jwSOlutw00wjne3Y5Q85DCU9gT92o7TQH1LVv8AhJ49JSRLlWWSx8w5DnjchwAFx71uJ4Q+23vm3OoTylUCQxtyIBg8jH3iD06CplOMWk9zelSnK8l0Mtnii8Vyy3Et5ayCPzpWkuFETtnqUAyAO24j6VV1t0sLiGe3h+0PfESPII/KjkUHK8vy7c5wP1qfVtPltLCzE+nadArSl0M8LXF1ePn/AFkjJhAf9k8D3609LK/S2k1Apf3mrIxM0N3KqraJ/tNnd07KR6VcWlZmLbd0yvd+JLyzkDWunxRtMN7l4hJIT6MSpxjsBRSW4S6kkubSey0vzcFoZ7V55GOPvHaSFB5wM59aKhzpQ92dO79H+hMryd03+Bl6nc+LUe5R9SkvI7RgXisb3eu3PVYzjI+g4zVK5uNS1+RbaMSPG8wEl6oZth6fOMZRgPXrXokelaT4sj3Nb3XlndbkGLyJ7aYY67vvA88gnpVuy0pNK1ZLd7KSCeR/LYH5EuQOhc9+OhzzQ2XBN3SegtrpUGlCax8xZ3tmbyXdAXiDqN2GXqCf51Tur7zoNUltzdSSWkQd5beIycNkBlwfY5HtzReXeqNYyz6dp6X3l3BEsNgSQsfrxlvYjqAa4mwvNS/0yxWzuLe21F1iKFyZIzu4IcABkHQk+hzVRiupcp8q5YliDT5dUtv7W025a61NE8me2j/cyKMYM3I9Mfian1O0QWIVGE2oykgylt/mEZxu9Se59a0bi0tbdZIrc3F7dQuqveK215yuRvYn+DHHfIAzXPmK91WSRp9DknkVGga6SUwi23fcbdnYD9exqW+bYqMVBcz3Zm38nkXy3+q2sburRytat+7CnGVdwpDKehABBOc1du7PUdR1SbXEs7Gwhv3BYzJ5tvcK/wA3ybhk528gYx1zV3W9E05be6tV1iKS6DIi3DwAsFGcsVB3ZxwDyMemc119v4V0zUNC0uxn2Xlv5v2uG6llK7CRyQc8JwBt9fahuyuZODlJ3GXGkXX2s3dlP9gngkR54CC6SF/u7A5BjHbAGcH2qrqesS3FzbyNbswhUxSNYsYz5i5JRVI5bOfXlj9K7nVtOsoIY3g1R7i6QqrrA6tggcZ5+XtjJ6ZrkNV8K2mp2Md9fy3NqbMSOs1uRz824+YT0xgnPvyelTGaZXKmuaJh3PiDxTf4a0sr230+dWW2H2Uq0TYO89BjPcHGanttI/tjw+X8RYOqTbRbSoB9oUcgrKiY8wAAEBvn5x6CsnS9XuZ55IPLaEvs3yTTMX8gH5jISegGB9SMA9a6R7zV3067ttF01YNQltxNDKrohj3PhTluMBcnHU+9OV1oOEIPXc0ND0qx8KaSEuNTuLSQbpItyMxQqRnewwdx7Rrz698UhrGteIZC6ia20lshppwEkmGckqvXHsTtH1qTxXf2+ta1pGl3l1EksMUcFxsfCSTYBwM/dUnjoMn6VleGdQijt9ejkvWk1G31Fra3tnkw0USKOUjP8OTjOOuKy1Sub0rOS5v00M67trLQIJ9RCPfXrkxW7Ptk246v5ZOSikAdOTnP3cG14Ps73xNeS6hrs1ne2jS/aGtpZds0bbSCyEcopwAU6EY4GK57xg08Ouy3QkkS0hEaRTRxmSKDCj5W4+Vt27OepJr0qz0SyguYtXsnlVL+JGAtleOMocMTGrjK7uxycbq0tyrzMHapO3QkshY6RbG1isYVt4pjO0TLkFzhcEH27+lcRdQ6XottNolpcat/aF9LHNGwi3IjAFQiYPzNtYgtycgV3t5rNtHpM8k4XS7e2kK/ZbaIRpJ8wwQSR5jDPPToTiuI1jX5dS1eyh8Lzx7klwgmiUOzg9VY4+XAzjINKCb3Lco221LPw5MVrc6ra2Woi9l3At58TK7EE5IJOMA5wBk559K6/X7jUHsJXijt01G3TyLSOedU82YfNgk8E8E4/wBn61xOlWVhcR6jrtheKlzbbrfyJoP3Sygg+bwQXTpggfeHOcCqMOiwa5c2cd5rs+o3iXBuLtIYf9ax6DeWG3jgsVJ54FNpP3mSm17sUdz4V8QQ65q1wsUbWd5dWvmN9pkDRMzY+VG/hYt/PjpisH4naebTUY9akmlW+jaO0cMA6xnGdwXkY6DuM59axrfS1tNan1LQdRuIIbVhHqInlDeQgOANwAyGwR0GCOtdTDq9j4vn1VYbVfsUJQLwCsh5wUwAPlP6cmlonzR2FFN3jI4PU5WV7fXdFn3zbxIxSJowXDfMSmcEFuCo4x7Guk0rxJp+vSGx8XLbWlpeuvkGBDv84EKvyp8yg/NycdRirq6FbaHEly4QiC4E8aKCqYOVePjuwOT6YGMVzGkCLw/q1reLpb2lrc3Jhja5EksgPA2I3y85K8nJ96pPmuregTi42s/U3fHmmNDq9uB5culqhVXTUpUwcYI2c8jHQ5PBNYUXimazmv5PDi3i6eJWuJ3a4WWSRiAp2FlDKoUD5V55yT6d54otP+Ke1FpbhLZbMxhEjJjkaXdjLMAcglsZ9QOgrg9O0mx1VLm41K81CaGILuAZJXOSc7XABHQds/XiiNmrvoKcG5ablm0kh1Dx1bW9re3UjXMW8AzO5ll2Fljkc9FyMcDA6dKrRQ6tBqDaj9m8mWOYQXNu3zoxcEPKRnDhQRwcjkelb0X9q27yywjTNLSG4KW01va7Gu7ePawDtyzAAjk8kk96zlNnDDp99P8AZoVbdII44/LadgeFC/dJx644x9aadxqDt72l9SKW51q3lVJlgguba3WSe2ktY3jmRyVKHHB3KFbBHtniumsdRsb3TNThURabFboXMNugQxA42qVA4YkkYyc8dK5K5uWure8+yrPNLcMssm1f3wGSAxbkjbyPk/vdhmuj8Mz6Xo3h+W1jK/aNQuvscLkCV5XA3OzkehYD680mroqNoyuU9L8Oa7relaz9shtxNGguNOj89fPZtxLoVBz8yAnB7qCOprF1WS5U6baaXNdQs7AOhdgrZx1JJ9TxjoRXceCbSwsPiCv26yuJJ7pvOs5WYnLjJcqB97bnoeg5ri9Tkn0LxBFqti0IW4LYQyMSGDbHIABDLwcY9e2Km75iY3XNGRoQzWl9rulWSXare2s32PULi+JimI34XaVOw7egz8wIXJ7jQ1y0tby1Cq5sb6JJ0E0SFVdpH+YSRpnEh65Xgk4OMCsrSZLSfXbkaqgvoChnMGonJSQ/ccgD5uwwTgjOQa0pX8u7aTdOJZm86TpkscBuT2OPw6dqzrTUEmjpw2Hc21LYq+HZrHw5G7woZIoY0NxOeDdq+RxnkcZIX/8AXWfYahptx4lSKDSNGn0uWQmKKW0SN0xymM4IIbHU8+lP8VzafFpzQ3EVzMlzIsny3Jik4UjynJU8r27YrY0zS9PPhmO80/SdTnEcJcy3UcU7Qtxgoyrhh9QKuDveTMqySkodjmfEdnof/CLSRabBeafrEt1595aXQbcWViR5b4x1JIAyD9cCoPCtpPf+IEvTp8KW8G28mklh3SErhsBT/F8v+c12/hHVpby31CW+02cPbbY47u5KkSTuRhGj/vhdz5A4wCe2a+va/oYh0+5lsmszcARIE3BI0PytIMDIkw2ckHB/GqUrS5UZRgmnLov6/Uj1e3M/jWbVLPTpLax1dnMOq2V0Li3uSehZMfI+QeMjn3681r+pE2YsodRnS6EojmzaCKRnT/aPY+5omtvC0N1M+mapN9ihVlt2Zky2O4IA3Nu5wAOTnNXhq+rXdvZXmoQHV9PFu3nyXcCj5485DN1LEFeTyQRj1q0rJeRmm7cpKNYvZWuPsesyXjWWkGRiIEJuG43NKwJ3bN2NuSvbPWtYa7YTaXGxlhaaeANJFdAyKs21tz5YYG18EA5A57Vk2hz4F1CaK9vRp8sv2iGHaFe3SMn5fl6xsWwRwMqDjOap2uuWT2EF1rUTPc3ESw6fI6gQyMDtLOI13qo9Qck05a6L+v6/QcXy6y2Zp6ld2+oaRYaVqv8AxN5k2zi/AEBSZSQEJGBIhXIJ6/kKzvFcs2sagtn/AGSHvpH2iJMnCLjJP+PoOaoSeFtQiuYopbqGYSSmNCsr+RExIG8ylSNoyCcj610Ny1zYaTaNNpzLrmiXDQJeTmRYpYmyykBSPMOT8pOARzzS0Tv/AF/Wwc1k4xW5kXNzeaPq7ac1m7wOyhIoMw+VkfKgzkyOe7GtaPxxbraXdtYy3cdwAPs1zsx8w+8pDdfT2rR8OXk+qXEF9qWkwwXVvu8p1gkVmJ/5bNKSVyeh6Yo003eoayWvk0ayliYiMJJFc7y/AMYBJU5x8xAx60nG613RrGpJfC3Z9DK0jV5GiYXt9cR20MhklklXayzEc7TnJP4GnHX9PurZbe+aWKKVyI5Nvn7lJ43A8kk+lZPiTwZrFvBaWX2Cd72S5kcyW0nmAg+qjofr1rO8I6PqGrXb/YdY06xu7OQQob248uVW5GMbSBjHbmrupXuYyqOnojqrawe3DW19rFukMXEMcdnJGyg8ksqIcZ46nPFFZlpcR6Nf6hZ3+vR3E6S/PIk5YM3cgkZP40VSlJ7DSh1Z0euXtpqF9b2utzXtrqcNwrwS6akkreV1IfOADnncKsS25S7nEvjXUtTtbgMWtTpz71yDjDs2FIOOVxms46f4q1PdIt5No9kE89JpndVlTcMqcZbJFWG8HxTG9j068uVm1EFZDNMD9nTIOBgAsT6e4rN36Mrku7pf19xmXOjRXahv7QksXmKLNC6uyMVPyurdsHkg561ow+HdStnuYYrqC/F4URHguPlmbI3o+OR8mTuPI2981Bd+G5fCmpWcc99a/wBn3kZ8yS8dlcEYyQi9D6HBGetW/ESP9osotJFyl3BLBM7RLnzWXO4KR2bAPsCc9alyktehpGMJbblrxN4Lt9Odb2bV1Agt3E2nW+55XiAAyAMleAMsRx25IFYO/W77RYrrwtCzafADDEjRbXRlxnarHGORlhljzkmqviOGwtr6Z/KY3FxcPNqL2V7HHc27qxwqMxII5GQc546Vp+E/FcUmjLpD2IdoW8wTz3ytJMC3tgg47L2ycA81STsY8z5rSf3EsXgizufE8Go2st7e3bsLhrNVUKsgAy7PnAQHnDYzjHeurvZbC1srnUNZcfZoYPLVIyD5x5C8pwNxJGF6DnOBmuJ1bxtBba7/AGRHpzW2mwXJS5hu5WCBARhmUfezyRu3Y61Q12S/v1m/t3VI5tEaUy2qwxb3hByE8vIAwVx3OetKzb95lcys1A2fCniNI9Ba0m1S3uNWkkM1lbyhmDxrzsaTAAbAYAHpxzVC41HxbqUF/p0+hRGwJG+C4/drlegWQMu5icZ5I46cVqS2OlxaYHRtDknBgiRJHRp1LnarHC4BkYEkA+mar+Itdi0mSFGuI0u52dpZYXWV1zkMQFO1PmyPY9uhpXu9EVZOPvS0KV7Y6fHqlydMtIESSNDNa28hZkcFcoZCxwhI7dePStbUJfs/h77VqTT2ejiVY0igPnyIW4HykjC4BALdcYA5Fcta6c4h0+bwnZT3kt0vlXFwELukpJUwycnaCCCG465rr/DvgrTdN06VdQeQzywPHcFZt0Cq+AFGACduDgHuM9uB+bFGXSCMaPVdC0eW4fSrbU3mtblAJWlQgLnckwGwgncBwR+JrV1HWtK1PWbLVbp4rrX7aMBHMBhd1JBPKkrIwK4wQuMnGeldTo1m2h+GJ9MjnaSyEjyC4nCxLIuSxjH97HTjgfNkjthXXhzSTo0mpaTGq35hke2+zXHngyDPKrnG8dgTjPJ6YMvlbGrpp7mJpuqR+GfGDand3mn29ncpJ+9jjPmMhwc46B92ARj8a6LWdU8Pa7pMg1O+uFsYwsiXCN8yMMryo5PLYKjp1rkdAuZo7m3skuLywu3Vibi/RDCGUk/OGH3ccbsEjqR3rpVhe1jaUeGdKvPtQa4ijiXz4p8rj5EDbcMPXiiTtuOMOdvlOQ1i6sdelttKW8urvEx2XsYO4YUAN5ecNx1J2nGD1zUel3Fh4Y83TbloLvV55RbyJAMgc7SgOM/Nnk8DHStZdT1QQJef2dHZWEsP2eO1hRbdU5OBlcYRTk4Oevqajk0+XTdNin01TLqa36XVvKbTZAFHJDMPvZOMEZPXkilOV9EXCFveaudFBHrDePmmsG0e70mOb7LfQy3ERVYt2G44YE4yoA4IA55rC8V+E10GOLUbDUvPhklO2Nl8p1JOVUEdRgdasaRexab41vtSksLi90TWVkkt7u1JlVQzbyPTKMdjDOQR+fVRrHdJDJDGl3bSFZDbum4rnkZHOCPwPXFVdqzRnTgp3u9Tk9IukmM9/GgikQi1uJZJC2SRlN564J4zgjv2qrpus33h7WW0yKzkkttTCkLHL5ib+RlG4B5yD+XUVqeL7a806Aat4S07yiZl/tCK3Zt0mMjBQZHl8ncB3bnioNcvRFaWV5FYS3+kW/72MwsGu9JZuWUsp/hY98g8HIOcl0nfoy221yvdGr4o0OW6TUBfTTl9Ns/tHkQKUdZMAqfRhyc/SsbQL2yurDSvFGsalawRRiXTDM8TEW8/LLtXBwcOW3Dp+HD/AArp+tG187SfGajyZftVmJJD+/DKwkhkD/dbDAg8gNk8cGq2n6dqFnoqnW9LjGiQTTO585ZGSTjEjAAqD0XcSScY6Ypp6WuZPmctVY7fXJ4m0XWb2+a2QtE64BCmRugCggnO4hs4OM9hXF+CdKudWE0+uabLCAm1tQ8tYllQYO1hnBfOPmXOR+dZ9xJevplpbNb/ANtl5xJb22oRGSRRtbPlMGBG7qQPQVe0bQYNOspZ5bIQzTbJ5EkfzJYEA/1fKjDkngcnAJ6YytIRepcYynUStY1rK9hstXS6aMTR2UZJjG5tqbSCAF54BOPU4+tYel3MeuRa7dXj6jJMZJXt7WM/8svL4XkEgg7T8vXn1qS+Fm73lhd74gsSXEf2ThmPOPNY4LkjnHQdsVoWu5vCcc8F9ZwCSUPBK8SxvEinaw3gE4J789DilTjZXNa8lOVl0OY0Q39lbQ2b6fd21mzIIHwd0jSMAzsxH3duSB2x15rovDGgpFpMl3ALmOTTrqSGF2UcovDAAdOoBPXJPTFUoorpfELtq+vwNMY/Mso7ckRlcMA+eAS2Dz35pvivV2v9L0PXTN5NpBdrZvECUPmv85bA4xtB75Jx9at3vYxSSjfsbeueJNZ8PakZtGMbxz7LcCVPlEoQkAdNoxkls8gVyZh0K/g1G/uZLx7+1tAkNg9x5ETAkLuZwuVIyTsz82cV0F9qNrrVlceSimCyvQ1tOQd0kgGGLD2XnjkZHc8YV5dNqKT20CaTf3d6yid/sPRlzlm6EZ6knoATxQvxCotG+jNKS6a60ieBYmi0e1hjtEs7eABrWUAEOr43OMZO4k5zyATVb7SJxZq7RsrFXM7PgcNgnaehGCdvv7102rTz2/hiVi9rYQCwVrOeKTzY2G3KhSM9RkfN0GOuK57RZLrUbS0MN/BNcokcgnQbmkkjyd3I+Zl6En0HWufEJOO3U6sI+WVk+lyTVtDkn0+e00tZJru2iVbmzkZYZZ/3kjbkMnAwjIcDnGPWoLuwvteFtZWthdaZbxwBDdNqZJOFyRIvG3GGzg9+M8Z1bG/Mum61rWrTXlzA8ryYiVWAkG1fNYEYwCcgdgv0oeS2vvBEUd5rUF5A0scl3l9tw8ZkIKhecgMUOc9gO1aU1JRsYVXFtt9jB0hLq102O90rVL2TT7aeSW7+1EssGFAD4YkgsSuMDJ4HFM1w3uqeHtEbULVtYimMs/m6fC3yt5hUgy7cggjow288ZrT0W/0X/hF/Fc+seGxc6XIYwkFvM0kbtGBtdWOCCQULc54PrVDxB5r6Wl8lpbafY6zLFvElxJGsU6qAvyAFWjKqOSOCOK0sr7HO5ScbdA0fw9ZalcWtzFBqs9pp84mlhuPnYDG5kXAwx3BRyBkc1rSW2lppF7p+iQXU19eOGe3ublsuxyDuLcrtGCQCPwrLWHWI4nuUgsNNsVBmbUotSlnjaVeCmS2FY8HBUYHI4rB026jmt5tSnsxp8FyGjVUgyJ5P9iRyW6nLY45x3qrJ9QUkktPmdXqlnp0T2egai96s9raW1jHd6Qy+Us7BmclTgMDu69Tyaz2ttQXSrga3f67b2cE6QiCCwQZAIx8oK427eoyDnNZmmQT6lfImirML4+WPKJ8tI3Cvlx2UKQc7uME8CuovNav5LTR57S+0fUrW1IiP2nfHJcuMeYIm4G3PTpnGTmhaMXKnuWIdM8Nz6qrWMy/2gUaFrbzmPmJwWYjpk9+mKz7u3u7vW9W+e7jmVI1toDOZImU/K25uQuByBVmTw5ZLr97O1i+m6I1rIW1W3nYyF3wWTBzk5+UADp+NO0qDShp4ntNLxOEbE1uphllxwsYGcEk9SeuOBSvZGtm9LWKvhe6ttR0c6FdXskdwg2RiF2ZyMYO4EAY698VlT6q+mG6sLuORbxwNk5hQztED9w7BwOmAM1b8KarqPiO5uNK8O366My53MtuVcqCeGkBLZycAtg9K2tHvbGW4RJLmfTfEVqGjZLidXuLhQMgOwjzuI5xkdRVvf+vvIUttfmQ3njG+03w6sOp3A8+5JZYUYiVE5AJbruBOcGs7wrrl1KVtZ5la4U7raW4hyMN1Ysq9uO+TRqdnOmjPO/h15wOEmcDzEY99oYFh32k9eaxtV0axjtoZtTj23MaqZ7Zle2KBhkFgORkduKSsrscr82nQ7jVtB8L6rcLNqesQx3YXDqIWjJ9zgkHNFeeQ2K3cCDTbW0dEz84LAkHoDvPbFFVGNlZP8hpt68p7leK6QbhKltAhCxjzRGp7ABiccemO9c3qHjK107SpP7Khi1K6VvLcqWTav8TZHz57Bl781x+laE+o/a7nXhqEulFleGa1KSQySE7VMMuQQ4PBTaTnrjFdVcDTPDdoktja6VbX4GJLiRvtNxE3oGYbd+eCFGBzlqzdk7JXHzOa7IzIfDsawwatrRv5JpQZrfTr6QvLHGnWSSTOfK74IBboB3qexTUPEVsr+FrrILNDqTTFYJSrjAdTnhAOiqcjv1rLGrvrEjQQma2upryPzZrhtxmLDaplbuo54HGDwK9JggsdNnFjo1lbWQjI811PlomCRkk9mPTvn6UndavcUY3XKtjjbzwfpsGl2ttrMcUviTULgiCTZI6K6qXEchUkYZcZIHPTqK5TUfB19pVrFFdWCRtegFrmNQ4twhDF1XG4q3TAwcjv0rt7XxZqem3F7q2sTiaA3Wy3sbZCcxYIJUcHBx1J4I9a0nsnVDPrzyz6qUUbSj4aNm+RfmJO/APHIzj3NPWL1IUeY57w7o9/r9teLq8t1LFKrRwNdQJPNAQBjYST8xwvBIGMj3rUsvB+hWk8st19pv8AUJYkbNwwCOQD8wUfd5xlSTjGB1rdjt4fPtUtvtSyxlmA3+WY5O2WABbGSvzdh75p8Upe6UIPMYsNqqMgnpwOh4GPTp7VEpG0aXcqNpvh+GWJhp0KADd+8VniaTcNjHPREOTgde3vXs9E0e2ksy9tFLNE8rmWO33Q3cshw7bTwF4BCggDHHpXRtq7WdsIfs8KxbjsCqVOQec89c+lQXWpagbIW5tRIxRJyUzt2t0KjOM5OKm73K9kr7fiVtG0waTHO+nW0WnzTM0kzgktMSSB8vZecc8VYsChn8yCFL6fkM0w3Lv6gj888+prHuPEOhahrEmmRahcvqiSC3iaaFoQ8qjDDceh/u7gOR3BrjPEmpa/fTW2j6ilvopW9aRpLiUxlsAlZC33mUfMQyjljjtTUb7kurFLRHUeL/EVtpsV49/PHf6xFmIWu7IiD8ZxyoA6le/Q1zfhQ+IRptqmli5tWN7K8SNGY0mfCkM2eNmAFJ5UenWq19HpKyTalpF0uo3QbBu7pRHb7yc7gmCzNwTz37d6p660ms6YYGvjf38SRsIyzeXcrgkqnJZiBghSecNxmqSsvdFa61JtW0uS/l08THS7W/eOSVr63vXuEE/mnIEIBG0L9Fycg4GK6g3arAkGnWkgiibZbiAHgehI4JPXtzmsKx0bxJeWc6WkX9jTQwrm0kj2sXAByNwLDIIPsDjpVHXtYtoA2mXWpype2IECz20ZVZpAMvg4G7nIB4zgeuaTjzqzZVKcaXvIlufGQF+IdIgiur7DxS3UqFmRz0WFG4Tb/ewS2P4eBWrq9p4o0/wJp2or4kCzWtzIboT3WFZ2GFwzHDAIQNo7kkCpvDKnxFpr6wlw8esWsvlSaotoqTMu3Cjcf9YQCQe4zzxzXWXOh6bJDp/260trt9omxMRiKQghiFOO236c0rqD5US4ur77d2cVZajpV+W0lp7i8iltopdQe2Xyd044MkI4wwJXOQA/8o9HGqeCdWNyssd94cuQzrIhyJo8YDEH5kkBwCOo5HNVzpWo+H/GEttDp8E3nqEaKLJacMMlYzyQAcNx6AdK1rRryz8SW+i67a7tI1+3Mc0Dx7DBc/MEcEYKt8pz69ugpv3fQVuaPmjq5ms9V09byFN+j6jCUZom8tj2J6ZDAg/j9a4mXwhrVjb3U9lfrFY2vKpaEtcXAyBu44XI5wT07Vf+Hmqy3ep6lo8sSfYbRW2RRmQmFi+CcP8AeyScluRnsK7DTNUFq5i2MwhOI/KVmYrxnbjt7+/pQ7xdkaJe0jfqjzHwxqMc08kMttK1uJFRJTuEsGcnc5Aw654weVz6V1kxWO9W2lVjGyncyABR7BRwMjv+Peub02bTtI+IfmapfeI9QBuCohi0/oJDj962ckDIOFGSRn2PS2x07SdT1WDWbK4uxpymIyRNtSSTI2YIIJfZg47ZPHArOsm2uRG+FrxjFxnd2Ker6x4f8JWdje39lJe3EzvGtukhygXGWO7gZBGKtn7Frselapo8lzb6VqG4CPywzRsPlV2APyjd1Cnt71xviCeTxKTf+G7DUdSs47prVbXdvVFC/efgsuSSMsei9eK1b3XEs9U07w99ki097XyYIUZfL+0RhflO6M/I2SdrY6Hk5zTjFtK61MpVvfupaP8Ar0DUbvUU1DUdGabTo5LaESXOoqqRuI1wdrEc7Nxxs5OSpqlNe6TcaVFq1/IJoBG0M9xbZi2yfwgIADjO37o7H1rZm8P6Zq/2q4tbrSle7/fBXl8tGfJxv6g4Oc46kA881malf+JvCOmzWrvYwsUVLQQNDIclsmVQMtkcjcQMZGK15l0M5Ll31uVZ/t/2wWl9eiCZ4RHa3hiwIyoCqqxFQcEd2A/E5r0HRPDej6LHJaXUsV5banDHMYwFxlB1Kk9ec8YIBIrz6C11TUJYNNseBGhmS/u23zb3G4kuckDfnHU5OTyadr2iagyW0d442xJLJLdqA23phcDjJI5H1qZe91KhTdtUQ+J9citrG0l05hZWN60qQQWpCMsYYfOGx1Y8kjk9O1WtTjuZtL0K4H2YaSlz9le9nuXiZ2kZRgquS4GcbiDnHXHFW4NKFpp2i2Ed7dxrFbo13Gs0SBZXyztGXXPcZwe3SrXi+90izh0+y1jRxe2s86/aVt59joqcrIi56jPzLnaRnpmqWi0IqXav2NPxilzY6U2leF9Ck1HQWUrLYLuJCh8FkcPuXBx0H6VzPjm1j0nWbO0+yJZRW9rEtzbW8hAjIj3vGJD97cD976DnFTaUulP8S31576LVrVGFzC1s3klcHCKExk7SAvBA9SazvF5uvE0Wp6nehFcOss8SHLlPuARqPvYAVfxHXk1zVvijDua4eL96qtkv8ivq01zdeF4NZt3/ALMNyPsy2IciLByH8snruGDg9Bnmt/R/D8K6xHcaksDxC18mGxbaVlQAfMQDxhuTjvzmoprG61rwpY3d/bW1lc26iNftUoiS2iYFg/lnox+UBmBzg+xrHGpX18LZtItI4ym+3gigUGe2ZgD5nnAHaxzux0GTwBzXXboc91e71NHxDq2jT31kdNu1+wm5xq62qPFsfGN8LL8u0EAcAZ/2qdN4xh1WxtLO82yaYYHivljQrNHJuYxMj8kYG0fnmrHiSS50eLUJV1RtUCyJbXC6tArQ3cIKKPkRRly4zuyDtAIOavaFYySeE9dkvfD+m6ZflRbxy21u+JIfMVtxBJ3FOoIJJwO4qU1a/QXv3sc7r0mu2F3GlmkVnpcpU21nuQq8JAG+TrlzgA5G7r0o1rV4JbrSY9JuIkuobhrVnt7IziNjjcRGcLgk8fpSJpd9pbPfT6Q8cUFwT9o1JnC3b7f4FHJ4yRjPA9c1b1KCKfXdMmudcWHTPsrXKvCzMNsY3fMV7lvkxknpgVSaBq0WbJ0iz0TWYpxqkkF5qdk9tb7gEiiuS5+UJyrbmBB7DI7ViSaRqC3a6KEjmO2N7p9XRRG0hwcRFTlepAYAE47dK0We28Q6xpN6CNTl0+S3ngjQkeahyVjkyMrzjqDknmsu11yx8T3V1e+If7L0TV1yxmaCUqrA8Blyee2evGcZqY3Ts/67FzsnfobFld2miSXNpeWN3psdxlo4zKZVOMj90G759DXF6YdT1Ixf2PdKZ4wv7hp0ZfvEbjG2dpBwQfXpXYeJUvrXTrHWo9Zs77TnheKOa1j85J5FB2qMnCnqCxxjB4rm/C9xby6bfSLHF9nKIsl1PB9nkjfIZsPHjKDHOfUVS623JlLmslsaE81/dB11eVLjU9Qg8uJ4r1rJ3lzhN8YHyscHDYHrWlfz3I0W3u9Sht9Eu/lik/tFhI0uwE7WkyWO7GQWzxgVU8R3NhqF2WttOntHjKXdnLYu1w1wijiSXd90cHAzwDzXPazqs+sWdpdXNlosEyt9pmsr+STdO7EiOQuwACnAwmQMc01dozclDYXVIbnxRNDc/wBq6bO0cPmgK+z7OM4ICuFfPvjHp2qbXIRdaleS3Lg3CRxQQwPNvGVUDLO/3m9u2aozm1i1GYatqH75p/tF0sNmwi8zGAiucEj2AwB3Na2uJa6reWVhBJpEFyUE8Uc4YSPuGSc5w2eTiqsnYFdpye5c0zw9dSwCeW7jhkcAOksRJDDrjbxiirGq63qWjmCzi0FbgImDOIywk9woGEHtRRdvVG3LBaO/4mtqF/Fo0Ft+6e206A7obKxIXy9w5kx16EgsQCcnGM5rn7DRr3X9Yc6xb3EtlbKJkaAbEFuT91G5A9dvJ4Peul8P6EbPVodY8QR2t9czRM21YzgOTgY45ypPynoe1dLHagjybFRFbRDlAAxjBHPI69R7j1xxWatG6RTTnurIr2UFlBb2llpWnwyRQ4e2lm+fDAnDFj948kjnHpjFedePNS1O4nmsn0+4+zR3Amu1dBLIXXI37x/DycKOAeTXoPinU9R0LRoWt57AESKifa3AdJOcKvocAYJ4x7ZrjdCsdRi8RT6z5rpLfP8Aafs0eExkkP5idEAPRwdrA5zTWiuyZLnfKjGsL7TdObStQv457ueS2aSCcSlfKIkZQjAg9Opx1zXe/wDCV6PZ6sLSO9+33MwBjuMBWSTaW+ZTkjp+G7pVPUk0ax0xn1Wy0SewmuIw/lXTD96Cf+WkbEAr95lHGKwYde0qx1WWfT/CejQapbzvaySzO02B/eXc2Gzg447e9S5X1sQ7xdkzd0rxPomtxtJZXzLNCr3V69xuXYobbgHoecd8nd+FbmqeMvByzRXjatBGklvh1EUh/iAGBt6YB/IVyWia/d30mofZrbwh9i8sQyC4sQgRS2SsmzbgdTyevSt4nwbBpDal9i0VrmJlgiW1t/NVR3IRyyg/e5256VL31RbdS1yg3ijXrvTZZ4vCNxdzTXj2oKI7mP5QykYGDk8licYGKydQuPEIe9uNd1Y6HeNPBcy29vNuZ0CBAvlxsfLO75gpIySeM12N/byeI9Ejmu7m6le7nC/Y2eRFaAyY+9kbhgAsF4HQD157V9Gj8OeEr9bCOKCygma5M06/u0nyIxjA+clDgZyADnGTmlGalKwpUWlzSehytlHZrZNbWsI1TUlVp5MSb5iFJOUyB/DknG4tt7YrOuNbttU0+UWVqIPJYLHLMvmOIyB8jMQQCDkjGM8jGcV1/hywuLCbR9Rmsf8AhIozIjLcac/y2QPADbVyCCSSDjoR716Lcomptcf6PbyMknET/wAQwQGz6447dqttJgry20R5voPhe08SR2OoC+dY441tb63VNqpt4ypONpIKsOD1yK62fwzpWm39ve2umPCh2iLzWchTjhoySAWwO/qT1qbWbFNR06CxRJIYYCskMka4YHKlu3fB/HNYXiC+8Q2smo3Ju2uo4CJbe2lQtJ5e75gQAONoOWBPpnvU/Fsy+Vxd2jemuoHXNzdzm4dM7ggCRKuc5/idjgDsPc1x3iS9mm8RWEsVtJqOnXERlW3e2QmbCkMgfBK5AAPcHkdjVPV7zxBqlsum3ekzteXBR7Z7X/WFThgeCVwNwySQB3xirej+HVt9Nl0y9kS8M1yrytFKVV2XK/IfTlsno2AenU0huUk6r5YFTwN4kbQL2KHVHFpod0DHEYn8yK3Yck7Tk7vuqW689eK720jENv50NwtyjMHDZVgwbDLgdlwR2rybUrTThqSW8NvPfwOd4jlOJyMfcAYhQM5xgEkflXoel6X/AGVdXVz/AGlFfTaokWNsqjbGi7doUcd8Ejj5cetOa6kUG1Ll6GL8QbaaW7W5hmgiNsqvJ5UwRy7cAlCd3ByMjjjNO8PtHcabCkx1GSKzIxPJdGZcHGShPMeOoUkjnjFdPqOgWurQlTFtu41K2zPDvCM2M5Xnj1z+Fef2Wm6x4c8VT2moK15HLG8EcUcixgpJwZQrEEgdff1o0lHlLt7KopGl4n1GXS5l1WwutMt2upDFcTLES90Vx8wwCCpwDgYOT3rrGF0dGhikdrGeS1bbLARmORhjeM4xg5HOD+Vc9LZTRaVHPZ3VvZWNgjGRCFdg275cIRyTkAEdPaum0y5tb3R7aWzFyzQKFKyoryOwOSzlc8c8E9cVN7xTLaUaji9jz/xHpN3Y31vcXD6lqGopEtw8rRsyhB9ws5PJ4A+orc1fVXvWubWPy3aeAamkl0QnlbgPmJGcOGLDAznHvXS3dhJ4g0S/s7mX5iTKHk/ebZF/i2/xMQCuM9/avOdIvl1LT9PshBAJi7afDuh2rHv/AHib8erl8ntuHWq+JLyM9acnHudb4Iur6Lw/LG15MFjJykdsIY8OckowH7wEgk85B5rV1HSItVsZrTUhHEzxNHJO0QEqMy4Qo5x1ByMnHXkYwcPQPF8sES+GtVvLZmjbyFeNWiSI7jkPvA4B7gCum1u+jt9L0vV70HZY+ZZXMzKzgAbWTKryTgk8e/4TNtP1FC3LZnldhZQQadeaFPqYtb2ZjCNisRHEvI8zYcZJwdozgE57CrenaFrOi+HmhFus7zTJdiO0mRsptOGMucKhx2P61F4wuLC61y01Gwnkh0uWFfMlWMxSzEEltquAccgZPXsT0Fa90vV/7P1C2u7kQQWj7riOQK0eA3LZweACDkZOM1T5k/J/mOHK1dJ3X5Emm6xa6D4t0/UrtLeG5YBriG1JlGWYgkPu25Iz8oB24616Fq2qtdRW+m6TcLYapdSmRAii4VgMkRyOqkoT16Y45OK8q1DSLa70q0eze6Miws7TW2mymFY2crsXOG35XrwGB7DNdBoun2sGm6xAs8ltJf2kcEEt2TCFy6l0cAnJOOVA5/GhLuHO5XSK3ibTWSS1b7FfJqiE+asLiZpJCeV2knryeCQM8VZvb+x1Ky/s6a31BL+CBzJdC2WaOAg5CuQflbAxnpwcdDUHifw1pekwWlrHrst1dOm9IpYXCxMCASrKOFPPBJ6D61p6dfyahZRW9iZYdWhmYyyWIKI+5QFkkGPmYYIz0AYmqWwpNvQs/De4vbm31trO4juLCz050t7SPyyskx5O4kbi4wTjPpzjisu21MaMBetqQtDsaMXPlmV1DbSNq9N3fqMGtXwtdXN3YeJ9Nl16xvLiSyZra0iUySfKcu27YBllyvUk59qy9Nig1zw7c6W8iW900hkguWG6MvjhJR2BwMPjjHPGa5qlvbJvY2oN+wmlvcLnRLi8ZL7Sb2O+sJUW+mur1AE3dy+4necfwnpuxXRaK1xPY3tzp97FeCTe66TbW5hiZgOAS33h3zgZ2461y6J4msTYaNq9nb2tu0URFrJNGq4GTksD8pcjHXk9Kltk1zQ9Svnkm0HTXvkd2im1GMyJtyY/LjGScY74z2ziuvfS5ycyjZmxrVlqU2iNJcZiv5IS97egB1aE5KqI88vkADbj7wyR1rB0zU7jR/D0tnYWWqR2moTrGDeXQ6qh4VlxtyM57+/FdO1+2pzGynlsLjZbYku3dDaybkOFJDcYOSQ2CQM4zWL4W09G1IpNNp99FZOZjLZzrJbpgEDKEBpPn7gAY7mptoy205KzuYdjIPDd/bz2F5NPPqSf6X9oWO7tbhgxIidn2vkcHfxycjina2Gt7yGxsIvszwIJLnTA7SmOdsF03H7w6HaMjtyal1KM+ddS/YoYrrTbtgtu7ApMhyFdTn5uQOvGCCPStuTEd8b7xKpliCeXLcMmx45CuEEe3qRnI69OlNdyVTDRon0Pwdf3N7bzvf3MwWWW3O5omHzRoQPukMNxx06cVDp02neM9Oi03WCiXiXBmV4fldl2kMzE49P4j7ireh6dCsFq2lrcXujvK8kpYF4wwHLEkLtPQHGMCo/CF9df8LJlbUksBbxwGZUskMkbRou7YZACDlQT8x+8BQ0m3cpvlS7FzSdL0ex8OXug6zbLIIZZLiCBbklrmbaRlWBOxm+RR249+ecSWVvDb2kCTWtuigahDcsLmVn3fuo4Y3I47kjJ9e1W/F9nodrrErapqMtst5JLLaRxRCTgt8jTYIKpzgEZyOT0rNum1fxFqLNbJOrou54Jv3OzHGYW+6wJGVwfWlTbau+oqnKpcsR1/wCIbSZIbfTde1Kz1DyxZzT3Z+ywNERyAq7wGHr8uMcZNVoproQsdem1LV9IuWC2RhvXk8oq3+tVmyGA6ENj2xzU76FoQn8rVrm6iuY7Tc8N6rx+c7H5Wjdc4AP3s9x78ZGnGKzkuovJjt7shAXkmwDt6fPwNuDxVox5G5e8aFoLa2mElxNL5rAwNPPm4mODzIuCUCfTnjrUlxd6xZeIZ5LbX9JRY0Vo/mWbcABjYmwhTinw3DfZjfXX2W3iVfJjM1sJvMduSwIBBj9ccj0711WgTC80SaTSr7SYrmGQRJNZpLHnjOwCRQAR6jPFPVajspPlX9fiM1LXNee3s54bnTNKSWPd/pANs857vs9PfAorAtreK4urtvtGn6hqG/N1JLfGHaxzgD5ee9FP2cnqvyL5vM9Sv3khna61i7trcupMSNwzqM8Y55IHOPavO9T8X3msahd6d4VtrqayjIheK1jbz5Y+OSR90A9u/eqoVXvbhr20ufEE0M5uIpPPW2EYGOPkU7gcLkDpjrWp/wAJFf6vZR6bpdq0ssSFjDHJmHPOUIXAIIB5OTxUbbFScpaPQpzaVbWVtfDxFfxXtyFMrxx3G9kVeM84zIMgbVJ75wKvJ4Q8S6pJpwkEdp4ZdlJYSIMQno0i7skhSODx0x610/g3Q7Gxih1rVrRZ9eeMxLDu3LCHI+UL0LYx9Mkdqm8Vy34F9BpV9af2usazvBPIEfy1zlQhyWOAB071N2yGuj0OR8SeArTTLVbWzu2mv445Li2s7hRsv1K5JXGAML1ycsRj0rMvNDg/sdtVbS9TbVtREarYRDZFDISQHDj5ipweOD6mukj1G01TTWuPF+jXaW1rdBoTJmZlLdVYEAhcqOnGOPeuuaW1kvEjhu3MM0ZZSzboolKZBHPpkAcZGKG31KjC7PL9HNlNfmPxXbtZM7ras0ACwR4YIF2JnJzjLMSfp1q3qWl3Wl2UlvBZWr2oMivIpO6NhnfxzvzxtOaoeJNPbSNVaCa6a10B4/PtycTMp2jjaMfOGPQkfWtO0hsLrwtYtZ3N61iZmKPNBtkZwBuLAMV7jABIGOvWlOClZ9jSjUcW4mnZWd5pHgGwFzeS/wBqXkL/AGQCTPkxE9PZiCB+NVNI1WbUNMudPErwrZQCzmuRLlG/urggrgkEYbjj3qpqVu1ne2uqPGy2tjiORQ2/aM/K5H+10z0J+vFazvb6C3sv7JutPmFw8jyWqzIjMW6tIrY2jKnPpjPQUW0Lfu6M6G1/tvSba5ksLiG78NLbs8qWMaROjbDgbYzwS20k46ZzjvseHvEM/iD7HFqVnbWKNaM8bCfDzhMZkVDhthOQABk4J5FYPhzUtIi1a4i0kObvdGS8F0VSRv7oOMnqR1ANVta0bSdYvLiaG9e21yV9y3F0Wj8w5IHmjJ2DJGJB2GCvel6mco8rvE7OWUL/AKNKRhT5ewc+V83XOfTnHqPwqnr0MWo6HcCa8k8yOB4CrSMsDofnfeFBZmAGRz2HPFchB4nvNNnt7DWtGuGUSfZ45CnlSEq4BdAflK4/76znIzXdKyx6rOHg+0JGScMP4s8sfqDj8alx5dTW8aqseb+D9MuFkLW9pb3TonlmzjudkgjdgGlKMOR83c+nAq5rmtXPh/xhb6e6XLW8EoDRLjEoDfeA9cY5649jXQeLNBS/nSfSba/WaRHkkjsoAUuZOpL5Ixk8DHXB4z15rT7ixutMsA+nSjUNJIt5DKG4yzkE5Pbpj+VVLXUmm3H3E7XKfibTJrnXbq6nV7uxhcyPNYw7xGmMrmEEEk8A85z610SeJLPRo4kh8LyX88sKpJPGptsktjase0mP1PoT6c1n6osC6FqaXTILsRxO9xFKY3GHAClQQTweuCOPpUz+H7vUkW91yHz9NvhCum30M3nSW4VQoMnTKNznIyrd8dXe61M5xcJ8qNqz1uDUotROkxTWupae0cc1ldSbvvcfK6/eAwR09MVk/EBbaGC0aNpdP1O6uxPLeRj5goXCl2wWVR2C9wTjNdZ4PiOgaVc6fqOy9V5Wnnk8sAFB86rkfM2MZ9PmI9K8p1Ga81TXdQxLKVnZmUXM+37Omd2TGehA6jJJogtdBzlJRtI6jVY0vtOeC/kMjTqgkmt4HCNKMhW2AbirfLnAznnHarPwyFwtxdafi7VLW1lhQ2ieVbs+8EjGNzyHbjecYxinWXlacgNoZJIIrXCToRIZW2bS0fO05P8ADkY6Hms/4fW15ZahfXsljqI0u5thaLMoVW2hh/rFzhRwQT0HvnFHRpDrLWLOp1eWSx8KXd5BqA0qSF8PdyIJjIrZwiR9dxGTnrx9a4yLT7+TxBb2EEiakdOYNcqbgwBt5BZymQ33CoPJwQOD0q540luL7VdOisbG6k0WB97zwGUBmyFZi4ABUEKN3TnjrU3g27kstf1uzuYXa41EGZpwQ0m0cZ77gCQQMg7vWktEDblJtFDRPD8fijXnu7v7SthE5SdJVP7vaD8gk4HUDscd816I1jqUHgq9+xO0l5b6gohluAW6oqKzbT8wBfHHZe1ZWskXemT28kV40S/vpIrMKpckAk4x8zEjOM1W8I+NoNShm0EwTR2V7ADbIAvnBmJwVBPzdAcZOcZ+qneSuhyi4a9TjPF13JczhNZa1vdQ04+TLeGwaGOEE4EZG47jnJBYD2zUsNxLPK2oxzybLmwWAeUWj3sm1MjAGMAFSAOhzzXR6jqdnf6DqqWWo2k9zbxnzLgS7hbjcct833ScEDHOeAa5rQboSaPLPfX17qE6M0aRrMzSRRMh3EZHDZwRgkcc05K8dOg6bVOpZ6p3G6bfpqFpBp2lxahZXYuWYsdXkuElZ9oDqx2KMbSACOhrSspbzU0uYtQisruaBykUiI8ZicjaBuO0oW559e44rLu9D0uDwpdJa2F19kulWVbi6uFd/OLBd2MKiLg4PpwTVj+yrdrTRNJu9VSSx1mJZ4UvJCZHkZgAG/uKG4z0J6ZzwSkkhUk46PTTuTa74W03T/Demy6zd3Ph+/nkm32+JLmOVgRt8yVdxQkEf3upwOuJNH1HXIdUW0N1FFbXGDNDGnEsTJ0BAByVPHTGOaoLqGpaN4mlsbTWdd05C5M9vBax3UKImQQvmOBtG0jAXOMVD4g13TtfCahF5hvQxjW2s5WEcijkny3XcnBBwGIP1ppmaWrTOt8HaRJpGr3dnq72NlNCwntYnQPKwViSzFflORg43YGOmTWJMYz4nb7ISiPEEzJhckkYOOwOM/iar6L4hg0yeW1iuFhslHnfZy7IInIGVGc+vI6ZHFXdQjtLlo2JCySDamXXce+Nvfrx65+lcmIequengaaUW01cueK4JNT0GCawgVtVhMaQPuG2BAMscHryDg9t2axn0RdYMGrahcS2Ooq4invFGY5wFwH/ANg9mPQjpgmr/h+8W01e1svMEltKxG3bhmAyWXH0HGKbPfapZ+KJrMx6Jdw3+1xJclTE9uuSkccfQDOO2SV/PppttHHiYRjPRXKnhQxalBqcjtafYo9/9pWD6fumuI+zxvHnDbuPQA961bVtMtdLeUQ6fp0kwNvBDD5itebEym5iMglsAnuTyaxLzV/7D1yy1zV7SO1uWjaGG3sLoxD7u3zR1C4zwoBBOOK6DxVY23iO/wBKsr6OWG6tYiTcxShWt3Lb9singjAHzKMjOccEVb7mEbp+ZX8L6FHPd3jarpzwvK0SJcs3zO5+dUwfvMNucDqODz1ZqNn4h07w1Pf3c2t3suoyKs9vHGim3jjbKkxndy3GCANvfOan1y71HV/GcFv4b3/a9HCpJBKdxmeNT5hUgdRkDnGSeKE8N6loupPqEF5o1lcyRsZbq4k865B6vGFGAMYGSTk/hihPqOSUtET+GNU+2SWcMhktFCuI7W8cec7HjH3gu32IGcmsKz06WMXVtrdxf2M9oziHMsVv9okmIQJ5CHIQDJyTwOO+KrX66lrN3e3Ednp3lSDdPc2NqzSO5PO6V1Cgnrxgc0y0bTbazOmafaXsV5dI0ySSQrcGB1PO8Y+YEDsPlzkgmreort/I1LmGTxFqurS2mgLF9lZcm/hLFdpwNrAjDHHTGMCjRDJr11qVhcyiaFyZk0qPUHhlWVRy0JUgDgHOf1rDivLXSb+zm0pba7vEgEtyb+4mg3OeSYyGHA6YI/Ct5LjTtYTdFo+mai1/MsMtvBfmN4OCSZHCgkHAIwADg5NHkiN1ruM1DwrFZyQ6gNL8RravD+9mN15k8Bznfs8s7gcY4I96pm50vVkt7PWNRvfLQhQbmLdLtPQFlG32GQCO9Z0F/CfNsLq21GSWCdjcWttqRitIZI2ODGrhjsIxkhx7dc1t6Pq+mWN/Fc3Vtav9qha4uzEgjZCoPyLz83Xjv1+tFtP69Qptc12rD5tH8M29tBaWrTXls98jIgf97v24dAwUAqOCcD8aL2x1aPUkh0/TkXUbGcJb26yIUKuD+9Cnvgc8VPHp0TabBc3epWtkjTmbT2hIhkhJXcYmYjC+uCc89ar6zLFpVz9oWCS7v4isravcLuU/KDtaIcdDgP170L3d/wCti2tPdNewudWtNR1CC51PQr7DKd94ixSKxB3Kdq/Nj1Jornbu1uLiXzbHToXtpv36GCTycbucHIbcPQ5oq4pNa/oQ4vovzOjuvBM19q2kwXQkj0+3t3R5bWRYnTByMkA5YjBPH411Gg6Hb+FdFlg0++luZbiRi9zIojmYgZVYwCDwCM4zyc/Tnr3X/Gtnaw2kWiWF4sgSWW4sm+0KSCuVbaeScAdKvtroubOca74P1+3WyG+3gjt5ZDJMGHzqwAI9B1G0d6xetieZXOiuLm3trO01R547W4ZmzMY18u4kUZwVznkA+hzivNL/AF3R9f8AGGo+IbXz/tFnH5UX2gBlunkBiRAODHgnPIJwDzk06406fVr5NYj1S60qK6YsdPvVZpYHGAoxwpRjnk7SAeM12HhHRfDPiTSryK31SOTUbCR3/dRbPsblSCwXAMnBI3Nn2wRUyagrjlZWkzkZNbew8RTaZb6VdJNdwxJLdfaXYucA5QcbV+Y569Diup0K2jtJIYZEMJVyTuPmr5hAyecZyOefYVxtxf7PFx1G/wBH8OW1usqI119sZJY5lA++m85J2kjCYxjnNbeleLdHm16e1tbO8ubNySmptERGkuC2wjuWAA989B1qmm0kbQnGLfMZ3xH1NYdf2Na6VJILRAjzRFjHywJwT5fzYBwVP51Xs7S8uNQtkjjSSI2qS7VBSCQsvJVABt6gYGO1WH07Ur/xcNb8QQrJYy75obK/bZMnO0JsyGjAx1I27cHkkVe+0yz2Ukek6Xc36g+R5ysYoOnzMG6+igccZOaG1ayCjHXnexmnSI9Zk1K8uZTpl8qCKGVpTJBKuQAsyhSdwXIypI7kcVliCxgUtdaroNxfIgtonsYJJ5HAHO5CoRTtO3OA2B7k10VzF4a8PokkkFnc3sylWMnmXsMI+623dgdMnkZ+tY97rItLpIND061uVeMyxXkUJYLFkBZEiAwCr/eV1PPGOaS5nsElHmuyXT9Gh01L+fU7wQWMyrLIQNrpEWAVggJdiSRggbf9rHNZlzqn9qX+62t1kmlug0TzkyFUUYCOfTABJ+vatTT/AAzrGoi71HX1li1IlrZ/tDYMgAI8xz12jjtzjPQV0ml+GrJbNY5Guv7OS3kjItrc7VaRSpbzTn2PJx+FNNR1buDvPW1kcdpOo6d4gWy07WIJbopO8kaKWRVUAthXUnAODkMCucfd5NJZyWOi6k82m+J557iRnmS1v0e2+0HjapfPltnnO4qcDgc1p+I9D0vwvoTyC2v7w3EZgcqTCqEYYscA5zwAOnB+9VTRbyzksI9Jjnu9SiktzPBpy264t8g70llP3lYHngAYU8UW6oh3vaW5taro/jLWtF+1zaabS+bFu6xzRqssQJZSp3kZ69Dg81BBpVzLNIdVszaahYhJlubYhfNwmH80DKuAAPmHPuaz7nRdMvNQgt30W0a3hgRHe1vyggDDK42HaQMn69zxiul03WJ2u7rT4bW4jFo0ccsswLB1OdrKeMEgHI54Gazc3tY6adJL3m7nJ+MHljsVWUxWltMfJaOEp9ov8HIcttyETjCE4zjnJ46XwdPpdlpSWlvqOoPYzK0saTzxq9s2CCroOdp5+7k8jHWk1uCxhnthf6Ot7BKxYzJd+WIwqrkAHhieu0DPT1Nef6Omi308q63aJbQvMIkFuhWbGc4Lkkqp6FuWxkgdKuKvEwrNxqNo9lkcAw3UEitCoDQy/wASBsFc5AyenauV+JGki60U3bQeTdq6o0xUOZskk/MDxn1IJ7d60tE1qb7Quk6lb29r4ito/tFxYw4eJYvlEaiTnjYw7k9+oralmtbMX1kbaOWG6ieMlwZC4YH5Sy84GcHHp61HwvQ0/iQ03PNdHngn0TT7Im1ZNsi/ZlhIaRg2dzMeD0Xkc5zz3p/g62uJb/WbiCeD+1prVrExWcBiZfmGQ+RtJyqjqc85qDSLD+xtXvtNZY2uI18zMUjbVVRuxkjnOQAOD9Sat+Gr6KC/vtVFzb2ek6iVa3t9u2V5wQGDYHBHznng7xxWj3YrKUY36FpZrCfW7x3e6TW/JFtMJZD5cRbCtgKAB06ZIyRSTX7eHvHom1NZYtPMimEzKsq3SYH7xSuQB3yclc881sTyeHtM1BbdrWRb7XJfKla3OSwUbw/J+X5sHAH16GuF8VomqtbR29zY3kqyi3iCbjcEBs7FDADAJyMk5zweCKSu5eTCorQt1T+89Ee5Fz56OfKR5AhcNujKHlTkdcYHIPbtXBaF58l9c6nqV3b3N5pcu61uQhYQlejqTjMYGcJ688d+80/S5orZLO6vJruRgxdpFVGVcYC4XAByOg/Diub08mDxjrvkx2dmI7d5oYoAPNV0VR8wxtbALZzxz0IJoXWxU1fluVNFnks5tWvfErWUtnqUYiEsUamGdsggkDDoVyCfrkZqtZHU9Hu5NGFjamFf9JdDuSaPb1Hme6nBBzwexq1rtt9rshBZWVjDFLOYmitzHAvmBcs5Zjxj/ZAHUcdKo3V9axX2kWFvqs9/bwxRqIpFBt5/m5O4N074YY44oUlKN0KUHTlyvdEWqy6mkct9ZXdtaxRwLELCGQz7izESM2DtAGcbc5P0FXbizn8V6faaoFS4njRLKRWcBrcJ9wtjgZXnAyM11mn+D7W2iv0uPE0ctmj/AC2s1sHaBFJIiDZ+Y/MBxgdzmqGsXun+H5rWz0meygdoHu792mMciIGGF2gFE3AjBJ3dOBnlddNxRa+0zlZZf7U8W29kLHUrnVYVQefbvsES4+dmbHHG75zx6Anr3mh+GbOKN/tY0q3vLK4KWkxLMGhJHluQTjzSSR2zjOBXMsLi2uHS3uNWvpobjy108boAARlGkRQXZSpyOD+XWfUZr/XtHFomiahYT2WGs3NqY180fdK+aB5hJ6nHA5FEdkE78z/AtfEn4f2EZe8hu5BqE8gmmgZMHcfvHn5ecZ+p7iuQ07VZvEFqYZLFo7mHEUTJnJGQFYnk8f8A6q6u08Q3uqi9gkW3sdVgmS3S5vPnBKqASinrIXB4HQZrI12FtGk0yOw1QQNYbmuJvMxPI7MMyFV6gEkY9PrUumprlkVTnKmueL9SGQ215PIL678i/wBNYPNMOC7DggLj7wzVvxfcXcTm+ih0iwtntobeO5dR5t0dgJMfXB/AY9c1V0rRLO50O4N1Cn9ruj+Tcm6WRjCACr+UHyGxn7wzgc8kVL4kkmTxXbaJp8zalY28EVqbSI7HDCMFgHbjcXywI4/AYq4qzsRUlzR5n1IZtevNN0rQSt/PA8d0FINqqvO4GcrNIvygdCQD1HatDWdQGnQyW1/p8wNxK1wv2lldpWZ+WJGDnPQDJAJPTikvfE0FnoKaZbXl5Pp8OVu5pLYuycAeWpztTHzcjaT2NRJpsMel30sEen/Y9JDtFZ3l2twbdWAYvujJcnvs9TjsavTqZptSbT1KcNxr8ur6nItxb6HN5iGa5WQI3zKMHzRkljxx9fWtzwXLPpt/d+H9O8OHUNak3Xfmo8SIny4Ej8jk5xyc89KuXzaX4k0uzkitYDAllFuYZjSKZdyyNhjuCgsCN3JrP0lba58GSWei6ssNncXBimlnXy18xTlC2cHBOOMng5AyKno1YtwbSknq9SK/1x57qbRfE8cNrqxkjaWzd5JFjXk4A+YZwF+fkdgetV/F95fW0dkNKNtaaTvaS0mYAC4+6rB2HzBuwAwPr1p+jz3LxCGfWFzafuHti6s93LuPyEH5gTzyOPzq3pi6800s2kQtqc8MZDxrLE6HJLCMgkjK56EA8VWwndxsxs+sxGxhsJPDt1LdXCbDHdW4ljdWGS0b/eVeQeePXmqOkJHpWi3yRaLay35kVJjA/wA9vz8gPOSDzypPpxWDrE2qNfqPEeoappt9tVgL2F4l9gsaAk9CAQuD7V1vgewsrW3McF6tz9puRJNcvC8LLtXPlFGGeXIOe4HA60dH/XUmMueSMvXSYXbSreKO81R7RV82V1RlZssEjGegB4zita2svEy3NnFPHoclrMjfaEu4AY4gi7juyODjIyvesrxLqBbWp57WyuLPW7DbCRFbKpnTkCRpSMcjjoT05rb1PUpL/TbXTL63jutQv4tz2slx5UeM5Ko+QM9OP/1U/s6bj0bd3oVNNFhrClU0x5LfUJVvvskWV+zuMo21ifulcE1o3unvLrk+rJqFm9nHEYLV7cl2RkAXYUXPmL69cVUs1vL3QtLgvNH/ALJ8tGi2RTLavIN3Qo/PUcr3xmsrS1+1ahBp9zeW+nvGzMI1KmREPJwRxz6HmmlrZAndK51thaW9pYW8c5llygYG4TBGecANgheeBRSWng/w3DaI2qQ6rcyuzbW84kYz7dDRWTpxk7tv72dCqTSsomXoMd54kurhrW2FnZW8pMk07NIBEB824ZBY5I+7Rb3t5oLiyvNTa61KSQmEwJthERHG6Nuevt0P41vW/inwyLVLa2WaF3hluYbQxmFZWU8qX+YFsgdTiufiv9Q167uNQ8PtYRqEUXCXs8cT24zgMHYYdR0JGOuMc1ShHVtWRg6zW8ijN4j1OW6QT20cxMnkL9iRREJG4G5SeM5rfh8a3/hX+3Zb60WVdOC8uAWkk3hSCvGBzwc5/lXH31naz2ciXGoaUZrGdDGbcStJMyliFKsoV0HXOenHetLwvoyeJZ5DsRpbkPO88I8hBh+YirMxPzEnIzx09aSppbhOtKfu9CvqfiHRbsalv0bTbuaOWGZ4zZjaFcfejGQwK5wQTg9cGnxahqd9tsNGintDbEz5traKAqzHbvJCjacADdwffiu1GiPJvTTp3ubsxzx2koZQYZGUjc5XsvJDc8Y9af4H0weHI9QM+sTXiTMhlQxEBpP4uScnP9O5p3VhODbOOutE8UaJFBIljFc3t9CbhmmIunUox3I7MSCWGDjnkYByK0n0TW71Wn1m9u7Wxls1thEkgeOF1APlgB+MY5AGDzz1rvLdPsFxcXEbSSAvtmhcgqofGcZ6Do2enNc7reraVo+pDR7m5ci4Ecm8MAIUOR8/GOcnGOeeeKWvQahquYwNV8HXMEFk95Ne6oqgyybJFHmMmdgbf1G1SMkc8j3rY+Fdxpl7pNyFkXT5hcFhbD5Hh3kN5aMeWDFQRjj5OxrnvGN1bavdnTbiIfa4bhjbyvIyI8ZA5UnhSOMgnGORWNBoGt26af5UE8scVw11G8I3puOAp9V4Xo2MZxVWurMlpuWh6uS0UlpNNYC4uZ90avetuQg8D92uARg8bicc4qhqfi5Z7sJd62B5Z8p48FId+ScEAYIA4IOe/Irk9cXxZcyW8D3g+zta+YZ7mWOExSnOF3Ehgc4+761z19YafB5R1XV7f98Ntxb2rtcSM39+MqNpzk/eIrPlgnd7l3u78ps+KfEVx4k1e30bQBNEsAdJLdyFhuVBBaU85AABOTngZ4Oani0ywtPsn9iXt208BcSwDAVg2RsDddpGRhg2A1XNI0aK1skjs1eEv8pv7yNUZAcfKWA4XjOMkscYHSqWs6vpVlFrWl2slymoXESR/bBAjJI28Fvl4VAR0IPGOueKabei2G4qCvPcpWVtpyabO1vcTJHb+XBcRLGVBLH7pyOST0J7Vr+IIbzybG0h1YabEi+XjDs7np1UZzgjrjiuZ1rWEYzLpz6tBHBbm2huZJDJ57sQ2DGwyMgNtwSRgda6HRL3z7KyHksLmHKFAhcpwMF3xjc3J+oxRNNe8XRqRk3B6GVbalc2M5stQ02N9Atpf9HkvISJHY8blbOcnHQHBAHpWp4n0q4utN1G7sdOiuNRuvKZngBLiNQA20Z+QnA5GSa1H0ewvryXV7iESyb1aXzZjsLg/L8jZ5yDgdP0FRa7qNwTbwacfJvXYkDaSSDxwx68jj26VKlf4TT2CSftGYFj4ju7MXkMsRE0NvFaNcxoEKuoKqjuByOCuCckirXgnxcNFsbXTNXsttoglnN4uS6Slsg/TsR1Oa0rm9vNOjnsr68aS4Cq8sSxoTKDzkx4JbHByee9QTXN6bi404TyC4v4mLTLhgUwdksLj5TICcBc9CQfak+Z2aMZ0lFXUjnvFmqjXNdTUdLvru7WRkAsnQxgonZepYjGWGBg8itC0vwmt6Uqs32HcrXNgYN7u+44yxB5O5QSCCPeq/hy6v8A+0LmOXUL24+xx+VcRG53tIAxAEeR931APT1qKGWzj1aNb2/MU0swYajDhIkQDJyS3POOAOuavS9jNXUG3pc9E8QabewWmoxWTxJdyRnyQGUBCc5BbsCMj+fWua0bwmJNOvbjxhpSpDGYUthHIIfN5+/hc5B4APGTn610Vnb2sgvtXs4J4BeShhHvYqyjI3Kc9SQcg9P0rM1i5/4R+M6peahFeXTTh7i3QqT5WCscajnaowTuHGfWojf4UaT95KUi5rOt31np1zqaIUmB2XBQs/koBjO/IwSTwOxxXP6FIbXRru+1DUY7htVKQi8lm85o4s5ZZGySrfKvfo3IGK3IdZlvdCB8NXVwwuozun+x7/sfJyJs9P7vAJ5z25y9L020g0+K3ksrW1dijTvFKzpPMxwrbW4U4AHT1NJ6RtYuK56ia1SOR1M2LyywalfnTJopfLiuvJ82A5Zso4XLoTj7wDcDngZqDSHsbJpFkeEagts0FrZyp5md45kDcrwfmA6nr0HOx4o1Cyn025EFtp7vNe+UzzgqJQqHcVIPysrY++MHIIzzW1Z+EwbO0/s7WTd25jaNZoYFtkXJPzYK9AevHbmqT01MXG9X3SC4sdUvNZ0dre1L6LqCxPqEkcY2t5a7n80nhQhzluM54yatXml6Re20jtJp91IwPmy2yFSWQEI2WIyq8HuCQK5zULC8a5n8P3jzQRWcgMcEdyJ/tWRje2Dg5YbsfwjI9atmTUri8hi/4SGGC31F4gli0W0CFFMbIvGFyc8AYbPtRfuyo9WtUafhbSLGCBtci125S8FoYy8rFV80McrIwyQQo4ycHPpxT/N0+C3a7/tWe8utTyIbm9uZJIwRknZuOBgD72CB2Nal7ZwaRpz6ZZ6ddWyFysMouAY3TOSBnkkjnLDJJ9uMSGZFsrnRIGsbXV74o0T30amILkAhMggMR068j6Vjz807I6lS5KXM0ULZV8Q3MOr6ffwReKbES26yLGj216wB2OXYjY5BbOQd2ARisZmvn1mPSdcgvE1qNdxmcQTNGvUlwWClT7NxnnPSu18I6bHHb3sF3bL9pZmj4cJnGBuES8A9SCOfoCaZqmipe3mn6YI9HtNMUYms2tvnuGzlgJAMruHT5lwfWtOZRlys51h5uHPH5nCNDHo+pQ6hqKJDdRRG7aKa3VJpHBYAMyfLlu3bgexPU2OnC11bZ5onvYWSX7Vp8vl3EMMybhJPHjbKFLDlcHGcnmotZ0O6uYZ4NMsFub21XyLIuB5plDr0U8eXsJAQ5A2g+tampTX1k+j3l5d2N1qyL5MsdqqyTsV6sm3gqOhHseKcZX2JlT5JcstipY6TBqcUGhieR4llkuJNSidIra+dR80MqNhhIowQwyOT65qndS6FZaNHZtNfaUy3UcUE0O15ZEYEb5lOBsTgqFOfmPXk0mriztLGbV9e0C4kuZ7svFGGKxRoy8ysAQQMjGwgDJyT0FUfCSWgP2HULK3YXTx25BjYtKB9wKRwvGPmyDnrVrUya10NrWLaHwzNb3uh2lpdaMsaENPJ532hCGy0hGFzuxnHAxiq/h9NMh0K+fWo9PkjgKXMts9ssoj6k4yeMgjp0OBWp4i8MrZWtzYRanZTWttIBIySJGxVsjCDcTlQcY9TnFXrLw8mlaPd6fpMiwQ3TeU7XMwmLR5GUdcYLMM9srng9TSTunZmii7LToc3bT3Um7WtXmiP2mFJLFI7hIUZivySRFgfLbCkbTx16UumaS/2CbULaG+ihsx9nutMmnFv87NjcWwASAQQevA6VcubzWUZ9Gaz0PV4VdXETWgg+xxDhCuMBiPUZIPrmmaxdXkuitHqNhNbX9xdCW3VbxJ7WYfdYLg7wcjBjYdSee1URpsznte1q61HVbJBaee1rGLeKSYrdneARl9w3bs/wg/41p3VvqVv4XjtILZL7xFcq73kEsYDrEp4dNpGHwevXGeKr+DoEtp9RSeCHTNclhdYhM7+UJiwOGRQTEAAACTyeMGtPTbyLR4LkSxTaxqkqmea5tZFEfynIUnk8HJIIGcU7Eq+rN/VtR1zQ/CVv9lMt4lqgS4guSJCFZcqdp6lSQMDk4rjoZr3X4fDsr6VYXFz57LFPdRTBGOd2SV4Cgckn0AxU9zq1t4wu4NGaSfT/NRwb4r5sRAO9ZGxjAwCN3Y1fvtW1HWtWv4LK1+0WNt5bxR3sxRTGo2q+7IO443c8fNjiktHfruN2l7sdv1IvG9601tC0WuWE1nHM8V215MWkeQZyqqVGTjn5T34on0OGCPR7zTtHsriLbve9nkdI4lIGCxJGMds5qxpVnY6p4Z1jUF1GSzaScCextyLhI5VX/WDkMAQeV59iaTUp430W2srHV3jYwBpbdrRl+1jjaxLYK/keOlO1kEfe/rzJl8WXfhS1hTVb6W4W6zJBLFIG3oDjO7+IHtRVDw1d69o8E0OhPJJbM+5v+JdNIgfuEJjOR06YopNwvr/AF+DFzyWlixrE+nWmjy2ltEISjfaYWnbz2jHcgY5zxgcDvWDNYvJAJLEWdxFqarxGCRAACSrgDEfPzdO3tXdy+EILm7hvNUlkl1g7DOYJN0bkqDnaR07dgav3GjWHh3wvPqGnRBZiQxV5CQGzgHBPIHPf9KaeyKnHrbQ86i0u6hR7yNftlvZ7ApntmJBfklSOSRg4PpjnOK7mWyn07Rz/wAInoKy3oliaa3llQu1vzkhS2/HK4Jxg/N71x66hdamZX1eyX7BNF88tvOUZYgQduFPG5h6Z4q94Qmia5fXbK1gWDTdpt0iVll2gEFAu4lvlJ+bvRJX2ISfQ09e1y503U/Emn6bq8H2QYZbeGEy3EjjHmOTwMBQ2QOMYwO9WINag1OTQYdFkBhnj+03k93bFYZ1yQyh1J8ogqcEjqRzVW2tdQ1zXdP1XQdCspL6SISTxzKx+z5GASSQN+MEknnPSt06NJNo6+H9TnTUGChJmtpCCGByFLABdw/u8jism43NIxd7XL3iHUhpejtfYDz2ySQxtNjDueAHA6sBwCMcZz1rzfWL6Dxhqen/AGbTJIiIh590AX2swOUfsEz0zjGfwqbVbC4OvNpdkVe4tR5ML3E23zIhzk9s4Jzzniut0axsnjls9Ms5Z4EkIP2dC5cDjk446ngnoBwetNtU0XCPO9dEtzmptLg0jRbu+dZdTiljQm0mWMBnBASUO5AwFyCe4yPpv6le2lnpFnrF7a3klrGkM12tiyyOTJuPlq4YKUUIMlT0OB6ja1kWF+hxOXhjkxKLlNquw43ZYFBjGAvHU9OK5Tx3dwX0ltZpfC3njj+0W/lwExvHjaFAXK9j09+oNRbndmW7qLcNCtpugajrECzpqujMIiz+VpL/ADzbuULFvmQjurdAO5qxNpPjOSwsS+p3vmsxhYSSiMIueG5Gdjc89ePSrHgZmltIIUtrCFESQXFyAFG4HMYbjkEdx0I+orqryyayvp7kzXJNw/lRLKwJi7s3XAz/AJ65q27GSipW11PKdbt7KCOXTtK1FtQ2xpFqVwzl4hPuDvKjdXAICjI6LxVY6ffWEbvpMsiWlxC9tNfzput7iXrhCRj5gARnB5969Xt9MVGuTZQxRtMRIT5QXMnVODzjtjHQnPBzVSxttTlvIfEMmqXUdrcW7QXunxlvkkxjy1BO3jqDxjPoc0c2hLp20PM9UuJru7L3Om20JgtQ0LzAiG3aEAb1j9SfujoWIyCM1qadqOqeIre4SK2tZJ/MWaY2p8iZoxnDyoTg/MTwh5LHjvWZ4pvLabWLqUWFlFM7C2BnLRbDwd8nTc3UkgAexFaL6VNa6fYXeoAO2mBpFguI2eSSUHC/LGPlhKYIJz9eRVepMbqWh0E4aw1NbO6MkkM7KYTBEX37+AyY64zn8K5EyalqOrXlnYNrGswRBrD7V5m8oqNjzFxwue3bH41oaRcjVZdHgS11SK8lneJPszhVVg4wOeCOck5GAe/IPQ+H5PDei+Jb+9g8RzaldRyToYBZsFbfncC2NrfdOGGB+fMJcuxrVqe1aOY1Cwv9I1TWreaeS+jS0hs5Lpl3GN1ZOAx+620MvJwQSKz0luI4LPS5rmC2gvWiktrZUYogLBVlyuSJTk88+/GK9UnnsNa0H7LPLusJNuViYM6LGdwUjrjIHJ7HOeK4zWvC9zBczX+jIt1DcJ5JhlIzB8mWC5IyPlGG4OTgcnmotbMmVNx2I9ZlurLxDc3t7apEkHy3EcSKSANqqvAHzdGPpgmsfxBJpg0+G9tNJd5pWDLKZGS13HOVCkZycAnJHtxxWj4T1C2e+sLPUYrZHtQxAk/drIEJZYnJ9zx09OelSeOXhsktLiaPT3CzTApJa/aWUnB3JuYLgLtHIJ6dKlX5rGkrOlc6fw3fDV9OWcxzRyxxxwychlWQDnb6dM8jOKyvEGkaVDq2k3TW1sPtim3uCHMS4G3BBACqwzkZOT1xgHG54ZVYtLtpIdOTTYwN5hZh5rdzLJ355wuTgH3rA8e6ikOj28E8UE1tcBlbErxSQTdxHwQ2Fx8wH8WKV/eHL+ErmZ4WsUGpXl9afaTbZeCMyOfN4PCEhsMCCCeMHGRXQaFqmnTjU/Oi802QW4BkcKjMq4Q5JwOSevWs/wALeaND02QWixW6SSxI0dx5o5IyWzzkkkfTGOKe1rY39o9pYyRRylZCks2VRmjJyGYjhee/YUpv3tTehH91oZWoWGp31rMmmWWmy2b3UbB9KbzmLPkbZRuJAXJ6jaOcGut8P2GuNoM+i6paTaUbAPaWtx5scizsQx3+vHOO2CO5zXnptdFudPu521u8gvbdtrJb2MqxkHI7OAec8jHGeDXdQ6hJqHgy0vYbdtTvok2B7eQ2fnbcrk5BO4DHGPmOauS0sccdZ3OEttL0821jqVzfX1lGl3KklrLbH7RthVC3lY+Q5LdWIwDnnBrpB4htrvV9BFrbqbS8DfZvtHzvazbsBA3pnnIxkFe4rPufEU1h4hGrNbahAjZhb7RP5hMgTawjG0YUAqpbPPIGTwINVisvs9u0VxBJHBKpU2jEiIPj50z82QQMq3I/WlNbXKotxb5WdPq2o389rOkEsF0yZQ2a43Bl6knr1/wqrA2qpbLfz2unXV8oxBZTyqGtgeM9DgZGcK3fnHa7NJb2c819qXmzzFFjjuLKMSAbSSzHGMEdckcgY96zQqPJLIXcmc797EKGXjlsHgnjj+dc8nyq61PUinUlyu6N26vHnLtLpk1rdNw6zSZiMg4OP4h34JyB7VEJEgELXe3zGUlm2YVlA547egxWTqupJbSLHcOzxKP3MjHDRkDClTg5A6YJwRx2rVEovIvskgDtJGdrdt2OPwyMVzynd6o6adNRjaL1Qw6tZWUJuw072UsRUSw/fjHRtp+hPHHXmufXTv7DvtNtby78KSXEk260ujZPJOVYlgoRU6YOSx98E4rT0nSI4PCy2s37xprrzU2ZxExGAwHU8HBH0PWtqztL+LStNsYrqKNoBIqyKqvL5RYgxK/UHJBHI6ntxXXTlFaRPNxFOpO0pLU5M3NvrF9FY/6RJfQyOY7+2hIhWJjzDKGwcEgjJGPmFRazZ3Vj4vnvNJnintFt3IQTKJLaPYVO+M8kDPDLkHjJrd1OJ9L1DTLK58R3AiCmOS1e382NwGOdzjIOc42kHGOD3qjoYsG8WavYJIILO4tpUiiuJJHkXC7z5fy4UHawxuHynHJre+mhySTWr7nGlFsr68W5upiDFguo2w2jkDazn1Hftz1OK6HStKtPEtleyajc3n2lYlUiMhJRJGv7sgA4U4Bzx8w5HJzTW1LVdF1e613UPJu9HjujBGkl8jPKjE7YRE4J+7yAw4x7Vqad4wlea9bXLGxhkeRZorN4RC0kWQN7OcZ2jqCckAgDNO/YzTTk+YbqENvN4UsrPWbG5d5cRwyXqNujbJ2M6qQzJz6rx17VyXhDT7CW/ntryxFzFaCRTKZDbuWbohjfk/NnAHPOa6ayhfTxci1sbC41GW4OotcQtL9kuoj0SMocEgduAD1zisvUZrO+v7SPS7jVZNSmnMsVnrDRjymbOVLg5bPYEcDGTTW/9f13CdnytlzxZqGm+RbwWMMcN60RAnjs080joHkYYLHg8jrVy5s49BstL1GwguLy6uiIvstqEhS5+XnCkFweRwM5JzVXU7rUY9Ls7PVtCs5TBLvguBe/ZniDLn93sIPr1UgHtWh4g8Pahf2ehixmuJzHMZGe8vIVY8ggfvAu7nI4PT3oXug3rJpbF3xK0OnQy6Vptu1taFRd6g8NkrxwLgExzKrDlTnIzjJ7muR8TWNrCum6xodvNNbXQcSXUSlEK9NpOflPXhvTvWhqVnLff2nHpbypetbi7ni+0bI1jQneobGXAOCPX3xVeOAa7apKdQlurKyAEEskP2OO3UcuCQC8oJ5PA/ClFW1e45Sd+VD7XRV/t23nhkgsoYIFuJLiZmEqy+hCHGQSOg7VZ02OW7m1OSa8W7m0tDIJ5GKidi3QMefTH1rqfBA0XxFpc/2jWhd2OnbnMa6aYwuSMAbwS4OeMc/SqWpeH4rTRdX0yKVrQXAjaO4BZNyo7NllYA7fmAOOmO9DlrYqPK9YGTo9t4o1wT37+J73RVlb5LWW6lGF7Y2np7nmiq2keNrjTbNLF4pLlbYCNJrW5MiOPbA4orTl/l2+X6mSjTavJ6noFzr2mw3FtZyavAJDN5QtkjVdnAGTtGF9K5m6Nx4ovs3VxBpmnaY7GIDe02FPzSEYIVMDG48dgCeK5g6Its1sbi0kmtZgHmCSDzoAMZJ5yTySB36GttLO/wDEFhdS2if2b4dt5QlsJSWkunB275Gx83yk8H5V6KKhq2xbk2rFyeza2gt9W8LyQXtldbUuFhU743yQ55w6ryeDjg9K6JdOtINGhkYzeSsjQh2cOWA6N6gknGOeBVXw5pp8Mtem7u7e4txJ+6tFiBDL/fLg9OSMH1PfFZsniOyt/EjxapdOuiXeBbRFCBbzZxjJGVU9AxGOc+9J3ZcXyWcjr7q/vL+yjs7Rfs1kn7sxW+Q8qgDIYjt6gde9cdr/AIijLWNh4cvzYX0TiYSQpi2mYceSSPfnBGBkj0rHmv8AXvEnnHSLObTdNhZre78yYRKMnDFnbaDwBlRngYwak0Wy0u3tlmtdXWe3aYW76tJEY0VuSI4lPzbvl/1hI49BkmUlAXMp6R0Q+DSv7M/tCaa+K2ylmmmhTmBCuXiXs0hOVAHABBOOcUbOHVfGFxHa6Q9vptlp3EFuZmRI8PlJMjJaQn7zdcjPAxTG0fUvFmpxwQWrWlpbSGJPOwiWq8lgxyA5IB+Ycn6Yr0XTo4dF0Kz0vjbbklGPyM33jvcc4JBOTk/dHfFD01e4uVzdlsjldT0TV9D8Q6Vf6ReTXFxdWzxPcW8LsYpQArluMBDngnn5T0xXN+L7aNtQsmkMi3EkDfaxC6o8cikgXGw9AQAGA25IJ4ya7nxV4sfw7o+q2tlIh1QzRpKjoTtDYOSOhXGflH94dq89nuLXUphLrMEmoSSv/pDLMVeFCSSVc8HBPGegyOKqKe7IkkrpM7O18Hafq2m6a9/PfTwvF50kEsYR9zMDuyvKkJxk5/IjHcSWIdIktPOjtYh5cLyx/KdmNgLdyc++aztX0+O60ayt9O1aTTwJQ1rcWkvLRKnKZBHXI5zg45zXG+MJYtH1WHU7PVNV0681AiMmNsq1uvGNoIAOduOSDyfao1Zrfk1SO+tLe8kto/IiCAs3ntO2I1C9XyBkcgg9QOPXNcj4o1a+06OSWxsY7Rr2VLJbu4LPb3AJwrhlPl7QOh647muefxDfWHhfSWhjmWK7mluJb24uXJWQOUVAikcbRnvnJ693WlxqEOjy3iai11bW12kN5FMAIZ1kLDcUPAYMAOnpjuCJNEym5Mb42u7C4fUo9P3X14uBdy7Ase5GAYRhucEjufpT7TUZ47eGzvDdSiyt4pJLpLgGe2VsDG77rLu6KccdxVV9I1ea/KT3UayRO/mX4QokoZi2Q4A3D73X121jaykGlX0lnaXFs8Uc24R/ZWDgqeAcjAOCeASOc1VieaUXzI73W51itpJrtP7RurdAsc5wZIFYZEsbMeMA5OckdVrmNSI0zStPl0kC2sLy33SSpIQ2/kOjMuSXHGeRwRjrmtzSZpL+JLFryK9uFh2XaOCpZsbsR5wCqj067TgVU0rVNPl1nUNCvdHuJNFMWJZCxEcTDhJkCgMGycEBtxU98VCvBnRO01zR3Lmg+JpPIY+C/Dt0LWB1AW2iIMb7fmlMvK5Y8ENkkexrtD9lNt9qe2MtjKgSWK2IKRyDmSI4+6M4YY69q86e61XwhIiu1m+nSjaLa0Qrbu397c2SZO+5slePpXosa2l5pE9xogjGmtEGBzhsryX9cqcrjoffIokupnTve0tDyrXdLTRb9JdVnYRXJeWIQWwcJGxON7vgs2OwA6dTT75rm4sJbHQ/Lu3tZUdrycAhIWj3NcEgZVOACQMjAGM12XxA8Py33hSN7GIRyW7CaSGdmDToV/hG48j7xJGcAgY5rlPC0yT2FxLbxiwzbf2YblQZhFLjKyMmcsOpwMnnI5UCqvpcLauK6noPh65sZfDGn3EVxqGo2xjmEZmXBcncvmc8kFySGJBx16VzXjWa6uNXsrdtXj0iKO3aPybt3MFyu4fwJk7juILHg4AGMc5FtquveF5E06KAauhBljxITGY1DEvjhkOMnnnHrVG2vl1y8XW/EF0HhtSDHAq4KjjCgAYIHJx360kkncLcy5Opc8NWlna3MD2cdtFMWlJNtM4X5V+USLJkjJPUHGOfWraWOqtEitaslzqIhS8j2qkXLYdjzgfLyee2aoW160eo6tZWcRkv7m5xbyiLEUqdcADoMfxHseemK6DUbaOSwXMKyyRlpIg02yJT28w55H1/Spk7O500oc0HboclqsMunQzWHiK+uNHWHIt7GII/PTzyucrn9e3FejeHLa20rRrawFxJqF5O32ibUbiJoi/Up8jANgAjHXJ/CvPFlhn8UXEk10NIjmZo3kDmXzJCDtVS5yc4AAztAA9q7/wlqEGq+EoLS2GpSz6bKI2e/kWQybtzEblJwc5GCeFANXLY5Ka5aiueUa9ZWVxdrbwTSWasBGIrjg24JJ8xm6bOpwBn8as6VcNJJ9j02/dwLdoEkgJa3u0A+aWXOGVicHBXPQDFdr8UZoEsoTHcxwC5f/niJdyBfuuTkuuSTg8D04zWHpVhJPHBLdJAWcRxQzWtrGjDdgMGAUZDfQ8nPFVfS7D2cnU90dd3gsVsSgeSFlSRnxtjZiMYPfDD174681b1OCEwQTaeZLaOMgKhO7Y4AOBjqO/PIycZwRVlNAu4YyYr0SOt1LPFaSMgE0OACjBmyyoAvOOAePUVdPms7vTJikbwSkhGEjZAYLgLtPH8P3h659646sFyWiepRm3O8/QdDfLq1zbNeW9gkhjKvNErL5hOeTzj64GfrV+0jMrNEzMojUkhG25HXj8M8VU0m38i3km0yyM1zN8kjk5zGMHhMfK2QM46jOOCaliu5BEfsksU0sMxPmo3ysm7lSSO2Dhhx1rCSblzo6qclGLg9/Lsa9rNDZRf6Y/lweY2xmIBVQOpHY9M/jTF1KaNrr+yEdr1oWWBo3SPazrhXDNwehP1ArM1yyneYSsI3hMbeXLH2+YE5HY9Fx2x3BzUEqXMKQywxiWOa0lVoy2QWU/MMck5U9q1UeSS16GU6ntIyVvIl0GbW9X0QNd31rdXtlMYZZJyG8peMIwiysh6nkHjuaz9LvNZuvFPiLUNVmudNm0ywZUs4oJY08sggFVPDKAC+Ock+nFXdP0VI9Pn1Pw008Aktvs1rbw3QVUdQoZcckOWySxyeQM1m3N5a2egN4VnvdWW9juXeeSES3KLPgHG7fuVQoIyvBJY4x17dbniyXupfqXfBzXt7o8uoakltIt4SUf5XEwyQTJEMbdrDk7dx9azdR0d7m8gOtakrWPmFZWto2K2c3C7mJU7Yj8pbPfPStmW7ii0ua/l0Fr2S0gSVb1A0jMrIIwwVWBxyQc4PAJ5FchLqetwaPDDdPOLaK5Ey7s7xFINrxTRg+Z5bAcM3fvzTe4pNRjys0rrUorO61Sx1K6tLPQzB5oTTHM63RYjy5VeNcfMVz9AQRmp4odP0G4l1C8sLB57oBDBprs32aPAwzbyG3HglW5GcVjWQk0+0u9Ss7OdxPGYrWK7SO5EYY4SVH25woGAuBzXXWS/21pBlm02HSL8QslzIsSXCOyHaBsPIcgFto5HNP1Jim3qcpqGk319qhuNLk069neVNstpfQtcO2OFT5g/GehzyPauk8QaYNS0eGG6sNVnvbVQLh1CLLEMZ2uz/KexO05rK0+31HUtbaWzuRBp7Okv2i5EX3QMAxxj7pPOMAdOeea19W1CbWpGlsdRltFs52spkllAeZSQEdTgp8pzuzjA6mjpZFRTs2+o/wALBNP0e1lvN9nFYTEJezMELk4YRqS3J7kDt9ayr2GxtL6UWWo+IL1JpMRX09urafJ83zHepJI6jtz1q3qxvbXT4NNv5dJSeOBpooJJY5IZUyWLZXIBOCckg/TpVW/1nUCtnpjXmm2dlLEt4Ht1EW1Sv3W2j5hx9fWjVu9xOWiXYuWsq/2DerZuJNOt1dJr20YRraytjavllstkdCCeDWjo0EF/4YgtVme9hDYC3K4kgIPzBVLcK3Thie9cfozwxWN6tlCPENteAx3NoT9m8oDBDBPvbs4w+AMZFXtJ8QX+gGLSLF4bbU5pVyoslklii5+UsQN3XrzxVvUmNRLV7E1lqUGhTXNvYaLc2MPmYBnR2aTH+0nUDPfnmitLxNLeSPBPd+abh9wdtLTdG2COSFcAH8KKj2klp/X5mnIjZ8KWGm+IfiAs0kyXHkWhnkha1MeM4GFYHBxnkn8BXXnUItOF0szRrpIj2Q/MowhyFCDgN3/nXBaLpGsXGjXFlaNJYveSIJdo3ySxdCm4EEL1JHfPSofEXhey0V2/tvVruzSCUNa5G9gpGCDgnBIHRQam192FnFvQ1ZPiJoQnNva6ZfXk0sRSKNYgW83ICqFBzyeTkHoOKzbbTNPtpItb1oX8/iGV2b7DqmzETKflkkQHJXqVViCePlwCazDrdto7bLa2/shrqH5Au8XEg/haSTqATjIXbkVk6Fpl34hvVsriS303TTIXJb7u7GfkJ5kOeeT75otfYT397U6rV7qxFzLe6rrUt7JJF5S+feebBtcDcURAccHHXv1HbBFzLqln5UEUdrYrMUsowf3c7jA8t16K+054GAcAZzmt+XwXpsMsNvZ3EkbOYyFnG4BshWDAdjknjpV/TtG0/wAN+O7awcLHpM9uW+0TASqJVJKsCw4Ixj6Ec0RtHVFzctmrIt+Dv7TvdIksb/RpdNubCOIwM29knBz2OSrccjp9Kf4p1WLw7YS/O8OpTJ5dnI0YcxEg/M654XryAeT0rM8cXdlaajpt9DfTQz2qSrLYQSlJ8uuAVbpjHPsKxrXw3LdadZ6xruqedpyIRHDcFvNukxlQuTkZYkE9sHBNFrasOZ/Aip/ZN+5S+vpYJLq4Ry0ct0g8x8/u5CW6A5Bzn29KTR9Ak1zxA0WvSQ6eUXZKkSpvQHJG4fdzk9R+lbmqxC1vSbmNZb2/tw9tBJGrDa3G9lOdqkKQuR1U9OtaPgTS1tNCl8m0lTU5LvybiN1aMwsASqgHIwQD8wP8Q9qSk2rjnCPMop6fqOtHu9C8B3dpPqtujW9o0NrLFCdsbA7QygjqQcZbucjpk8P4bsUvZpLhZ5biytNsMgl+6srDiNQeWJ5PsoLHpiul8fXGsjVdK0bS0tyk6rnT7pUDSO7bQr7uCvpz79cU95YLRr+2sraFbXRov3xt22RswQGQg4yXY7fmweGQdBSbcVpuwjGMp76IuXN5La6fLaQXZsrFg8dvZoxKysSP3S564JG5jjrgcnh/hmxkjuI9QJmW4vbcxvbTAbdqtu39N3O0dckdea5jw7ZSeMr/AO1tBceRYmNWhs5kOzJJQKXIxkjLZBJwT1Oa9GVC5vL+9kVILYt/rGba4HBA5PBPBGTntxmpa5Va+pcZRk3K1kh7ymG0j0/fZ3Z3KxDwssSk52rvJAZm6cKATx7V5HdvaWD3UM2lajHZCY4muZQly3BBiQlSCvOcY685q1rD3fiPWvI1YSWEsiZEckzJCfLAIVDggZAOODlu/NdHIn2bTIpv7SvrNLPF39pP75rkIQqKAWDElu/IOTnHWqXuOzM2ueLa6HHWV9caTdOsUVtp9/ayC8eC4XbJNEcDBZunynpwSGPJ6V2Vlds2ixyCNbTT9QcxiJpd4VgQ3fuCODzwetcG/wBk/s20Mk2rQanNG0eJwtxbPHvOT13DBJ45xx0rqvD8i6dpNynn6WkbbbW4JJIcoC2FZicnHyjHHBPUUTjzqxWHqckjSNvb6lafZdYWOWZi7xvGga4s9pwH8rPzx89cZ9+K5u2nvPBerWKQyy6pLdI8hhSYxxzMxIUBOS4yM8gDP0zW3aQWF451iz1SzeWFNquVZCmcKFw6jJOT0pniKyu7WGaPVdNN3pUmA19bMC0Z9NyncoPccZ/Koi3H4tjarCNT3ovU6jw5c3Ou+WEtLS2kS1MksSrucPuAaMkthk5PBOOB6kVkfESHUNK/s3U4o9OMlu4aRBZhpWLHqARhVIHPArhrO3u9Ct7e6fz7rSww8yS2uTHGWznywPvKwx3HT8a7zSPENjqVjaxObbMzNLcxqWkMDk5TLMpQ5AztByCx960S6rY5m3tLcm0a0tL8Qajp8cunm7BWCw1B/l83jMSlhhgd2RjGeR2rN8V6ZZaTbXFimovEIpN0wt0SacLjDCNCAABzuOeOmaxNPKy+NtQElol35lx508s18waADOIkjJBIz8pHzcEdAK1fB9zo2m+ItTaSDWrbUldlghviZ1UM2GO/b972btyCahRd/IvnfKkvQqaPq1jp139rt7zVrjSUiSFbj7FmMs2RiQKwZc8jAPNa2oyxstzfFLf7GhRHjg+aKAhQw3KcMDg/dI45zW9q73L2VwdFhjTUVBe1Z8IiSJg7pFxtfAY46+/Fea61o1/4cv7LUdQL6jZCXzLi5gkUh3LAsQx5+bjtyM8VXKpFKpOk9dSbxPHYT2013DNdx3EjL8zFXgXjcCgPIzsx2xz1q1oyasz3d/bWY/tLULdjHZCRY53fjMoibG4Ny/uenGKjuRHe38KWmo/abDcZPMhjIkiOC2zAxux2BP05rKk1WTTbfU2aa+vpbuBWOozTbLlQSAojXLFecqSTkgDGB1qN0rEVV73Ojs7a6vxo9hbeIby10vVb6X7OIpISzTADlSNpCycjqQM1z/gi+kttRex1C9mjSTJcShi8hRvkbJ5BBPPHTtXX6TJBFpUFnbtPFNFCxgimmEkij+NlJ4J+Y5BGe3SuPmXWdL1V1WyNzcXNx9ltvtoMIEIAdzvYcuW2/MW4A4Bzwmt0i+ZxcZN3NrxR4cis/Ekcl7pd7Fo8sLQytYKryzPgeYd7kBQxIHOSQCcDNO1a1tza6dqkYYRSIomjuFG5ivyqZlX5csONykZwDwal8SyrqNnbvq11qjWtnEFWG0nVYyVzg4IwOeCxBbHAFVdS1E3CvrNnGwF1bAOoX92qj5du09vlJ6fzrCc7xXc3oUJQm+b+kW9Au7fRpLTWY7W5ntER9tuXKsVxkYbHOD3781Ws7qfU21m5Fun2mWbG6BeSXO7DAe+AO5znisuOcqxt7oiSDa8aMg5VefkB9Rxx6d6sRaOsd3byw3MXmFUtxHHI0YYk4J498g54JqIpuTjI6JWjapAc901oJ/7QiZYriNIknUfIxJwCxAzjIB5PDYwOK1Ykc2kUBijlkBJaMYJc8Z/ME1o6tJH4fuNNt7Lz7SdDE2918weaWY89ScAE+4PHrXKySS6M9jPC7eTczOqWMiN5kTeYdxVujR4+ZCDnBAwCOZlBzat00LhVjSbUtnr/AF5djYubK70WO8i8L2WnDR3iZ5IY8m+tGUAyYjcksSejAkBSRgdSzRtUtdV0pX055LS4ihNsZsATKgXGcgf73I54NbkdzNFcx3PnKLuAko4Xk5GMsG6kjgg1jw3ekWvjK6t9Ult4re4QC4sbe0ESSMygqQ6kFSOuQRnJz61vSm5J33OOtQeHd1qmcRpKX+p31g8TpJMqNHp10l3IHllTIDzE4LIAemMjjqM11DaRpGn3s1rq4sZ7i4gSP7PaEgIvBZTM+5zmQbgAcjA5HAqTTEFhd31h4chubXSgzeSzFpChI2q/mSMSuMnJXHUcmrmnHRbrSns9ch8q7t3+zTyTyGNlYnhg/bJIz698itpSa+E5qVK+szL8Ravc6nYXkWgW+nw6fIWa8mghEW9yRuXzWJU/wnjByM4re0LQrSzFvcaeJRNdqria5I2vLtx+7buTzznqa5E6NJHoUSXeoafLY21wzCC0dblICT80r7PmlYD+AdeBxVW/1fUoLiYJ4lupLJQGtp7WcvEYl5+6DgMRxtIGDxRbSyEpqDvY7rxDDolpqU95f6XB9pnCmF5bffIzYzlhnavKt8wHpxWJpvi7T7jVbN0jmX7bMzO0ojBKhcEPtUKFBB4HPesq91W4udO0AW2svp+9vMkM0R+UNnYDgEkDJB4xz7Vv2Xh3T7jSBJamye7k8xJLmJSqKc8/JnHt0HWnayuyrtv3Dk7i0stNX7dbwrffa3eNY4pRJHb9CAAMFuPmA9PpTo9KvPEEUF7ZyXV01qpWVbmxBWJGblgGBAGO2T7Cp/COh22s3OoWMiXWlG0Xymnh+Yhx0ZkbqcZ4BGa51rlXt7yyF7Je6fJMjGdrFleRlJwSyyZQcnrmrXY5pvq1ozqbDw54YuJ55JtG066tZsxSPYvPFNED0dNzHjplcED6VLbWHh7ToLqwsRDL5aGRf7VnINup6FWUDCnocH3rSmMdtoekHRnWe5jcATmNWIQ8nnjHTGRmtDTbqTVEnkvNLWS7ifZLZyOrbUHTPZgfTvRaz0NVTitlqc4n9iSAWpF1aSWwCusN2nlsxHVDICWXpggmipk1bT9O3xXlnptsC5McMFm6qg7/AC8hefTiiuepWjGVnFv5GsdFq0jsNJ+1ReEbyfRre10vUZdnlSXRBS3LZbeN3cAnA5pl9FbG0hhkkZ13ArLccys5PzzNju2SMds1zEnP2aS+Z/slmf3UMS7lVj/GefmYDp2FVvEOuXS2iX2mqsdmJPIN1JHuMUmPQd+epzVcjbLU4U7yluQeJr+w1fxeXubx4rczILi11CP5FUYU7GHOMDgcc1uL4hstfJ0iaJPPj/49JpWCIip2LDGAV9OlZPhSwa2v4jrmlRG58wG2mnAdJS3RhnpgZ45/PFdZPf6No37/AFXTxbJcDyVNii5dB94MO49fwq210MYp2uRSavql1pVs/h/TrO7tVO25ghl2ksp/dsufv4A5wTz+FYt343nFhqNl4h0ppriJt9uk67Gwx5Rv9kdR9aNK0v7Jc3VxBPp50y6RnP2aV0khTHG1Dwre5wKoPqNvp9s9jHcG50+TdGZL4idvN6kFivA4BwPXrxS0Wg2m1zbGj/Zg1m3udW1Z4/IvHW7srQuwaQjIK5P3Ux8vB7cc1e1HS/O1qHXJNRn1GSND5FoyYVCoyCIxkBM8AHnAzXPXGuaxNcXVrp0VxBIxRw8yAzx7VzgNx+7I7DAwR+Kraa94hm829mvraUL5iziYoynrgcglTnIx+FHK3qwi4r4Vdk4ttV8QeJLa7v7NodRjIvBJFcbUlAYYCnnBPTjH0610PjLWbyztTINQhaC6haBILciKZHT5sBwCFfOBzjjp61leHvBVrb6w0818L5UjEkW8mFg38RLKecHkAYz+FXfFPgvU2u7vxFby20GnTL517HcvlWGOXHBDHI4yu7JPWhuN7EO8FqjmtGuzqfiJ/FF/NO01nFuurSeILM8oTEe3jGCQDu4IAPfFLbajNreiaJ9kEcWqXTHZHNMYyQFChR2IJUYzgnA9K0fD8VwNFiWyitb15rp3+Ryd23A25429ckH24x1pXmiX+lwafqd/o7R31tI8kkQnEfyKNyvFtyP7w9sDtU/aLs4w9TvrFRDp1hEkRtLqWAm6hjC7RIQeAwAzkjGWzgVz/iy8sIdAS3u4XniWTa0MTFHjyuQxHTB6BvzFdHpeqW2qomp2cclq2wRulwUVVYggLnOG6EeuecV55Kltrnia6e41LUo45LoxzJHGu6FwSevdMLjGM/XmhLW7KcvdUYlnTrSSGz36YJ76YW5lEclw3lMnVVdcgA9jj0OOtWdY8SW8JdZljuLm4RVmjhcLtiKYLI2CM+3G3jjrVGTWIJdPu7mB4NNiu7hltleBirrGvAGz7iruI9MnJrpfD3hTS5tA87xBCjapCXcT20hKRrkbVYrlWI65zwG696S/mZU52XLE4KGyktrCW3fTprmxWVJbXzFaPzA/K847gDI7/rXR614S1CT7TcWekwDE0SJBBKzBpdpL+WD/AAg5ON2R69q7zVpGPnqlzN5IIYmPl5sKOhJIHTrnvz1rjPiDrQWyGmpqk+nXkAW+hLxP5qxcgKCnCtn5iRxxyR0qlJvRGUocsbsy7nwlawG2tdR1NbOa6/dMpZWjEmdwG04yOozkduua17Dwxb2PiXV4vtF1c6c0AgbyF3u5KqdxC9xgn2/WsvVvF9mJrOUWdlrTQeVDc3EsTRtOpALEY+7IcfeA7A8iuu8IJbzXk2seHrmUTz7PMsZZFV7cgFVXA4YnkZ75obdgXK5HIahB/Z4eLW7/AE27nv8AaIIUQmO5RDx5wGNjdApByTuBPeodZutXXQtPvru6s54dPuAIbWG3VVZDgrmPbxjlSew7k5rR8eS2uoLus9W04S6dIRNb3cMglaUtn5WVQSASeM988VQ8Q6vJZ21u1jLLPZXEQlQh2UbdxHOOQcjGD+IOc0rtO5pZTun02I7a7a/1iTW7VHlu3je4W0n08YibPCLNn2AU8Hp3rX0uWHw74hlhlbOi6nAlw13Nc+bNIwTcX8oZYEOXU5A6daZpmpJDpkItoSbZAWljE+8OSMkPk5I7j3HFMuTpFnf6T4kIa7ZIniEKHDXEuTgsMdMHn6c80c12EqThFNM9A0+zgvJRHFKY3lGFLnhiy8HruHP4dqzbzRm1PQtWstZTy7i2fzY/JjDKojGcBDjO/LEAcZAzWHonjGGT7Qbv7Fa6hCwOZPkhAJChFOeGHfrXUXMj6ixmuEk+1Rfu3RmDBGHIYd+2CM857VDTizS3tVvoeTWWpSWBueIdItLxgwiSRvtDOOhcHORkEkYAH0rZgtxqskV/ZaYl+5R/JS7B+dQSDwh2k5yQM+pFbvi3RINZ0i9K2mmQXKFZJZZY8SOMkEhh8wzznr+NczcWepWevXtjJczadbKtvcWwQuIDjaBszgDkkDjrmtNJbGSUoPleqJvA1jAnid7mfTNR027iLhPtkubd5WRsBiVDY5yDn09q6TSL863od3az3tvJdOjws8TiVZUAwygHJwRj5vwrDtxquqavcXEKw36wrIt5MwZXGSANocnLL8vPIOcdKdp+k3elvDcuYdK1G2kMVwDYKizQZDHDg4B4xkDB45oautQur2SMxbSHw74pm0nQZr/7PNDuilnyGRu4XGAVHI5B5FbdlZXWq2s8USrbhWYpGM796jIGOgB25+rAfTF1Gb+1vE1z/ZJmazdFC3TyOTuVeB5blWUEYGO5Xd3xXR6NNqdulxHcInltHvmlZiPKUD5MfNnOC2cD09KynZO9uh1Ye7jZPS9jlrn7OIz9qL7sKyDBPynsR/CT/QVsXKMZfNhmijEREsiFc7484yB6YHPQnOQa5nX5zfMspf8Ad+YcsT98dAT6/j/jVjQ9QNnfW+qJtkktmBcyjcsgBHDD8sfSuJ4hJpo7o0tWmv6R3mqeIrNp1uLa0mhspodotCAvzhW2YKc7TgHJ5zx3rFkhUapbXcQb7bLGA7TDmPA+8ufukhh+K4HXinfa5a2TT+dHDFESWmMcZYbi2flXrtU9O4wcGqOrabqdtJ4iieWGG7uIo/KvLfUFaJijrvG1yCu9WAKMRjdnJHXppJy1OOrUhRSjv+h0OqXNwtz9mGnXM0f/AD2QoVCEZLk5JA7FiMDHUda5/VrjR0knvrjzynlL5IaTzEn4ACZAyGwegzVbw4t/YJBc6ho0sKW0zwrPPIgUMyEELg/OMHOBkdDn11Nfe40Oa5urW8trDT7KXybKxmU/vS/DPn7x6Z68cemK2pwUdDCtWdRc+6Fs7a41eCa3WSO1026t4UnsJH2ywgcgkHkHIzk/3sEc1o6zp9jo8Yi1O0vtSWWML5TwszSKFO0ORgDgdc9vY1zcmo6D4f0qW6tYnXX7+EM4lDSKXJywG7DAEjPJ9Ac10uqy3F1o8serXllZG4RBaTQyqg8lsEg8nd82Rt9yOKtx1uRCfuuPU5e3ttPkiXUrfSLKxs7F0zbRXxe45OeG6fhkVq6JpOi3mqXdvd6LqUuqFPOuJm2wG3d8kIoUnOBzntWdd+EtZuNPa4htIrprJlSKxhdVlZFH+ueNWO4HjqM/hQvjK31fS7e1s4fM1Lz9ipIWQBsggs3Axnjaau6asjmi0n7wmqmDRrnU9MS0e5s7RNySXk7TtDIf4m24Gwd/qc1o6prd9cWI0210WSa4uY42lAiUxyAqd2zHbOOQe3XNZdtqDNq1rf3hg0+7ikcXcMUcjRTN6bdwxnkHqOfSuu8Ja34ejsb6Syvb6GWAloLXbswuDu2PjHbPKjkd6HKy11NI6p2duxixlPDejW1np82oPeTujmKYI5gcdYQw7e5pY7jTvDXjiWzSdv7KmUSGeO1WRS5GdjBRuwCcYPIxUt74yso7C4k0UJ/aTKsq/aLQlUibI3KckF+nUAdfpWX4gvtS1fUbS3OmyMYUWO6ntIA3nH1ZCAGwO38qceZvX+v+GFUlGK9x7HdXE8+r2Jezt7W3SYtCSkZUD/aEb89PT04IrA0i4trGGWC5t9X+x2LlftSQyPDMCclDye/IBx7Gq2s6XDBfXGl6P41sLSBTltN1K3nWWBiASqsCcr3AHTPesW6ddPltmuPEW/TZSI5ZtLS4gljYDgyI2Qy+46jPTpUxa6EyqbO2q8jT1PSP7QuTc2llZWlrL88YzMocHvwSM+vSitYXlxYaZZzrN9ljutzLJYAXNtcYIHmRnI254yuMj0FFU6jWkbW9f+AXGEZrmK/jxrTStQ05bsPceUgcQq5Ve3cc1fsdSm1Dwtcy6jotz/ZQcNAkQKpI5P3s5zwOpqnrmuavq+qWkXh+2iuLWzRVUTRoZJsY3M/YA47HpXZXn2q9sJF1ISW8MkSxvDGwEMJPfjnHTtS2SQK8pNnA+M0vYLiytE0u6a1uF3RNZK8mOh2qeQOf/r1zsVrZTytdHSQqxP8A6Wbi5fCHONuepY9cD3r0zTfD974dtoIh4kS6KybhDaTs3yk/dIPCrzUXj6/1KHQbeSwWySOW5CzmZUO3AIG1CMZ680RaexEk5LnexzeoQi8s9M0rQGlt3uIGuTdTx/vI7cOEVeONxLE8dFC881astGtz4qj0y/uW1HVrUCaS1uJWVfs/8L5UYPbC5PUZqWDX7NLO3l1STF/bsqvakjzG+YBSoHABAzz+NSR/ENN+p6qbKCMLarbBZEDSAbxySMHp24AJGOlSr7JFT6NO531lNpvzNqt/cmWQ7VsrSFxlcnCllBLcY6EAdO1RLf6BAi3EOhKbZ5DEWv7n+P8AuhWLAnPbrya5OfxHrerWt/eaZows7KG0knt7mePLrIANoLHAYuTgKBn1ripbG/k0yW61bUBazXMwu2gRWZElHJY87c5PQZNZ+zXV/wBfIXx3td/gv0PTfE+rNYK0WqC0tbTcwWC1t9qMU+YDpuz074OR0ri9Z+IT6hY3OnaNprB518uKSQBmRQNzALgjtjac+oxTWt9BkvzLcXGrXcspEu1rtBECQCQzfMQD26EDii38R6DpF5BPZJY2M9xGoN0kUk8yLzhucAPxyQAcGqsktEU7tW0SOn8LWaadoukC8tre0u1Wa7vVigMJXcAqeYpzh9q5PTgDgZp+s614d12zniintruFlMTJ5mCD17EMMkDp1GcVzd/4wh07TgLC0le7dN6yXEoaIBmwSYwAC2M4LE4PY8Vl6hPfarrFp5emaVF59uEtke3iCXpYkFgCMM+5e+MYIqVTbd2aKtGnFRjqUHtreSS0nnmURW119o+zwANHFHkZDYOQCQATjOPWu18P2KQ6BPdabaFv7QbFxJGzOu0k4RG5AGGPUjqeax9Wt7PTLXSbjXLBY5r6QtAsagC2VCqsfMwGCsxyByABkgjiu30W4e0hZbASokiSRRmKNDJGSCFdUHyMykdCBnnjPFKpJ2LopXcoq7RzV/o0aaTBpb6dYzmCSQCW7umt4rThcZGQSWzkckcVZ8Cz2ltONGtYPIkZjI13YxvLbO4TBZ3Y4GcAAgYrRPhuSfwyhubwatcTl4phehoXaZHzC67TuABODznDDoBXCjVtT0n7XpuoW4hlRw15yVSGJOigA4wCPvYPpzmrj7ysYzl719v62N3xadWTU4NR0eYWs4f7OZEuwQityxAxgZGSfoK5aX7c8unf2lb3c1wspNvMHVjOCwxtBGOx4yevSrw8WT3SxtdXyWcE8Dfa5oIVVnfnYF46j5Rn2PY10PgAT3Wi3Vw6z3F2Zwkd0XVS52jC53fKfcn+Ic1Xw6k6SluZsuka6l1awahfX0ttekPOsUywCwVRkMR93IAxxg5GO4rpNTs7KNILzUJr2z+4xa5ZYozxhZDwGY+hOOc8nFWUv7vQ5786vPp9vGkcciSTKJZV3HG5SM85xnPQEVifEu8ay0UzfaftdzqWWLSLv4UDOf4dpHRRnvip5m3Y0tFXMjxzPPq2sNt07T7hlCMuoJMkxuhgdVUnfjH8IyMZNVbkXNrf61aTxx+XBAqTSCLEZuDtKIWxlSey9s1mabaxL4TfWn22d8blbOGaFSpkRlZpOBgbgoA3DHDEHJxXT+E7xr3SEE2tRG+mczTC5i+Q20QCrlXG0k4BDHDdKrRIyT17HI7phIFubKJLMXCNLaWq7HkQ5wwJB6ZOCfX8a14vEFqH1S3t7a3Fq80YtZppNj7j8vzqSRt27jnoMAEnNek29/b/AG3H9nWQg2Mjg2YKc4O4juSRjHA71jyeGtAuJZZorW2e6ldVe0u94DBQTlCPusSccnB54FSpLqa8lSLucXoySXd9bQ29gNPjikZJhGnmQTBuNyMw9cdM9sYrovCXiN7wyPd3s0llFL9mNw8G5o2BGHdxgBfz78Y5rkNIuLvRNQlXX4podPuB5kAEuxoRuOGQDJ7YIHXvVzW4lXZe3GoRSG3g+1WlgT5aykNzPJjGR154JAA6VXkyU9OZbnp1tcJJJObaxk1SdYiXhtJwsyjjJTPyk85AJ5rzDT1TXZ5r1rW/sfsBMCN5rOyKxZxEysvzHhzkYOc1s2Ou3lzpcmkW9xZ2VyqfaGuL0gsyumWRjGAyBBzuyPvY7YqlpmsWsfhjTtP1NDm5u3XEbMoeOaMokys2T8uCAeQNx96lJxvYHJzmmyjpUxXxBenUNSezv7tB9lvZN6uFbquSoAJUbcfQA+vo+mx2j3Pk/aI7i4tAFmhVwzYI+Xg9DuxnB715/oumTa0Hh1GclLQNFpou43nU85J3jnn1A9Onbt9XlttMiXVJbq6S1tFZ5o1RXaQBeSTwQSegzTnYqldXZxdvLdav44vZp4jf3d05i8u5ja2t2KkgAdWbGODxziuwu1uNd8K6hBCJI762Mc0LMuDcWpYB9rY5AYc9xgf3ueS1CyjufFOjarJqtlq6ahF9stHnd4roKo+TcMKByAAuf4T1rq77Xr/Sb6Syt4kn8uSQXCMwPlbiAWGeQpJyevIHFZVVexeHbcWou2qPOtVgW3uBFcrC5Vckb/kUDPJPuc1naSWLQNcOTIZl4RQMjPIA7D3PpRrKXct/clg7+YxwFGAEz0A9KrYa2eLHUnKsG/z0rx5aSsj1uZvV7I9O8I3OirLM2tyRQWikRQXE0PnLFds2ImYYPP3iN3GTjris77DH4L1PWNJu/EWl319fXSllt5HFyzkZbzU2lVyrdM9wKxdA1KXS7cusyo0Vys6gkbQ0Y3BznrjI4PcVqeN7DQvGFxN4h0CW5sb24nCTieE+W0oUDcrJuPzALjtnkkV6eHk7I8vGxl7X2kfu9CjqrabYeMYPs2gssEECKbuzVo53mIIDb0yqjPU7ccHjNL4mm0+6unn1fTGaS3dYpzBPs8nBOOD/AKzqemOPrVPSbSz0p7d9TmurO7X5Lm8YSAyZP7uPyv8Alpjk7icHj0Geh8QyR6xY6jG9qt1bLIm1m2xeXIF25Qj7pwATxgg9K67bMwgnyy8+hBqv9t3OjPexWmlGSAHYfs+We3wGXbwWxycdCenrVLRb2a/tND1K5bS9G0m2MsIS5QRYlHzLMmVLNkk8cqCOtR6LMug6pOuq3Tx30cGxIikkjNt5PJGGPTAzisRdRsrqK6utSu9YnvrpirmcLtQH7sg5+VQCcLx9arXoRJ7O5s6/pS2Xiex1LU9RfR4p5kuFuokJ4JBDq4PzZxwc/UCvUfE/ic6h4ZutS0bW5LE/Zy3l+ZHuVhgAB2yAWJwoJySGx0rz2z1SbQbOGDxC8OteF7xBFaQzoJH8zy87lOcxEZ+Zsn2yap6f4ghg1Ai10i1Xw/qA2XOmyymSEqDgHecNvBGQcZU9M98pRvoF9XK2pBonhmbVdPOo32rrbSFzvuGmdpJFPqAMYz3yKWeM6LO8lvqFhdW8EZ8wbFaP5hjIUA7jz06cYq9PHpulaik9jr10umFWMdlNwCykhojjggfyrHaDUdG1MXa6R5wu1yEJWVGjb+HK8Akcgg5HWtlrsJpRXmdL4Kjh1FWNt4gvLmS0GFWKARxqh7bOu3r1GKseLp9Gl1G1u9WuL+QLhIYbNyzR45BK8Efgaw9KuNVsI5tV8NWF1eaK0oinW7Ql4c9sLww7ZXj1AqyNY1C4NqBY20cpcmW8MIjZEB4XJ5/A5p395FRs4WW5Y1OMavrf2V9atrYRH/iXSSHLZ4YKcDcB65Jwe1F1p+tWensLi5sWkW4BDsoIb1HIwVPoap+KIUs9dt7qCSx/ervRpoinG7nDDjPv71q6zfvM8sGrm2OkyJgCF9xDcEMH78+1OOiTQnbmae424uU0y5ZdA1qfS7eVVkeDT0Ji3kcnGeP/ANVFYF1owS0tbgRXVyk6nbJaLuXAxwR1B+tFTyR6od09bHr2j+HrdLj7N4ftikaLiSQ5wf8AeJ7+3f0rn9U8L6nomqXJ2KguVJa8MxLO57InQenTpXpml3kWn2pcsqqqZKfdAHXn3964vV/FVvfyS3Uc4eGM+X5uBzzyF9vfvWSlLmfYdpOXLskYunNqETz6VfX32vWMb2a2gIZVx0D4ClsEdBWD491a3gvVt7cl5jGiyTeXjkDBXYRjI7mm+IPEVzJdSWWiXBVp49nmFj5m3Ayqt/Dnpx270+wuTp1nZ2t55Uk7t5olkRbiXcDj92vovOC3U89sVpflYNX0vt1Fi0aFfLN5apLqiqs4lU7fIQYIMg7duvtir1/rbWAe3stStNNjf9+VsbYfvJO477ieCWYgcfgasmk32t6nd75HXTi4EyeeBLPjnc7Hqwznnj0HFal14R0m/i062V5o722ypKDe9wo7YHGR64qZRT+JjTaXuxOY02417xLfxzrcPPNayLIZJ3xsyeN3YDHoK6CbwZp8sM0IluLi6kInjRHztB6qAPmySR8x7DpXV6H4bgstI86dW0XSYvmmllG2eU5GMd+pxkjJ7DnNWPEGvrpGnynTrf8AsnSgM+aqYnuW7e4zjOT8xHJK949pry00Smm7bv8ABFDTtGsLIPNBo8a3UKbVnuowj8jLcNjkZI49RUJ8LaJqO/GkWlu+xZElxkylSD5agEgY9R2Ge5rjoPGGoS6pdRx2CTaVPayskTncy/uyCwfrnOcitvwtZa35FnNbSW9lonktE+nygl4WC4PzEZGfvDnpxVWl1Y/deljW0TwhpNppk0pW2gYb1ea6clossV24I7t+XXvTr3SLKDVNEj1Oz2X9vZB4GEW826BsBGK4XgknOP8AGs3UdXsPtolu2v1aW5FvEk6hUn4ALNztZQSP/wBdZsnxE1xtXv5rZZXto7yMTQORLHjbgpGT90HGQfUg1LUrie5V+Ikd0fKntbovZIoSWBgd0DA/w9znqcD9K6XwxrVtpHhi4OtXQIuRj7ReB0ZgygggkfMwPTjPGa4C8v2fTI7VLie8aeWSa1eSQIZUBw3mnORsI2kDqc4q9qkmuyadpjXesWV7bIBFBaBcRwBl4DBhubHI5ztwOtOUeZJFxlq3a6Z6PNZ3N3ZyPpFl9rlKghlkVFkDYO4MeOAcnPp3Nc0XeWKSfUNJtrqCRlllmdSQx6AuVGG6dec/Wufm1G4067AfTmuVjgRrpxlRJkHI3L/D2K+npVbSNfl1rVbu01ne0l1bGGCdCC9mMgqWIGTED6fMue9QqTjqzaeJu7b/ACLn2XStWuZtY0h5rqaFjM9hPIGyFzlY1KgyAgZ2cNjjHr0Hg21t4vDs19cW02ho8kk1xbxWbFZFVQVbyz8w+Xdx7cdjXI6zB4ht7yDcqlI49zqm1hKg5LErwx77hzWbqlzff2nC2uxTxTWKhYp2LGIxjlWHJK54wenbirab0bMG1F3Wny/4cva5rEsmrahd6JDPLpskf+mwGdhHIjHG8I2SnABGCefyqKC/uH8INpVvL5zR3QISQbmMG3KGI4+7uByPUr2NX9Mex1Mzx+IZDPDefLAwYxtFKvU52hlYjjowPv1q3pWnWUWp2c2nXF3ZWqo7Nd3Ekc8EiqOSHAGwkDBBA6dsjN3SJs203sbGm6d/ZkMVrOlq9lHbtLcm9TeDMg3rsJ4Rh5mxccnkMD25i912C1eBdS0Owu54R/oYMjvhNx+aaQ/eOeQO2e1aGn6zd2ula1Deajb3WmRMkljDDIv7yRzhwrDkqAee2c1yrpI/ztqNq80q/L9oiARFJwATzx7D8qiF3q9C6iS0R6TFr+jzadDe29ziQgbobWNpjG3csCOF4bJx0HGTV2bUbG1gSwkvLb7e7F0gbdl4yRgoTwyHnGMnk46GvI9dbUNBukfUvtltcyKjQSW0yquf48EZBwOOOBzVzT/F0Go30Nrd2oe8ClbC5aOOM28pzkFsZKMfxB5zyaHFEqvJOzPRPEulQ+ILWOO/VmAVDFNEeQ/Q/MAdwxxjjHFclb6HqWn64IrKG4utOgDTC7kUnzAFB8s9Qv8Adx2ODW54e1SO61ARQy2kFvNFGkCmQsJ5lH71ApGDjnn26multoWvmuIYd1tIshzFFLtD8dSMkEgn8R0qWrKzOhcsmpx0Z5BqH2nwheXwW7g8+6k8q4a5InaaN8FhswfXnjntzxSzWLQ6hfaVeXVpbGR23WlsZWKSI+6LarqPKXnpnpkGvUF0uH+0ftEdnH/aY27rsITIm3kbcZxjHUk+1cNeQ623i68TVLu1lcKrz7CdzqduOD8ynkdad9NDH2VppPY0NKvLiy8XS2QO+wuifMW4fy3jK8+YvOMZOBxhhkAV187RQrC8kQkhiyGZhxJu5Vcf3sA4wDwPauC8fWEvlafrExDWUUSxTNbgBvlbA5PucD0rZXwt4o1eGKPUtQFv5Ef2qyuGJVmGQSCuS2QCPdc1TSauXzum3FmYbewHj2YS3rzQMY7mfUbt/KW2aRuViJHK9FyQOhwBit/xQJo5grRodThR0klZs+amThWHY84z2PQ1mXtrYaF4TQS6fLqMd5dCJbq8hEnlyHlpGHTa3Cr1IGeSTimy6rca8bu/aORJ7S7No0RjKuqrjAYk5LYHtx2zUTu1p0KoK0uVmZqYWSIBotvQwxI24pkdd3c9vSsK60bUbu6t7Sxs/Nu5WVFERAVs85z0UcjPpXVGyuL2bNlDENxVfMMnyKpJyQe2fU+nTmmX+p2mnWU10ryieDdBLPgRrKWX5Qh/iON2BgcA9uvnww6l7zPUr1VZx2/IpQaFpF9Z6PZT65Y2clpcyi8ilRnW4k2/eWVeBHjjJx0J5qDw7YWXh3X9OkXXft0xybb7NC/2WbJ+XbJ03dR0xkYJp9hKl5o+j2fh68sPt4WcvaXUIHnxuyoqkMNhIw4weucita80O5s7LSb26je1SxjZTYQR4jLli2EJzx1JIHHbpXpcqirHixUpS59/6RQs9PstS1xzKL64lsrs2Zhl5g2jOxweuc5yvbOe9WNTg/s7ypLK6urzSbgHy/KzJDEQ2GDYP7yRe+enFaDTDV9Q0zUYdUnt5YAWmsFVZHdehY9A2RtG48/KKiScNJZw+FbbyIYIJp9Ou3UzqDjdMWVefM4IHB4AHNNO+hbhbX8TmdDvZmXyZdZvfsqTtcLHFMXkmzzyScqCcfrVgjXZL6zvolKao26422gDW18qHLIxU/eCZyMcgHGDTtK8UQS6zI95qSafHbjyna3slEd4T94MgGQD7/p0rZ8F+Xpmra2qMlpBbu1ta2ZYkRzNlTIGOdi4Y/nxWnmYK0klczLvWreez063uLGO+SYl3tF3u6EZw6lVJUAMQD17HPFRWN34a0y1tZJHlu4rgN9nt2st/wBnYNk7XOHfnsRineK9OXTtQjurW2v7dbobndrhQpPcB1OSPbgj3q/4re5LabqUN9Y21qpVUlCjgjGDnBY85zgfWhfmOSerfQq39jp82o3ebLN45823bBKgtysjDsD0II9M9ObvhLxHrEmoS6XfGA5QqXRk+Xb0A2DBH15pZZLbXESaTVWfUJT/AGe2oLCfLE2C8aygYJVgCAw9MU7QbXyr6bTYHtpb8DEc2mqxhj4/jVsHP50k+ha+JO5zmmzTx32ryXWqXEuyTbGkt0UMkmeu0feOPStm38QKvi5NVis4biY2xingu33xkgffA4w/Hvn61nQWcs/ic2lo1tc6jAGeSEwFJGlB5AyB+tb3hS8vdTknTXLG4le4dmE7QIVGOCp9e3Paq5eZW8v+AZR35dtStomqaJflrHxLOot7mbz0by2b7PJnoF/uY4PetPxho+hC9N8urxXkEe2NIFhIEQxwevIrF1vQYLTUvN02a2kbeCY3nCSQt/dIOPTqMj3qPT9Xks9L1G01SMLPJKywtKN6DnJUgHjjkEcGoUUkrPRGjfNO8tzT8OeGVu7eS4ucFHI8rypicD0PcfjzRTNA169Nlse5sLtF4RoEC7RjowbBz9aK3vLohRhBq7udvqVzb3V6LAJI07KZGUE4VccszdAK4G4nsH1TnTZJdgKq7lo4kH94nof6/pXqVwqAM0NlsLqB8qckD1Y9T9K5vWzZxPDd6pFCfLbEUA4+hIHH51hc0km9dDjX0yz1i6Y6fpN48i/KDhoAR0yAeTk+/eum0jR/DkEkNixfU73T2VrgI+35ieI+DgAdxn2PpVDUvEeo3Gt3TQyXE9s0JSKC2BUJ2OCB+v1rnrHRNfvnafTNCvIFlb70aHYQDnknqM1TTaMLxi9T1J7q9bWvtuhXtvLZRTA3NrCsecAguASOTjPNdDqmqWNlMdW024tbSS5hxIZ02nIzgEHGOevrXki+FdUtzZytPZaTfrlTFJcjcVJ5Oxck59Kjl8MXN+IPtWvWySRSHclwJC6/8Ax0PHFZSjF6tlWUtbHoeqXEam41DVr1pZbSMfaCDv8ALVx8pRR0B9h3rzDR47nxpr01hfX8sSQxPJb3DjMcUanJLdAAAevrgGuiu/BdjZ2Ulzc+Ibp0t1SSZoLRyB83IZmwAMZAyRVrwjawatf/ANnwpHZeG5I3uPtEtyBPc5PBcjHIIztGFHXk80cygtAd5aPRL+tjPtIdHvdGvra01GCCxtmMDujHz2bOTKyjnacDgfd6YODnJ1Aaj/YenQ215aX0kEryIYpDkrjjduxuPYdeM1f8d2um6RqEMfhtpLnSo1VXisI1I3574GHOR1+tb114IiuNJsbhsvfW8TRQPAxxIV+7E6gfKwzjjpzRF2V77ltp20/r7jhRp+u37Zk05YLeMbkjXDRK20k4JOBkAkjtmrVh4ZANvqU9zPDp8qm6ukX78Tjjy8njDYGD6EnHFbfhzzNZt7yaRbBdTtJdstnGDu2g4DKDwcY7+lGs3tvZeH/t0umw6gDefZ2jckRqmzOWAPVjx+FHPK/LY09lTcee9yhqunQ3t9Z+I9UEX2CRvJDLINqMucRqo4BACYLDHO7mu5tIrK4jhltWgY/Z1lVWYT4J45AIyc8HA61wmm2moSabNLY6VFd2E+2f7DF88e8HABVvmVlXkNkHpjNZmm/aG1O51LTLkWjyQOkUc0mwxHcoKK/Qr6GiztZkJpO66npt5ZBILxrlbJg0ZWI+eI5GGCSBuONxOB7V53Jan+yJIdWuI7RER7oRaWweWFeAAzkHfuJ27QeMAkiuwg1Vl8SnSb6SA3ssaySwP8iMBES0hf7oG0bsg5GPwrmH8Vpb3No+kPY6tZKPLlUwgtIDj5mcBW4BHPGe/rQk2EpK2rNDQtZ0XUYRpWl3mqm6iQSJFqkaoJXQ8vHLGxMbj8Q2CMGuh+329zJb29zDBBfouxSwWSKYEYOAPlOckFR17c8Vx2sPbX+gJdXtrNHqC3CNDJEhQhyx3qp6OgUEnIOBzmqS+MYdVF4kljb3trNumjQ/Iq/LwEH8W44wuc9MdKORhGaivedzV1SKx0SBkt2R06mEuy7MnAG4ZyvYcZGMEEc1zSy2+rNY2dpb2sczz+Q7TXW+NkLYGMY29T+VUprK6vNNS5RnktpNwkgmLeZEoKhfmwTt+YAE/dKnqMGujitPDS396tja6rFcNarbKEZWaRujSDC4LY+XJIDdetV8JDlKpstCwlz4Y0HxgjWc1jFpxhNqyXSy3Cwy7SMBVBLoWAyx4+Y1FpWlzaprrXItNM8Qm5uleWS3u/LuAm4CVY4WKuipx1UY+UDg017PTpooxLoWq6XFCvl/aGaOSS7ixyZOwfJOMHGPpWn4XuLbTrqyvbKzk32wYRSmJDcAtkGQNyChUkdSOB0wahzsrgqE56JWKTXaWTRwOtpdaXNPK0flxLNDM7NzIrnO04IBXORgVk3ukaVdxW11Bbxyywy75TaXR5IIKgjnqOu3pj3rrbTU/DmqLeQtYTeWJWPnbAFSUk5ZVDBQeMk4yfpVa10+806xTSbeKC6nv4mmhurD5UcdSpTHYA8g8H2pps2ajs9jkrD7VDrV1/ZzWs01qQ8DXP7sLuYllCk4Lckd8bSeK9L8OXd4sqX2oMLiC5TfK0WUVGxztLEH0wQAK4vxDpmL2Gf7UIdRu4mS1875IVBJDkN1z1GeepNWPA+txyLbaRY2t7cyq2xI9qMHyOW+YgKoxjBJ9Rzmm9URG0JWex0cFxrH2vU7HUpLaPyissF68GQ8EhPy4xyQR161iarbQ6J4jl02G1g+2XyebcXxmMkpY/vAu0sdi/L6kng9OK9K8Ihbi7ms7rZcpIm2QpIJFAx2b0+nQ15z44Fr4S8RXmoSCC7clYWku3IkmwqnzBjp8oVM4xx2zioTV+UqTtL01+RNeA6loUlz4cnkXU4ZUgaGN9hKAk529C27nPHApdSu5/Dtq17fSXV1rcEnlfZYmEioZAWcuRnap5I7k9vTF8Pvd6J9nfd5lrqD4co+Ht1K5Unj/aIB77aqvpk+j3+oHT7m7s5hKkEv2iZJJJoxkg7YxlTjbkPjt0JqlsE2+a63Zp+H5ZLTxNFpVpG5i1WNN8l/I37xl3lFiGCu1jkYJwCccHro6fEf7NubxxrFpdXV4zGz1MndbFUCvgk5ZdxGGIHAI7ZrIt9Qi1LR/EaaxNHHptgFFrYW/wArR5kxuyMEg5PqMj6V1d7YJ/ZC2zSSpZ21ubeMSM+9UBJ3gnJbJ4/DGKzq/Ca4ZXqpp6K5j6FNdNcyreQp5EAMmFk2p6L14/HmuWWyn1GG7TVWvLO0FyrCRYgWzjAAAO1lxx17A1u6VPqVza6ky3Fx5Bi8mJfLDNtDZCnH3RtBxjvj1qzILK2mFxZ6jHZGTI+zG1JWZQSN5Ycc854B49aI2jLQ1qXlC7uZ2qPb6h4v0LSr+0uG8mUxLcW88QZ0AJKsvbG0HaMd8HNdjqd9st5PPtrbNyhJxIGIUp90n+HPPuO/TNc/oWiWFj4i1bUZIiEtPMSyNy5dZNzZLjGCSVJA574NVvEWtNHDDBbXdpD5pdJlmcoyqcDcGAI3DkcggjrnFOXvNRRnS9xSqS0Rn+F7Oxg8TslxbXSNKjbbpGiaOHPK7cNmTI+XAGctntVbRF1qz1e6jhXEx3th0MXmP1UleinjHyn34q9ZeHrafXEaSyR7x41nKTzgw9AVdGQYIbg7QwyDxWnHpdza6q1zc+IbS5v4H8y5sDOJmHfIwMhQOSOTj860klYwoytPXa5F4nu7Of7LJqduYPEP2UPsgQySq54DyEjBGO5ycCjwr4mu52lsRp11IYpN89z5xVgh6uVIwSMdjnFSaHcX2s2N8tqFk1SyYTb9m4CJs7NpPIB9Pu8VhWNzFp/iM3mo2l3B5WF+zOvlwFjxJknJx37n6YqopMUnyu6O91PTRrWmTRbT9pP7yMzQFnBI+V8DkEjrjP65rzvSNO03S5pD4gu4uFZYoQrNJKW4PA+6P1r1jVJ4LPXLZ7tjBY3KwMslu4KrxjrjpjnnGRmuF+K9nY2t1IhubySKD5YZIIhukPdd2OQp6/WohKzsVV5WlLra/kcpJps+lTq+n2t7Lp+o/uUCKcMp5xgdGUgEE4IIzSW0cl9qUqalFbwm6Uyu0MRikbacM4K8Egg7kx3zV3w3q2m2WkxxXGq61btdEKwhx+6B/jweOo65zRrGgWK3Ms6eLrP7YxZleKJkjnIA+Y44SQjr2JHXudb8rOVtXuh97JqFp4igC39xJBHtezkA3bxj5WJPJH51r6V4ku9I1bUTqeoTW0dyVcs2HUDv8g/mOorKuNOmaPTf7Na5a7SLMjTjbHN6MjAkDPoajnsku7e5ub1LaeaKMnyYiXx68joR+lO2hd3uiXW57PU9YM0ka6fKFC3ETZeK4iPImjf39Dj69qggttHnvZ7UzzRbAJIHAMiuOuQRzx6HNUbBLZLK0e7TzEC+QqQMC3lnnIB7g/hXYaToelIkM3kF5Ihviu48xq691cH7rj2qkrddAV5LVanMato93b3CPbLAYJkDo8UgKsPUf4Giuu1S8TS5hFDzC43oZEVwQf7p9KKqL00LcY33MjUvEGq3UJaW+myW52kDt1pLiJNK8FnU4x595LO0W+4JfYAAeBwMnPU5oorIxbaZjxa7qsujXUg1CaNnZVJiCpxt6DA4HtXVfDqaSLw3rd/cSSXt0zxQq105kCKeTtGcA0UVFRJRuh05N1FqP1HWZ9I1eKHT4baJTsd28vLOzYySx5/wqLw4T/bur3DMzOZVJDHIJdjk49eOKKKlapnZPp6nqj2cGqeD9U0u6jzaNcIhAJyRlT1OfQV5l8SrVNMgit7Vm8t7nad2M7VGQPpRRUUNyNoza7/5FXxTqVxpGgyWOnsIYnlEjMBli20c5NP0/TRqPhDSb64vL0S2qHy1jmKrkSZycc5989qKK1gtSazd7eSLHhvUJ7nxJqWqP5a3XlZbZGoViOASuMZHX69c1onMet26RnbHqcKJcpgbWEu4tgdsEAqeoPTgkUUVnV6GtFaSXkcrDeXZuotPF1MIrSTMbhvnLEZ3E9z+mO1db4pb+z7fU3sFjtZJraMzSQxqrSZwSGIGSOaKKp7mEdUzG8JatqNppMk9tdujRytEFKI67cZIAYEDOTnGKs6bqmpXLpbWl8+l2oOPJ02KK3U55J+VPaiis2l7Sx1ckXRU2te460vdXTU5Sde1aRkjLIZLjdt4zgDGMcdKoW/jXxHc3em21xqsktteZWWNoYjgElSFbbuXjI4PGeKKKUopPREwhFxV11Lfj+e4tPFel6RZ3E0FhAYwsaNkYIBxg5GKfDcQP4uhgTTdPij1QFpxHABtOMDb6YxxRRVbGcdW7/1oiisP2j4jxaTPI8liXCmMgDjbnqB7Cp00y00+x8aNbRAC0t4pYEYlljMrfOAp4wcdD07Yooq6i0XyJi3Zs53wJq13a+NbOyhaNbSeZUli8tcOMEYPHpxV/wAN2a3ur6pY3Us8ljLIQ9u0hMZ2vkcdvTjsSO9FFEjNbHYabp9lceNr/wANJai3sLGPFs0Usm+LcgY43MV6k8bcD0rl76D7XDcaqZZIb62AMckOFAKttB24xnv060UVMNzVa03fyOx0bUrhdFttb3KdSQRxGXGA67ScFR8o59AKj8aWVpcap/a1xaW818ITteSMMEx0IU8ZGe4Paiipej0Lik1r2PL9G8Rahf8AhvWLy5kja6t8PHKIwCC2Gz6cEcVoeJS1jptt9idreS5uRJLKhy7Nkscscnk8miirYJt0m/I2fBWpTa3feILzUUhknNnAwOwDaC5yo/2ec4Na6vLehLe6nllEkcjs7tljgHA57UUVjW1SuduB+0zB1ZI4PD+ozRRqskSjB555Gfzz2qbSW2q0LASeU4VWfk8g/hn3xRRRa0XYtNupr2ZsWUvk6lqBdEmhiWMLBIPk4HfGCeeevJ61yvizVmtcK1lYXMck4LJPAG5YAEhhhhxxwfT0FFFaJ2ascdXW9/61Zq/E/TYfB2ueHNQ8NtNYTRrGoVHLIdq5yQ2c5zg9iPzrn/FNrFJfzz7dk82oGVpI/kO4dOnTFFFafZT/AK6HFS2fyN7Sw2h291dWUkpmuZoonZ5CcK4YtjBHcDrmuciuri71y8jvJ5LhLSF2hWQ5CFcY/wAmiirtaSNLtxVzpfFUstxBbNLIxL2yScYG1sk5GOlZ/iR2vfHoYvJBLFaLKJIHMZJUDGQDtx+FFFTHdFVPh+4z9Zv7oX2qWs0vn28u1dkiKdu7BJUgAg55zmta60uyhu4NOS3TyFhSUN/HvJwW3epH4e1FFXslYy3k7/1qVdftItKl0y5hXzJIZTEvm8grk9QMVDdXE2ga/JFpj+XAGEnllQQSTyM4zjn1ooqmD/yIdHjR9dW2kRXt5ZXbyyowrA9V7g/SutuNx06/2O0bKjNuTjJC9x0P5UUVM/h+RpSWkn5nI6VpEM+iWV0s1xC8ykukb/LkHqAQcfhRRRXRY5o7H//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a Sertoli cell tumor of the ovary. The tumor shows a greater degree of tubular differentation in the left half of this photomicrograph than in the right half.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Marisa Nucci, Department of Pathology, Brigham and Womens Hospital, Boston, MA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31015=[""].join("\n");
var outline_f30_18_31015=null;
var title_f30_18_31016="Tinea corporis on trunk";
var content_f30_18_31016=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75928%7EDERM%2F55949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75928%7EDERM%2F55949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea corporis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An inflammatory, annular plaque with peripheral scale is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea corporis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple annular erythematous plaques with peripheral scale are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31016=[""].join("\n");
var outline_f30_18_31016=null;
var title_f30_18_31017="Aspiration pneumonia in adults";
var content_f30_18_31017=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Aspiration pneumonia in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31017/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31017/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31017/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31017/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31017/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31017/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/18/31017/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aspiration is a common event even in healthy individuals and usually resolves without detectable sequelae. Markers placed in the stomach can often be detected in the lungs of healthy persons using scintigraphic methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/1\">",
"     1",
"    </a>",
"    ]. Aspiration pneumonia refers to the pulmonary consequences resulting from the abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the lower airways. There are usually two requirements to produce aspiration pneumonia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compromise in the usual defenses that protect the lower airways including glottic closure, cough reflex, and other clearing mechanisms",
"     </li>",
"     <li>",
"      An inoculum deleterious to the lower airways by a direct toxic effect, stimulation of an inflammatory process from a large enough bacterial inoculum, or obstruction due to a sufficient volume of material or particulate matter",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most pneumonia arises following the aspiration of microorganisms from the oral cavity or nasopharynx. The term aspiration pneumonia should be reserved for pneumonitis resulting from the altered clearance defenses noted above. The pathogens that commonly produce pneumonia, such as Streptococcus pneumoniae, Haemophilus influenzae, gram-negative bacilli, and Staphylococcus aureus, are relatively virulent bacteria so that only a small inoculum is required and the aspiration is usually subtle. A true aspiration pneumonia, by convention, usually refers to an infection caused by less virulent bacteria, primarily anaerobes, which are common constituents of the normal flora in a susceptible host prone to aspiration.",
"   </p>",
"   <p>",
"    The predisposing conditions, clinical syndromes, diagnosis, and treatment of aspiration pneumonia will be reviewed here. Community-acquired pneumonia, nosocomial pneumonia, pneumonia due to specific pathogens, empyema, and lung abscess are discussed separately. (See related topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREDISPOSING CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions that predispose to aspiration pneumonia include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduced consciousness, resulting in a compromise of the cough reflex and glottic closure",
"     </li>",
"     <li>",
"      Dysphagia from neurologic deficits",
"     </li>",
"     <li>",
"      Disorders of the upper gastrointestinal tract including esophageal disease, surgery involving the upper airways or esophagus, and gastric reflux",
"     </li>",
"     <li>",
"      Mechanical disruption of the glottic closure or cardiac sphincter due to tracheostomy, endotracheal intubation, bronchoscopy, upper endoscopy, and nasogastric feeding",
"     </li>",
"     <li>",
"      Pharyngeal anesthesia, and miscellaneous conditions such as protracted vomiting, large volume tube feedings, feeding gastrostomy, and the recumbent position",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These conditions all share properties of frequent or large volume aspiration, which increase the probability of developing aspiration pneumonitis (",
"    <a class=\"graphic graphic_table graphicRef56501 \" href=\"mobipreview.htm?10/14/10475\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Risk factors for aspiration pneumonia were examined in a prospective population-based study of 1946 hospitalized patients with pneumonia admitted from continuing care facilities or the community [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/2\">",
"     2",
"    </a>",
"    ]. Ten percent of patients with community-acquired pneumonia (CAP) had aspirated compared with 30 percent of those with continuing care facility (CCF) acquired pneumonia. The risk factors for aspiration differed between the two groups. The most common risk factors for those with community-acquired aspiration pneumonia included impaired consciousness due to alcohol, drugs, or hepatic failure, whereas 72 percent of those with CCF-acquired aspiration pneumonia had neurologic disease that resulted in dysphagia. In another report that included 134 elderly patients (mean age 84 years), 55 percent had oropharyngeal dysphagia based on a water swallow test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a well established association between use of acid suppressive medications and community-acquired pneumonia, ventilator-associated pneumonia, and hospital-acquired pneumonia. The assumed common mechanism in all of these conditions is loss of the gastric acid barrier resulting in a higher bacterial load in the lung when aspiration of gastric contents, which is both common and subtle, occurs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/49/31514?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults\", section on 'Predisposing host conditions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13433?source=see_link&amp;anchor=H6#H6\">",
"     \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\", section on 'Role of gastric pH'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Evaluation of dysphagia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of coughing while eating or drinking is likely to indicate aspiration, but aspiration may also be silent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/4\">",
"     4",
"    </a>",
"    ]. Dysphagia can easily be confirmed with a bedside swallowing test using fluids in various volumes and consistencies. Some geriatricians also suggest that pulse oximetry following a 10 cc fluid challenge as a simple and safe bedside test for identifying stroke patients who need fluid restriction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/5\">",
"     5",
"    </a>",
"    ]. Alternative methods to more formally assess dysphagia are video fluoroscopic swallow studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/6\">",
"     6",
"    </a>",
"    ], or endoscopic evaluations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of interventions (eg, positioning, dietary changes, drugs, oral hygiene, tube feeding) have been proposed to prevent aspiration, especially in elderly patients. However, a 2003 systematic review of randomized controlled trials of such measures found insufficient data to assess effectiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent randomized trial compared chin-down position and oral feedings of two consistencies (nectar-thickened or honey-thickened) on the incidence of aspiration as assessed by videofluorography in 711 patients with dementia or Parkinson disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/8\">",
"     8",
"    </a>",
"    ]. Significantly more patients aspirated on thin liquids using the chin-down posture (68 percent) than when using nectar-thickened liquids (63 percent) or honey-thickened liquids (53 percent). However, a separate report evaluating the incidence of pneumonia at three months in a subset of 515 patients found no significant difference between the two groups (9.8 versus 11.6 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/9\">",
"     9",
"    </a>",
"    ]. There was no control group, so one cannot determine if the interventions were effective.",
"   </p>",
"   <p>",
"    Techniques for the prevention of aspiration in hospitalized patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13433?source=see_link\">",
"     \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The character of the inoculum, pathogenesis of the pulmonary conditions, presentation, and management guidelines all assist in distinguishing clinical syndromes within the category of aspiration pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/10\">",
"     10",
"    </a>",
"    ]. The three syndromes that are most frequently seen clinically and best studied are chemical pneumonitis, bacterial infection, and airway obstruction. Although there may occasionally be overlap and inability to classify individual cases, this classification is essential to an understanding of aspiration pneumonia (",
"    <a class=\"graphic graphic_table graphicRef66505 \" href=\"mobipreview.htm?8/41/8860\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CHEMICAL PNEUMONITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term chemical pneumonitis refers to the aspiration of substances that are toxic to the lower airways, independent of bacterial infection. The prototype and best studied clinical example is chemical pneumonitis associated with the aspiration of gastric acid first described by Mendelson in 1946 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/11\">",
"     11",
"    </a>",
"    ] and sometimes referred to as Mendelson's syndrome.",
"   </p>",
"   <p>",
"    The original series included 61 obstetrical patients who aspirated gastric contents during ether anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/11\">",
"     11",
"    </a>",
"    ]. Respiratory distress and cyanosis rapidly followed, usually within two hours of a witnessed aspiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/12\">",
"     12",
"    </a>",
"    ]. Chest radiographs showed infiltrates that were usually located in one or both lower lobes. Despite the initial severity of the illness, all 61 patients had a rapid clinical recovery within 24 to 36 hours, with radiographic resolution within four to seven days without the use of antimicrobial therapy.",
"   </p>",
"   <p>",
"    Subsequent studies have shown that this form of aspiration pneumonia commonly follows a more fulminant course that may result in the acute respiratory distress syndrome (ARDS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/13\">",
"     13",
"    </a>",
"    ]. In patients with aspiration pneumonia resulting in ARDS, blood gas studies usually show that the partial pressure of oxygen is reduced, accompanied by a normal or low partial pressure of CO2 with respiratory alkalosis. Factors that contribute to hypoxemia include pulmonary edema, reduced surfactant activity, reflex airway closure, alveolar hemorrhage, and hyaline membrane formation. Pulmonary function tests show decreased compliance, abnormal ventilation-perfusion, and reduced diffusing capacity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/16/10505?source=see_link\">",
"     \"Acute respiratory distress syndrome: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major explanation for the difference in the clinical course of chemical pneumonitis since the initial report of the entity by Mendelson in 1946 are differences in the type of patients who develop this complication. Mendelson described healthy, young obstetrical patients, whereas the subjects of subsequent reports were often elderly, debilitated, or burdened with defined comorbid conditions.",
"   </p>",
"   <p>",
"    Bile may also elicit an inflammatory response in the lungs and has been found frequently in endotracheal tubes of patients on ventilators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of acid pneumonitis has been studied extensively in experimental animals using intratracheal installation of acid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. These animal models require an inoculum that has a pH of &le;2.5 and that is relatively large (usually 1 to 4",
"    <span class=\"nowrap\">",
"     mL/kg).",
"    </span>",
"    This would translate to an inoculum of at least 25 mL of gastric acid in adult humans. It is probable that smaller volumes produce a more subtle process that either escapes clinical detection or causes a less fulminant form of pneumonitis. The clinical observation that patients with esophageal or gastric reflux experience frequent bouts of recurrent pneumonitis, often accompanied by pulmonary fibrosis, supports this concept [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathologic changes in the preceding animal models of acid pneumonitis evolve rapidly. Within three minutes, there is atelectasis, peribronchial hemorrhage, pulmonary edema, and degeneration of bronchial epithelial cells. By four hours, the alveolar spaces are filled with polymorphonuclear leukocytes and fibrin. Hyaline membranes are seen within 48 hours. The lung at this time is also grossly edematous and hemorrhagic with alveolar consolidation.",
"   </p>",
"   <p>",
"    All of the findings described above have also been noted on autopsy of patients with fatal aspiration pneumonia. The presumed mechanism is the release of proinflammatory cytokines, especially tumor necrosis factor-alpha (TNFa) and interleukin (IL)-8.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a rabbit model, administration of an anti-IL-8 monoclonal antibody decreased IL-8 levels, neutrophil sequestration in air spaces, and prevented the acid-mediated abnormalities in oxygenation and extravascular lung water seen in control animals given hydrochloric acid into the lungs without anti-IL-8 antibody [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a rat model, TNF-alpha levels in serum and bronchoalveolar lavage (BAL) fluid and neutrophil sequestration were reduced in animals treated with a drug that inhibits the complement cascade at C5 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/21\">",
"       21",
"      </a>",
"      ]. In another study in rats, anti-TNF-alpha antiserum decreased neutrophil counts, BAL fluid protein concentration, and edema in the heart and kidneys [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Long-term follow-up studies of patients who survive severe aspiration pneumonia have revealed complete recovery in some patients and radiographic evidence of pulmonary fibrosis in others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following clinical features should raise the possibility of chemical pneumonitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abrupt onset of symptoms with prominent dyspnea",
"     </li>",
"     <li>",
"      Fever, which is usually low-grade",
"     </li>",
"     <li>",
"      Cyanosis and diffuse crackles on lung auscultation",
"     </li>",
"     <li>",
"      Severe hypoxemia and infiltrates on chest radiograph involving dependent pulmonary segments. The dependent lobes in the upright position are the lower lobes. However, aspiration that occurs while patients are in the recumbent position may result in infection in the superior segments of the lower lobes and the posterior segments of the upper lobes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The course of this disease varies. In one retrospective review of 50 cases, three outcomes were observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      12 percent of patients had a fulminant course and died shortly after aspiration, presumably from ARDS",
"     </li>",
"     <li>",
"      62 percent had a rapid clinical improvement with clearing of the chest radiograph",
"     </li>",
"     <li>",
"      26 percent had initial rapid improvement but then developed new expanding infiltrates on chest x-ray, which probably represented secondary bacterial infection or the development of ARDS superimposed on the acid-injured lung",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acid pneumonitis is usually presumptive based upon the clinical features and course noted above. After a suspected aspiration, chest x-ray abnormalities typically appear within two hours. Bronchoscopy, if performed, demonstrates erythema of the bronchi, indicating acid injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with an observed aspiration should have immediate tracheal suction to clear fluids and particulate matter that may cause obstruction. However, this maneuver will not protect the lungs from chemical injury, which occurs instantly in a manner that has been compared with a \"flash burn\"; the acid inoculum is rapidly neutralized by the physiologic response.",
"   </p>",
"   <p>",
"    The major therapeutic approach is to support pulmonary function. Studies in animal models show benefit from positive-pressure ventilation, high molecular weight colloids given intravenously, and sodium",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    infused into the pulmonary artery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. Mechanical ventilation is indicated in patients with respiratory failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/42/2730?source=see_link\">",
"     \"Mechanical ventilation in acute respiratory distress syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/52/9033?source=see_link\">",
"     \"Novel therapies for the acute respiratory distress syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of glucocorticoids in the treatment of chemical pneumonitis is controversial. Animal studies have shown variable results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/30-32\">",
"     30-32",
"    </a>",
"    ], but studies in humans have generally been unsuccessful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/33\">",
"     33",
"    </a>",
"    ]. The administration of glucocorticoids for acute respiratory distress syndrome has also been controversial, and is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/52/9033?source=see_link\">",
"     \"Novel therapies for the acute respiratory distress syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies in experimental animals show that the acid-injured lung is highly susceptible to bacterial challenge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/34\">",
"     34",
"    </a>",
"    ], and clinical studies show 13 to 26 percent of patients acquire pulmonary superinfections during the course of recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/12,35,36\">",
"     12,35,36",
"    </a>",
"    ]. Antimicrobial agents are commonly given because of the difficulty in excluding bacterial infection as a contributing or primary factor in patients with aspiration. Since these patients are often severely ill, the empiric use of antibiotics is reasonable. However, if no infiltrates develop after 48 to 72 hours, it is appropriate to stop antibiotics. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Choice of regimen'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     BACTERIAL INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common form of aspiration pneumonia is caused by bacteria that normally reside in the upper airways or stomach. A true aspiration pneumonia usually refers to an infection caused by less virulent bacteria, primarily anaerobes and streptococci, which are common constituents of the normal flora in a susceptible host prone to aspiration (",
"    <a class=\"graphic graphic_table graphicRef67569 \" href=\"mobipreview.htm?12/13/12509\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presenting findings in aspiration pneumonia due to bacterial infection are highly variable depending upon the time the patient is seen during course of the infection, the bacteria involved, and the status of the host. As noted, most cases involve anaerobic bacteria and aerobic or microaerophilic streptococci that normally reside in the gingival crevices. Compared with most cases of community-acquired pneumonia, the tempo of the disease in this type of aspiration pneumonia often evolves slowly and chills are uncommon. There is an association with periodontal disease, and this complication is less common in patients with good dental hygiene and those who are edentulous. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=see_link\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients present with the common manifestations of pneumonia including cough, fever, purulent, sputum and dyspnea, but the process evolves over a period of several days or weeks instead of hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Many patients have accompanying weight loss and anemia as common features of a more chronic process.",
"   </p>",
"   <p>",
"    Although the majority of patients have an indolent course, some patients have a relatively abrupt onset suggestive of a pyogenic pneumonia due to common bacterial pathogens, including Streptococcus pneumoniae. One symptom, which assists in distinguishing these entities, is rigors since patients with aspiration pneumonia almost never have shaking chills.",
"   </p>",
"   <p>",
"    Many patients with aspiration pneumonia do not present with the acute infection but present later with complications characterized by suppuration and necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. Lung abscess, necrotizing pneumonia, or empyema secondary to a bronchopleural fistula all represent later stages of untreated aspiration pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/9/24729?source=see_link\">",
"     \"Lung abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical features, which are characteristic of aspiration pneumonia involving anaerobic bacteria, include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indolent symptoms",
"     </li>",
"     <li>",
"      A predisposing condition for aspiration, usually compromised consciousness due to drug abuse, alcoholism, or anesthesia; or dysphagia",
"     </li>",
"     <li>",
"      Absence of rigors",
"     </li>",
"     <li>",
"      Failure to recover likely pulmonary pathogens with cultures of expectorated sputum",
"     </li>",
"     <li>",
"      Sputum that often has a putrid odor",
"     </li>",
"     <li>",
"      Concurrent evidence of periodontal disease",
"     </li>",
"     <li>",
"      X-ray or computed tomography (CT) scans showing evidence of pulmonary necrosis with lung abscess",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an empyema",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of putrid discharge in sputum or pleural fluid is regarded as diagnostic of anaerobic infection. Chest radiographs show involvement of dependent pulmonary segments, which are favored in aspiration: the lower lobes when aspiration occurs in the upright position; or the superior segments of the lower lobes or posterior segment of the upper lobes when aspiration occurs in the recumbent position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaerobic bacteria are the dominant organisms in the upper airways. The critical role of these microbes in aspiration pneumonia, lung abscess, and empyema was established in the 1970s in studies employing careful techniques for the isolation of anaerobes and transtracheal aspiration as a method to obtain uncontaminated specimens from the lower airways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/10,37-44\">",
"     10,37-44",
"    </a>",
"    ]. Expectorated sputum is unsuitable for anaerobic culture because of inevitable contamination by the normal flora of the mouth. There is a limited experience with quantitative cultures of specimens obtained at bronchoscopy by a protected brush or bronchoalveolar lavage, but available data suggest these may be suitable when combined with high quality anaerobic cultures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/43,45,46\">",
"     43,45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another problem is that anaerobic bacteria are extremely difficult to cultivate when specimens are collected after the inception of antibiotic treatment. In current practice, anaerobic bacteria are virtually never detected in pulmonary infections due to lack of access to specimens that are uncontaminated with the normal flora of the upper airways. Specimens with well established validity for anaerobic culture include transthoracic needle aspirate, transtracheal aspirates, and pleural fluid. The yield of anaerobes using transtracheal or transthoracic aspiration in patients with aspiration pneumonia is 62 to 93 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/39,40,47-49\">",
"     39,40,47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major isolates that have been isolated are Peptostreptococcus, Fusobacterium nucleatum, Prevotella, and Bacteroides spp [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/37-42\">",
"     37-42",
"    </a>",
"    ]. One contemporary prospective study of 95 patients from a long-term care facility admitted to an intensive care unit with pneumonia and risk factors for aspiration found that gram-negative bacilli were the most common isolates (49 percent) followed by anaerobes (16 percent) and S. aureus (12 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/50\">",
"     50",
"    </a>",
"    ]. Of the 43 patients with gram-negative bacilli isolated, 14 percent also had anaerobes recovered.",
"   </p>",
"   <p>",
"    Most patients with aspiration pneumonia acquired in the community have a mixed infection that includes anaerobic and aerobic bacteria, especially cases involving aerobic and microaerophilic streptococci which are thought to be important pathogens and necessary to treat. A report from Japan using fine needle transthoracic aspiration or a protected brush catheter to obtain cultures in 212 patients with lung abscess showed aerobic and microaerophilic streptococci to be the most common pathogens (60 percent of patients) and anaerobes to be the second most common (26 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/48\">",
"     48",
"    </a>",
"    ]. By contrast, patients with nosocomial aspiration pneumonia commonly involve a mixture of anaerobes and gram-negative bacilli or S. aureus; therapy is usually directed at both the anaerobes and aerobes in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/40,51\">",
"     40,51",
"    </a>",
"    ], but the role of the anaerobes in this setting is unclear. One explanation for the difference in organisms accompanying anaerobic bacteria in hospitalized patients is the high frequency of upper airway colonization by aerobic pathogens, especially gram-negative bacilli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to chemical pneumonitis, antibiotics are the most important component of treatment of aspiration pneumonia due to bacterial infection. The management of complications of aspiration pneumonia, such as lung abscess and empyema, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/9/24729?source=see_link\">",
"     \"Lung abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Historically, the antibiotic of choice for the treatment of aspiration pneumonia and lung abscess involving anaerobic bacteria was penicillin, usually given intravenously or orally in high doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. However, studies of the bacteriology of these infections in the 1970s raised questions about the adequacy of this therapy since approximately 25 percent of cases involved penicillinase-producing anaerobic bacteria, primarily F. nucleatum, Peptostreptococcus, Bacteroides spp. other than B. fragilis, and Prevotella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/37,38,42,53\">",
"     37,38,42,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two comparative studies of penicillin and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    in the treatment of putrid lung abscess showed clindamycin to be superior in terms of response rates and time to defervescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. One of these studies included 37 patients with lung abscess or necrotizing pneumonia in which the failure rate with clindamycin was 15 percent versus 44 percent with penicillin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized trial evaluated the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (600 mg twice daily),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1160?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    (half-dose, 1.5 g twice daily), ampicillin-sulbactam (full dose, 3 g twice daily), or imipenem (500 mg twice daily) in 100 elderly patients with aspiration pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/58\">",
"     58",
"    </a>",
"    ]. All regimens were equally effective (cure rates ranged from 76 to 88 percent), but clindamycin was associated with a lower rate of posttreatment occurrence of methicillin-resistant Staphylococcus aureus superinfection (0 of 25 compared to 5 to 8 of 25 in the other treatment arms), and clindamycin was also significantly less expensive.",
"   </p>",
"   <p>",
"    Alternative regimens that appear effective include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/59\">",
"     59",
"    </a>",
"    ] and penicillin combined with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/60\">",
"     60",
"    </a>",
"    ]. Metronidazole should NOT be used alone since monotherapy is associated with a failure rate of about 50 percent in the treatment of anaerobic pleuropulmonary infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. The presumed reason for the high failure rates with metronidazole is its lack of activity against microaerophilic and aerobic streptococci, which can be cultured in approximately 40 to 70 percent of cases.",
"   </p>",
"   <p>",
"    Among the fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    is preferred because early studies showed good in vitro activity against anaerobes and a small trial has shown benefit for aspiration pneumonia and primary lung abscess [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/63\">",
"     63",
"    </a>",
"    ]. However, moxifloxacin has not been studied adequately to recommend it as a first-line agent for aspiration pneumonia, and the rate of resistance of anaerobes to this drug is increasing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of alternative agents commonly employed for pulmonary infections such as macrolides and cephalosporins has not been systematically studied in aspiration pneumonia. It is unlikely that such studies will ever be performed in microbiologically-confirmed cases since current methods to obtain specimens are inappropriate for anaerobic culture, and these agents have never been well tested for efficacy in anaerobic infection at any anatomical site.",
"   </p>",
"   <p>",
"    Thus, decisions about drugs other than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , penicillin, and beta-lactam-beta-lactamase inhibitors for anaerobic lung infections will need to be based on predicted activity from studies of anaerobic infections of other anatomical sites such as carbapenems or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Drugs that show poor in vitro activity include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    , and aminoglycosides. The utility of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    , and macrolides is not well enough established to recommend.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Choice of regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;When anaerobic bacteria are probable pathogens in aspiration pneumonia, we suggest",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (600 mg IV every eight hours followed by 300 mg orally four times daily or 450 mg orally three times daily) as first-line therapy. Alternative agents with activity based upon clinical trials are",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (875 mg orally twice daily); or the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (500 mg orally or IV three times daily)",
"    <strong>",
"     plus",
"    </strong>",
"    either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    (500 mg orally three times daily)",
"    <strong>",
"     or",
"    </strong>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/42/22183?source=see_link\">",
"     penicillin G",
"    </a>",
"    (1 to 2 million units IV every four to six hours). Drugs that are probably effective, but should not be used preferentially, are",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    , macrolides, and selected cephalosporins.",
"   </p>",
"   <p>",
"    For nosocomial pneumonia, most authorities feel that the companion aerobic bacteria, especially gram-negative bacilli and S. aureus, are more important than the anaerobes and that therapy should be directed at the aerobic organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/51\">",
"     51",
"    </a>",
"    ]. When there is a perceived need to cover anaerobic bacteria as well as the aerobic gram-negative bacilli, we suggest a carbapenem or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    since these agents will cover virtually all anaerobes as well as most aerobic gram-negative bacilli. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12183?source=see_link\">",
"     \"Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36858?source=see_link\">",
"     \"Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of antibiotics for aspiration pneumonia is arbitrary and not well studied. The usual duration of therapy for cases that are not complicated by cavitation or empyema is 7 to 10 days; shorter therapy may be effective but has not been adequately studied. Patients with associated pleural effusions should have a thoracentesis to exclude empyema, which often complicates pneumonia involving anaerobes. Patients with lung abscess need a longer course of antibiotics, usually until there is radiographic clearance or significant improvement, such as a small stable residual lesion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/9/24729?source=see_link&amp;anchor=H19#H19\">",
"     \"Lung abscess\", section on 'Duration of therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     MECHANICAL OBSTRUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aspiration pneumonia may involve fluid or particulate matter, which are not inherently toxic to the lung, but can cause airway obstruction or reflux airway closure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Fluids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical fluids that are aspirated and are not toxic to the lungs include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Saline",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       Barium",
"      </a>",
"     </li>",
"     <li>",
"      Most ingested fluids including water",
"     </li>",
"     <li>",
"      Gastric contents with a pH exceeding 2.5",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Animal studies show that intratracheal instillation of such fluids in limited quantities results in transient, self-limited hypoxemia. On occasion, this will trigger pulmonary edema, more severe hypoxemia, and reduced lung compliance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/65\">",
"     65",
"    </a>",
"    ]. However, this reaction is reversible by vagotomy or administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    , suggesting an intrinsic pulmonary reflex closure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. This type of aspiration pneumonia is difficult to recognize clinically, but the appropriate treatment would be positive-pressure breathing with 100 percent oxygen combined with isoproterenol.",
"   </p>",
"   <p>",
"    The most frequently observed form of aspiration of fluids is simple mechanical obstruction that is noted in victims of drowning. Patients at risk for mechanical obstruction are those who cannot clear the inoculum due to a profound neurologic deficit such as absence of a cough reflex or impaired consciousness.",
"   </p>",
"   <p>",
"    The obvious critical clinical intervention is tracheal suctioning. If a subsequent chest x-ray does not show a pulmonary infiltrate, no further therapy is required except for measures intended to prevent subsequent episodes of aspiration. In hospitalized patients, the most important preventative measure is the semi-upright or upright position [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Solid particle aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The severity of respiratory obstruction depends upon the relative size of the object that is aspirated and the caliber of the lower airways. Foreign body aspiration is most common in children from one to three years of age. The usual objects recovered from the lower airways are peanuts, other vegetable particles, inorganic materials, and teeth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/67-70\">",
"     67-70",
"    </a>",
"    ]. Vegetable materials, including peanuts, are problematic because they are not visualized on plain chest radiographs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/36/35399?source=see_link\">",
"     \"Airway foreign bodies in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical consequences depend upon the level of obstruction. Large objects that lodge in the larynx or trachea cause sudden respiratory distress, cyanosis, and aphonia that lead quickly to death if the obstruction is not immediately reversed. This is sometimes referred to as the \"caf&eacute; coronary syndrome\" because the symptoms simulate those of myocardial infarction and are often seen with aspiration of meat during restaurant dining [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/71\">",
"     71",
"    </a>",
"    ]. The suggested treatment is the Heimlich maneuver consisting of firm and rapid pressure applied to the upper abdomen in an effort to force the diaphragm up to dislodge the particle.",
"   </p>",
"   <p>",
"    Aspiration of smaller particles cause less severe obstruction. These patients often present with an irritative cough, and chest radiograph shows atelectasis or obstructive emphysema with a cardiac shift and elevated diaphragm. When the obstruction is partial, unilateral wheezing may be appreciated. Bacterial superinfection is a frequent complication when the obstruction or partial obstruction persists for more than one week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]; the usual pathogens are anaerobic bacteria from the upper airways as described above. The primary therapeutic modality is removal of the foreign object, usually with fiberoptic or rigid bronchoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/74\">",
"     74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/36/35399?source=see_link\">",
"     \"Airway foreign bodies in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     LIPOID PNEUMONIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipoid pneumonia is caused most commonly by the aspiration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13316?source=see_link\">",
"     mineral oil",
"    </a>",
"    when used for constipation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/75\">",
"     75",
"    </a>",
"    ]. The most commonly affected patients are those at the extremes of age who have risk factors for aspiration. The result is either an inflammatory response with regional edema and intra-alveolar hemorrhage or a \"paraffinoma\" with aspirated oils encapsulated by fibrous tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31017/abstract/75-77\">",
"     75-77",
"    </a>",
"    ]. The former presents acutely with cough, fever, and dyspnea; the latter often presents with a mass seen on imaging in an asymptomatic patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/34/13858?source=see_link\">",
"       \"Patient information: Aspiration pneumonia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aspiration pneumonia refers to the pulmonary consequences resulting from the abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the lower airways. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are usually two requirements to produce aspiration pneumonia:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Compromise in the usual defenses that protect the lower airways including glottic closure, cough reflex, and other clearing mechanisms.",
"     </li>",
"     <li>",
"      An inoculum deleterious to the lower airways by a direct toxic effect, stimulation of an inflammatory process from a large enough bacterial inoculum, or obstruction due to a sufficient volume of material or particulate matter. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conditions that predispose to aspiration pneumonia include reduced consciousness, dysphagia, disorders of the upper gastrointestinal tract, mechanical disruption of the glottic closure or cardiac sphincter, pharyngeal anesthesia, and miscellaneous conditions such as protracted vomiting, large volume tube feedings, feeding gastrostomy, and the recumbent position. These conditions all share properties of frequent or large volume aspiration, which increase the probability of developing aspiration pneumonitis (",
"      <a class=\"graphic graphic_table graphicRef56501 \" href=\"mobipreview.htm?10/14/10475\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Predisposing conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The three syndromes that are most frequently seen clinically and best studied are chemical pneumonitis, bacterial infection, and airway obstruction. Although there may occasionally be overlap and inability to classify individual cases, this classification is essential to an understanding of aspiration pneumonia (",
"      <a class=\"graphic graphic_table graphicRef66505 \" href=\"mobipreview.htm?8/41/8860\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The term chemical pneumonitis refers to the aspiration of substances that are toxic to the lower airways, independent of bacterial infection. The prototype and best studied clinical example is chemical pneumonitis associated with the aspiration of gastric acid first. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chemical pneumonitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with an observed aspiration should have immediate tracheal suction to clear fluids and particulate matter that may cause obstruction. However, this maneuver will not protect the lungs from chemical injury, which occurs instantly in a manner that has been compared with a \"flash burn.\" (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Treatment'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Antimicrobial agents are commonly given following a witnessed aspiration because of the difficulty in excluding bacterial infection as a contributing or primary factor. Since these patients are often severely ill, the empiric use of antibiotics is reasonable. However, if no infiltrates develop after 48 to 72 hours, it is appropriate to stop antibiotics. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common form of aspiration pneumonia is infection caused by bacteria that normally reside in the upper airways or stomach. Aspiration pneumonia usually refers to an infection caused by less virulent bacteria, primarily anaerobes and streptococci, which are common constituents of the normal flora in a susceptible host prone to aspiration (",
"      <a class=\"graphic graphic_table graphicRef67569 \" href=\"mobipreview.htm?12/13/12509\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Bacterial infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with aspiration pneumonia acquired in the community have a mixed bacterial infection that includes anaerobes and aerobic and microaerophilic streptococci which are thought to be important pathogens. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When anaerobic bacteria are probable pathogens in aspiration pneumonia, we suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (600 mg IV every eight hours followed by 300 mg orally four times daily or 450 mg orally three times daily) as first-line therapy. Alternative agents with activity based upon clinical trials are",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      (875 mg orally twice daily); or the combination of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      (500 mg orally or IV three times daily) PLUS",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      (500 mg orally three times daily) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      (1 to 2 million units IV every four to six hours). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Choice of regimen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For nosocomial pneumonia, most authorities feel that the companion aerobic bacteria, especially gram-negative bacilli and Staphylococcus aureus, are more important than the anaerobes and that therapy should be directed at these organisms. When there is a perceived need to cover anaerobic bacteria as well as the aerobic gram-negative bacilli, we suggest a carbapenem or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"       piperacillin-tazobactam",
"      </a>",
"      since these agents will cover virtually all anaerobes as well as most aerobic gram-negative bacilli. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Choice of regimen'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36858?source=see_link\">",
"       \"Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The duration of antibiotics for aspiration pneumonia is arbitrary and not well studied. The usual duration of therapy for cases that are not complicated by cavitation or empyema is 7 to 10 days. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Duration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aspiration pneumonia may involve fluid or particulate matter, which are not inherently toxic to the lung, but can cause airway obstruction or reflux airway closure. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Mechanical obstruction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/1\">",
"      BERSON W, ADRIANI J. Silent regurgitation and aspiration during anesthesia. Anesthesiology 1954; 15:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/2\">",
"      Reza Shariatzadeh M, Huang JQ, Marrie TJ. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc 2006; 54:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/3\">",
"      Cabre M, Serra-Prat M, Palomera E, et al. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 2010; 39:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/4\">",
"      Smith Hammond C. Cough and aspiration of food and liquids due to oral pharyngeal Dysphagia. Lung 2008; 186 Suppl 1:S35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/5\">",
"      Smith HA, Lee SH, O'Neill PA, Connolly MJ. The combination of bedside swallowing assessment and oxygen saturation monitoring of swallowing in acute stroke: a safe and humane screening tool. Age Ageing 2000; 29:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/6\">",
"      Fink TA, Ross JB. Are we testing a true thin liquid? Dysphagia 2009; 24:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/7\">",
"      Loeb MB, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc 2003; 51:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/8\">",
"      Logemann JA, Gensler G, Robbins J, et al. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res 2008; 51:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/9\">",
"      Robbins J, Gensler G, Hind J, et al. Comparison of 2 interventions for liquid aspiration on pneumonia incidence: a randomized trial. Ann Intern Med 2008; 148:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/10\">",
"      Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975; 68:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/11\">",
"      MENDELSON CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol 1946; 52:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/12\">",
"      Bynum LJ, Pierce AK. Pulmonary aspiration of gastric contents. Am Rev Respir Dis 1976; 114:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/13\">",
"      Doyle RL, Szaflarski N, Modin GW, et al. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/14\">",
"      Wu YC, Hsu PK, Su KC, et al. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest 2009; 136:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/15\">",
"      TEABEAUT JR 2nd. Aspiration of gastric contents; an experimental study. Am J Pathol 1952; 28:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/16\">",
"      Fisk RL, Symes JF, Aldridge LL, Couves CM. The pathophysiology and experimental therapy of acid pneumonitis in ex vivo lungs. Chest 1970; 57:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/17\">",
"      Cameron JL, Caldini P, Toung JK, Zuidema GD. Aspiration pneumonia: physiologic data following experimental aspiration. Surgery 1972; 72:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/18\">",
"      Mays EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976; 69:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/19\">",
"      Johnson LF, Rajagopal KR. Aspiration resulting from gastroesophageal reflux. A cause of chronic bronchopulmonary disease. Chest 1988; 93:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/20\">",
"      Folkesson HG, Matthay MA, H&eacute;bert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995; 96:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/21\">",
"      Yamada H, Kudoh I, Nishizawa H, et al. Complement partially mediates acid aspiration-induced remote organ injury in the rat. Acta Anaesthesiol Scand 1997; 41:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/22\">",
"      Goldman G, Welbourn R, Kobzik L, et al. Tumor necrosis factor-alpha mediates acid aspiration-induced systemic organ injury. Ann Surg 1990; 212:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/23\">",
"      Sladen A, Zanca P, Hadnott WH. Aspiration pneumonitis--the sequelae. Chest 1971; 59:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/24\">",
"      Steiner J, Bachofen M, Bachofen H. Recovery from aspiration pneumonitis. Pneumonologie 1974; 151:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/25\">",
"      DePaso WJ. Aspiration pneumonia. Clin Chest Med 1991; 12:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/26\">",
"      Broe PJ, Toung TJ, Permutt S, Cameron JL. Aspiration pneumonia: treatment with pulmonary vasodilators. Surgery 1983; 94:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/27\">",
"      Cameron JL, Sebor J, Anderson RP, Zuidema GD. Aspiration pneumonia. Results of treatment by positive-pressure ventilation in dogs. J Surg Res 1968; 8:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/28\">",
"      Peitzman, AB, Shires, GT 3d, Illner, HK, Shires, GT. Pulmonary acid injury: Effects of positive end-expiratory pressure and crystalloid vs colloid fluid resuscitation. Arch Surg 1982; 117:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/29\">",
"      Toung TJ, Cameron JL, Kimura T, Permutt S. Aspiration pneumonia: treatment with osmotically active agents. Surgery 1981; 89:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/30\">",
"      Broe PJ, Toung TJ, Cameron JL. Aspiration pneumonia. Surg Clin North Am 1980; 60:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/31\">",
"      Toung TJ, Bordos D, Benson DW, et al. Aspiration pneumonia: experimental evaluation of albumin and steroid therapy. Ann Surg 1976; 183:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/32\">",
"      Chapman RL Jr, Downs JB, Modell JH, Hood CI. The ineffectiveness of steroid therapy in treating aspiration of hydrochloric acid. Arch Surg 1974; 108:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/33\">",
"      Wolfe JE, Bone RC, Ruth WE. Effects of corticosteroids in the treatment of patients with gastric aspiration. Am J Med 1977; 63:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/34\">",
"      Johanson WG Jr, Stephen JJ, Pierce AK. Bacterial growth in vivo. An important determinant of the pulmonary clearance of Diplococcus pneumoniae in rats. J Clin Invest 1974; 53:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/35\">",
"      Cameron JL, Mitchell WH, Zuidema GD. Aspiration pneumonia. Clinical outcome following documented aspiration. Arch Surg 1973; 106:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/36\">",
"      Dines DE, Titus JL, Sessler AD. Aspiration pneumonitis. Mayo Clin Proc 1970; 45:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/37\">",
"      Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 Suppl 4:S248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/38\">",
"      Finegold SM. Aspiration pneumonia. Rev Infect Dis 1991; 13 Suppl 9:S737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/39\">",
"      Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis 1979; 119:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/40\">",
"      Lorber B, Swenson RM. Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases. Ann Intern Med 1974; 81:329.",
"     </a>",
"    </li>",
"    <li>",
"     Beerens, H, Tahon-Castel, M. Infection Humaines a Bacteries Anaerobies Non-toxigenes, Presses Academiques Europeennes, Brussels 1965. p.91.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/42\">",
"      Finegold SM, George WL, Mulligan ME. Anaerobic infections. Part II. Dis Mon 1985; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/43\">",
"      Yamashita Y, Kohno S, Tanaka K, et al. [Anaerobic respiratory infection--evaluation of methods of obtaining specimens]. Kansenshogaku Zasshi 1994; 68:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/44\">",
"      Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977; 115:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/45\">",
"      Wimberley NW, Bass JB Jr, Boyd BW, et al. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 1982; 81:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/46\">",
"      Henriquez AH, Mendoza J, Gonzalez PC. Quantitative culture of bronchoalveolar lavage from patients with anaerobic lung abscesses. J Infect Dis 1991; 164:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/47\">",
"      Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics 1980; 65:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/48\">",
"      Takayanagi N, Kagiyama N, Ishiguro T, et al. Etiology and outcome of community-acquired lung abscess. Respiration 2010; 80:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/49\">",
"      Bartlett JG. Anaerobic bacterial infection of the lung. Anaerobe 2012; 18:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/50\">",
"      El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/51\">",
"      Bartlett JG, O'Keefe P, Tally FP, et al. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986; 146:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/52\">",
"      Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969; 281:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/53\">",
"      Bartlett JG. Treatment of anaerobic pleuropulmonary infections. Ann Intern Med 1975; 83:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/54\">",
"      Weiss W. Oral antibiotic therapy of acute primary lung abscess: comparison of penicillin G and tetracycline. Curr Ther Res Clin Exp 1970; 12:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/55\">",
"      Weiss W. Cavity behavior in acute, primary, nonspecific lung abscess. Am Rev Respir Dis 1973; 108:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/56\">",
"      Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983; 98:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/57\">",
"      Gudiol F, Manresa F, Pallares R, et al. Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/58\">",
"      Kadowaki M, Demura Y, Mizuno S, et al. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest 2005; 127:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/59\">",
"      Germaud P, Poirier J, Jacqueme P, et al. [Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases]. Rev Pneumol Clin 1993; 49:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/60\">",
"      Eykyn SJ. The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital. Surgery 1983; 93:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/61\">",
"      Sanders CV, Hanna BJ, Lewis AC. Metronidazole in the treatment of anaerobic infections. Am Rev Respir Dis 1979; 120:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/62\">",
"      Perlino CA. Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy. Arch Intern Med 1981; 141:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/63\">",
"      Ott SR, Allewelt M, Lorenz J, et al. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection 2008; 36:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/64\">",
"      Snydman DR, Jacobus NV, McDermott LA, et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis 2010; 50 Suppl 1:S26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/65\">",
"      Colebatch, HJ, Halmagyi, DF. Reflex airway reaction to fluid aspiration. J Appl Physiol 1964; 17:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/66\">",
"      Gipson SL, Stovall TG, Elkins TE, Crumrine RS. Pharmacologic reduction of the risk of aspiration. South Med J 1986; 79:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/67\">",
"      Abdulmajid OA, Ebeid AM, Motaweh MM, Kleibo IS. Aspirated foreign bodies in the tracheobronchial tree: report of 250 cases. Thorax 1976; 31:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/68\">",
"      Brooks JW. Foreign bodies in the air and food passages. Ann Surg 1972; 175:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/69\">",
"      Kim IG, Brummitt WM, Humphry A, et al. Foreign body in the airway: a review of 202 cases. Laryngoscope 1973; 83:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/70\">",
"      Baharloo F, Veyckemans F, Francis C, et al. Tracheobronchial foreign bodies: presentation and management in children and adults. Chest 1999; 115:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/71\">",
"      HAUGEN RK. THE CAF'E CORONARY. SUDDEN DEATHS IN RESTAURANTS. JAMA 1963; 186:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/72\">",
"      Lansing, AM, Jamieson, WG. Mechanisms of fever in pulmonary atelectasis. Arch Surg 1963; 87:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/73\">",
"      Hedblom CA. FOREIGN BODIES OF DENTAL ORIGIN IN A BRONCHUS PULMONARY COMPLICATION. Ann Surg 1920; 71:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/74\">",
"      Zavala DC, Rhodes ML. Foreign body removal: a new role for the fiberoptic bronchoscope. Ann Otol Rhinol Laryngol 1975; 84:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/75\">",
"      Spickard A 3rd, Hirschmann JV. Exogenous lipoid pneumonia. Arch Intern Med 1994; 154:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/76\">",
"      Betancourt SL, Martinez-Jimenez S, Rossi SE, et al. Lipoid pneumonia: spectrum of clinical and radiologic manifestations. AJR Am J Roentgenol 2010; 194:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31017/abstract/77\">",
"      Marchiori E, Zanetti G, Mano CM, et al. Lipoid pneumonia in 53 patients after aspiration of mineral oil: comparison of high-resolution computed tomography findings in adults and children. J Comput Assist Tomogr 2010; 34:9.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7024 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-199.231.185.123-90A40F4040-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31017=[""].join("\n");
var outline_f30_18_31017=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREDISPOSING CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Evaluation of dysphagia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CHEMICAL PNEUMONITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      BACTERIAL INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Choice of regimen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Duration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      MECHANICAL OBSTRUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Fluids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Solid particle aspiration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      LIPOID PNEUMONIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7024\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7024|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/14/10475\" title=\"table 1\">",
"      Predispositions for aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/41/8860\" title=\"table 2\">",
"      Aspiration pneumonia categories",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/13/12509\" title=\"table 3\">",
"      Anaerobic bacteria in lung infx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/16/10505?source=related_link\">",
"      Acute respiratory distress syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/36/35399?source=related_link\">",
"      Airway foreign bodies in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/49/31514?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12183?source=related_link\">",
"      Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/9/24729?source=related_link\">",
"      Lung abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/42/2730?source=related_link\">",
"      Mechanical ventilation in acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/52/9033?source=related_link\">",
"      Novel therapies for the acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=related_link\">",
"      Parapneumonic effusion and empyema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/34/13858?source=related_link\">",
"      Patient information: Aspiration pneumonia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13433?source=related_link\">",
"      Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36858?source=related_link\">",
"      Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_18_31018="Infectious mononucleosis in adults and adolescents";
var content_f30_18_31018=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Infectious mononucleosis in adults and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Paul G Auwaerter, MD, MBA, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/18/31018/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/18/31018/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious mononucleosis (IM) is characterized by a triad of fever, tonsillar pharyngitis, and lymphadenopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/1\">",
"     1",
"    </a>",
"    ]. It was initially described as \"Drusenfieber\" or glandular fever in 1889, but the term \"infectious mononucleosis\" was later used in 1920 to describe six college students with a febrile illness characterized by absolute lymphocytosis and atypical mononuclear cells in the blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The relationship between Epstein-Barr virus (EBV) and IM was established when a laboratory worker was infected with EBV and developed IM and a newly positive heterophile test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infectious mononucleosis in adults and adolescents will be reviewed here. A complete description of EBV and other clinical manifestations of EBV infection (including malignancy) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=see_link\">",
"     \"Clinical manifestations and treatment of Epstein-Barr virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3114?source=see_link\">",
"     \"Virology of Epstein-Barr virus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epstein-Barr virus (EBV) is a widely disseminated herpesvirus that is spread by intimate contact between susceptible persons and EBV shedders. The virus has not been recovered from environmental sources, suggesting that humans are the major reservoir.",
"   </p>",
"   <p>",
"    Antibodies to EBV have been demonstrated in all population groups with a worldwide distribution; approximately 90 to 95 percent of adults are eventually EBV-seropositive. By age four, EBV seroprevalence is close to 100 percent in developing countries and ranges from 25 to 50 percent in lower socioeconomic groups in the United States. Many attribute this finding to intense personal contact and poor personal hygiene among children, which provide opportunities for early acquisition and subsequent spread of EBV.",
"   </p>",
"   <p>",
"    EBV acquired during childhood years is often subclinical; less than 10 percent of children develop clinical infection despite the high rates of exposure. The incidence of symptomatic infection begins to rise in adolescent through adult years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/5\">",
"     5",
"    </a>",
"    ]. Large studies of infectious mononucleosis are now decades old, but traditionally the peak incidence of infection has been described in the 15 to 24-year age range [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/6\">",
"     6",
"    </a>",
"    ]. Some data derived in the United Kingdom suggest that infectious mononucleosis (IM) cases may be occurring later in life with increasing severity, requiring hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/7\">",
"     7",
"    </a>",
"    ]. IM is relatively uncommon in adults, accounting for less than two percent of pharyngitis in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/8\">",
"     8",
"    </a>",
"    ]. The vast majority of adults are not susceptible to infection because of prior exposure.",
"   </p>",
"   <p>",
"    The differences observed between infants and young adults with regard to symptomatic infection may relate to the size of the viral inoculum at the time of infection or to the intensity of cellular immune responses driven by EBV-infected B cells.",
"   </p>",
"   <p>",
"    The incidence of clinical infection is approximately 30 times higher in whites than blacks in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/9\">",
"     9",
"    </a>",
"    ]. This may reflect both earlier exposures to EBV among the latter group and the higher frequency of asymptomatic infection when acquired by young children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TRANSMISSION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25630532\">",
"    <span class=\"h2\">",
"     Person-to-person",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following infectious mononucleosis, virus may be shed in salivary secretions at high levels for a prolonged period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Oral shedding persists for a median duration of approximately six months after onset of illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/11\">",
"     11",
"    </a>",
"    ], although it should be pointed out that once infected with Epstein-Barr virus (EBV), virus may be intermittently shed in the oropharynx for decades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/10,12\">",
"     10,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although EBV primarily spreads via passage of saliva, it is not a particularly contagious disease. In a classic study conducted among college students, susceptible roommates of patients with either symptoms of infectious mononucleosis (IM) or asymptomatic viral shedding were no more likely to seroconvert or develop clinical illness than other college students without evidence of preexisting EBV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/13\">",
"     13",
"    </a>",
"    ]. The virus can persist in the oropharynx of patients with IM for up to 18 months following clinical recovery; this may explain in part why only a small number of patients with IM recall previous contact with an infected individual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Intrafamilial spread among siblings has also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/15\">",
"     15",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25630539\">",
"    <span class=\"h2\">",
"     Breastfeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;EBV has been isolated in breast milk from healthy nursing mothers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/16\">",
"     16",
"    </a>",
"    ]. However, in one study, there was no difference in EBV seropositivity between exclusively nursed or bottle-fed infants, suggesting that breastfeeding is not an important route of transmission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25630546\">",
"    <span class=\"h2\">",
"     Sexual transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;EBV has also been isolated in both cervical epithelial cells and in male seminal fluid, suggesting that transmission may also occur sexually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. In an epidemiologic study of more than 2000 university students in Scotland, questionnaires and serum samples were analyzed to examine risk factors for EBV seropositivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/21\">",
"     21",
"    </a>",
"    ]. Sexual activity before college admission was significantly associated with an increased risk of EBV seropositivity. Furthermore, the risk of a seropositive status increased with the number of sexual partners.",
"   </p>",
"   <p>",
"    Despite the recovery of EBV in genital secretions, studies have been unable to discriminate with certainty whether EBV was acquired through an oral or genital route. In one prospective study that followed EBV antibody-negative university freshmen, the time to infection in individuals reporting deep kissing without coitus was similar to those who reported deep kissing plus coitus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/11\">",
"     11",
"    </a>",
"    ]. Both groups had a significantly higher risk of acute EBV infection than subjects reporting no kissing or coitus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contact of Epstein-Barr virus (EBV) with oropharyngeal epithelial cells allows replication of the virus, release of EBV into the oropharyngeal secretions, and infection of B cells in the lymphoid-rich areas of the oropharynx [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/22\">",
"     22",
"    </a>",
"    ]. EBV-infected B cells are responsible for the dissemination of infection throughout the lymphoreticular system. The incubation period prior to the development of symptoms averages four to eight weeks.",
"   </p>",
"   <p>",
"    A prospective study was performed in 20 subjects with serologically confirmed primary EBV infection to assess viral kinetics in various compartments, including whole blood, peripheral blood mononuclear cells, and oral wash fluid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/23\">",
"     23",
"    </a>",
"    ]. The median half-life of viral elimination from whole blood in 19 subjects was three days; quantity in this compartment correlated with severity of symptoms. In contrast, virus persisted at an elevated level for 32 weeks in the oropharynx in asymptomatic subjects, consistent with the theory that EBV is transmitted via saliva.",
"   </p>",
"   <p>",
"    Primary EBV infection of B lymphocytes induces circulating antibodies directed against viral and unrelated antigens found on sheep and horse red cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/24\">",
"     24",
"    </a>",
"    ]. The latter antibodies, termed heterophile antibodies, are a heterogeneous group of mostly IgM antibodies that do not cross-react with EBV antigens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Rarely, infected cells produce antineutrophil, antierythrocyte, and antiplatelet antibodies, which are responsible for some of the less common clinical manifestations associated with infectious mononucleosis (IM) (see below). An EBV-specific serologic response can also be documented, although this is necessary for less than 10 percent of heterophile antibody-negative IM cases.",
"   </p>",
"   <p>",
"    EBV-specific cytotoxic T-lymphocytes are considered essential in controlling acute and reactivation infection. T cell activation leads to a T helper 1-type profile with production of interleukin-2 and interferon-gamma cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/27\">",
"     27",
"    </a>",
"    ]. The atypical lymphocytes, that appear in the peripheral blood of patients with acute IM between one and three weeks after the onset of symptoms, are primarily activated (HLA-DR+) CD8+ T-cells and also include CD16+ natural killer (NK) cells (",
"    <a class=\"graphic graphic_picture graphicRef55986 \" href=\"mobipreview.htm?1/24/1410\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/28-32\">",
"     28-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these immune responses, which control the initial lytic infection, EBV becomes a lifelong infection as it establishes latency with periodic reactivation with oral shedding of EBV. On the other hand, insufficient cellular immune responses may result in a poorly-controlled EBV infection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    generate an EBV-induced malignancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical manifestations and treatment of Epstein-Barr virus infection\", section on 'Malignancy'",
"    </a>",
"    .) Even with sufficient immune responses, some epidemiological studies have linked IM to increased risks of other conditions, such as Hodgkin lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Other studies have linked acquisition of infection to increased risks for autoimmune disorders, such as multiple sclerosis or systemic lupus erythematosus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Such associations will require significant additional study to prove causation as well as whether they could be a result of direct viral, or rather immunological consequences. Such concerns have heightened interest in exploring potential preventative strategies, such as an EBV vaccine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Classic IM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical features of infectious mononucleosis (IM) include fever, pharyngitis, adenopathy, fatigue, and atypical lymphocytosis (",
"    <a class=\"graphic graphic_table graphicRef57448 \" href=\"mobipreview.htm?37/58/38828\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/39\">",
"     39",
"    </a>",
"    ]. A review of over 500 patients found that lymphadenopathy was present in all patients, fever in 98 percent, and pharyngitis in 85 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The syndrome is often heralded by malaise, headache, and low grade fever before development of these more specific signs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/5,42\">",
"     5,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fatigue may be persistent and severe. In a prospective study of 150 patients, most initial symptoms (eg, fever, sore throat) had resolved by one month but fatigue resolved more slowly and persisted in 13 percent of patients at six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/41\">",
"     41",
"    </a>",
"    ]. Fatigue appears to be more common with a more profound impact on studies and exercise abilities in young female university students compared with male students [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymph node involvement in IM is typically symmetric and more commonly involves the posterior cervical than the anterior chains. The posterior cervical nodes are deep to the sternocleidomastoid muscles and must be carefully palpated. The nodes may be large and moderately tender. Lymphadenopathy may also become more generalized, which distinguishes IM from other causes of pharyngitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/8\">",
"     8",
"    </a>",
"    ]. Lymphadenopathy peaks in the first week and then gradually subsides over two to three weeks.",
"   </p>",
"   <p>",
"    A history of sore throat is often accompanied by pharyngeal inflammation and tonsillar exudates, which may appear white, gray-green, or even necrotic. Palatal petechiae with streaky hemorrhages and blotchy red macules are occasionally present; this finding may also be seen in patients with streptococcal pharyngitis.",
"   </p>",
"   <p>",
"    Rare complications of IM include peritonsillar abscess or airway occlusion secondary to edema of the soft palate and tonsils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical variants",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of clinical variants of IM in which some but not all of the classic findings are present:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many patients with acute EBV infection have relatively mild disease, and some present with pharyngitis and tonsillitis in the absence of a full-blown IM syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/45\">",
"       45",
"      </a>",
"      ]. Among 66 EBV-seronegative university students who developed primary EBV infection, 77 percent had the usual IM syndrome, 12 percent had atypical symptoms, and only 11 percent were asymptomatic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many patients present with fever and lymphadenopathy without pharyngitis, the so-called \"typhoidal form\" of illness. Many of these patients are heterophile antibody-negative, and should be termed \"heterophile-negative IM\". Other infectious causes of heterophile antibody-negative IM include most importantly cytomegalovirus (CMV) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/46\">",
"       46",
"      </a>",
"      ], or acute human immunodeficiency virus (HIV) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/47\">",
"       47",
"      </a>",
"      ], with other infections such as toxoplasmosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/48\">",
"       48",
"      </a>",
"      ], human herpesvirus type 6 (HHV-6) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/49\">",
"       49",
"      </a>",
"      ], and HHV-7 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/50\">",
"       50",
"      </a>",
"      ] possible. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Differential diagnosis'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Very young or older adults frequently do not develop the classic clinical syndrome (",
"      <a class=\"graphic graphic_table graphicRef62342 \" href=\"mobipreview.htm?25/63/26619\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/51\">",
"       51",
"      </a>",
"      ]. In a study of patients ages 40 to 78, pharyngitis and myalgia were the most frequent complaints, while cervical lymphadenopathy was less commonly noted on physical examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/52\">",
"       52",
"      </a>",
"      ]. Fever is common among older individuals and can last for several weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other clinical manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Splenomegaly and splenic rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenomegaly is seen in 50 to 60 percent of patients with IM and usually begins to recede by the third week of the illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Splenic rupture is a rare but potentially life-threatening complication of IM, estimated to occur in one to two cases per thousand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/54\">",
"     54",
"    </a>",
"    ]; almost all reports have been in males. When splenic rupture occurs, it does so spontaneously in over one-half of patients. It mostly occurs between the fourth and twenty-first day of symptomatic illness, but can be the presenting symptom [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/55\">",
"     55",
"    </a>",
"    ]. The typical manifestations are abdominal pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a falling hematocrit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of splenic rupture is similar to other forms of splenic injury. Nonoperative treatment with intensive supportive care and splenic preservation is preferred, but some require splenectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/56\">",
"     56",
"    </a>",
"    ]. Despite its life-threatening potential, fatality from IM-related splenic rupture is rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Rash",
"    </span>",
"    &nbsp;&mdash;&nbsp;A generalized maculopapular, urticarial, or petechial rash is occasionally seen, while erythema nodosum is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/51\">",
"     51",
"    </a>",
"    ]. A maculopapular rash almost always occurs following the administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    , although it has been also described occasionally with a variety of other antibiotics including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/57\">",
"     57",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/58\">",
"     58",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=see_link\">",
"      piperacillin",
"     </a>",
"     /tazobactam",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/59\">",
"     59",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef57224 \" href=\"mobipreview.htm?31/33/32272\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/60\">",
"     60",
"    </a>",
"    ]. The incidence of rash associated with beta-lactams initially was reported to be as high as 70 to 90 percent, but is probably lower [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/48\">",
"     48",
"    </a>",
"    ]. The mechanism responsible for the rash is not well understood.",
"   </p>",
"   <p>",
"    Development of a drug-related rash during IM does not appear to presage a true drug allergy, as patients subsequently tolerate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    without an adverse reaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Neurologic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic syndromes include Guillain-Barr&eacute; syndrome, facial and other cranial nerve palsies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/61-63\">",
"     61-63",
"    </a>",
"    ], meningoencephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/64\">",
"     64",
"    </a>",
"    ], aseptic meningitis, transverse myelitis, peripheral neuritis, optic neuritis, and encephalomyelitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/65\">",
"     65",
"    </a>",
"    ]. These manifestations tend to occur two to four weeks or more after initial symptom onset. There may also be an association between a clinical presentation of IM and the subsequent development of multiple sclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;EBV can affect virtually any organ system and has been associated with such diverse disease manifestations as hepatitis or cholestasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/68,69\">",
"     68,69",
"    </a>",
"    ], pneumonia, pleural effusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/70\">",
"     70",
"    </a>",
"    ], myocarditis, pancreatitis, mesenteric adenitis, myositis, acute renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/71\">",
"     71",
"    </a>",
"    ], glomerulonephritis, gastric pseudolymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/72\">",
"     72",
"    </a>",
"    ], and genital ulceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/73\">",
"     73",
"    </a>",
"    ]. Jaundice and hepatomegaly are less common, although ascites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/68,70\">",
"     68,70",
"    </a>",
"    ] and fatal cases of hepatitis have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     EBV infection during pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is little evidence of a teratogenic risk to the fetus in women who develop infection during pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/74\">",
"     74",
"    </a>",
"    ]. Transplacental transmission of EBV appears to be rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     LABORATORY ABNORMALITIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Hematologic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common laboratory finding in association with infectious mononucleosis (IM) is lymphocytosis, defined as an absolute count",
"    <span class=\"nowrap\">",
"     &gt;4500/microL",
"    </span>",
"    or, on peripheral smear, a differential count &gt;50 percent. The smear may also identify significant atypical lymphocytosis, defined as more than 10 percent of total lymphocytes. The majority of reactive lymphocytes in patients with IM are CD8+ cytotoxic T cells. In one study, the severity of illness correlated with the magnitude of CD8+ lymphocytosis (as well as with blood Epstein-Barr viral (EBV) load) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Hematologic findings'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H27\">",
"     'Detection of EBV virus'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The total white blood cell count in patients with IM averages 12,000 to",
"    <span class=\"nowrap\">",
"     18,000/microL,",
"    </span>",
"    although it may be much higher. Some patients have a mild relative and absolute neutropenia and thrombocytopenia. These are generally benign findings that are self-limited.",
"   </p>",
"   <p>",
"    Unusual hematologic manifestations include hemolytic anemia, thrombocytopenia, aplastic anemia, thrombotic thrombocytopenic",
"    <span class=\"nowrap\">",
"     purpura/hemolytic-uremic",
"    </span>",
"    syndrome, and disseminated intravascular coagulation. Some of these complications result from EBV-induced production of antibodies directed against red blood cells, white blood cells, and platelets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/51\">",
"     51",
"    </a>",
"    ]. The hemolytic anemia is typically associated with an anti-i cold agglutinin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30535?source=see_link\">",
"     \"Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Liver function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated aminotransferases are seen in the vast majority of patients, but are self-limited. Abnormal liver function tests in a patient with pharyngitis strongly suggest the diagnostic possibility of IM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with fever, pharyngitis, and lymphadenopathy may have streptococcal, cytomegalovirus, acute HIV, or, rarely, toxoplasma infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Streptococcal infection is not usually accompanied by significant fatigue or splenomegaly on examination. Pharyngitis associated with cytomegalovirus (CMV) tends to be extremely mild, if present at all, but may cause liver function test elevations, as does acute Epstein-Barr virus (EBV).",
"   </p>",
"   <p>",
"    Differentiating between infectious mononucleosis (IM) caused by EBV and a similar syndrome due to CMV or HIV infection is often not possible clinically. Diagnostic testing is particularly important if the patient is pregnant, since CMV, HIV, and toxoplasma infections can have significant adverse effects on pregnancy outcomes. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'EBV-negative mononucleosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=see_link\">",
"     \"Cytomegalovirus infection in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28041?source=see_link&amp;anchor=H650131395#H650131395\">",
"     \"Overview of TORCH infections\", section on 'Clinical features of TORCH infections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A mononucleosis syndrome with atypical lymphocytosis can also be induced by several drugs, particularly anticonvulsants such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , and antibiotics, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Patients with lymphadenopathy and splenomegaly may also have lymphoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epstein-Barr virus (EBV)-induced infectious mononucleosis (IM) should be suspected when an adolescent or young adult complains of sore throat, fever, and malaise and also has lymphadenopathy and pharyngitis on physical examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/8,80\">",
"     8,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Supportive evidence of EBV infection is derived from the observation of lymphocytosis and increased circulating atypical lymphocytes along with a positive heterophile antibody test. Occasionally EBV-specific antibodies are warranted.",
"   </p>",
"   <p>",
"    The presence of palatal petechiae, splenomegaly, and posterior cervical adenopathy are highly suggestive of IM, while the absence of cervical lymphadenopathy and fatigue make the diagnosis much less likely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with fever, lymphadenopathy, and pharyngitis should also have a diagnostic evaluation for streptococcal infection by culture or antigen testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5738?source=see_link\">",
"     \"Evaluation of acute pharyngitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Hematologic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common laboratory finding in association with IM is lymphocytosis, defined as an absolute count",
"    <span class=\"nowrap\">",
"     &gt;4500/microL",
"    </span>",
"    or, on peripheral smear, a differential count &gt;50 percent. The smear may also identify significant atypical lymphocytosis, defined as more than 10 percent of total lymphocytes (",
"    <a class=\"graphic graphic_picture graphicRef55986 \" href=\"mobipreview.htm?1/24/1410\">",
"     picture 1",
"    </a>",
"    ). In a review of 156 heterophile-positive patients, a lymphocytosis &ge;50 percent was seen in two-thirds percent of heterophile-positive patients and an atypical lymphocytosis of &ge;10 percent was present in 75 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/82\">",
"     82",
"    </a>",
"    ]. The specificity of these two findings, compared to a heterophile-negative control group with similar manifestations, was 85 and 92 percent, respectively.",
"   </p>",
"   <p>",
"    Atypical lymphocytes may also be found in patients with toxoplasmosis, rubella, roseola, viral hepatitis, mumps, CMV, acute HIV infection, and some drug reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/51\">",
"     51",
"    </a>",
"    ]. On the other hand, older individuals may have less prominent absolute lymphocytosis and fewer atypical lymphocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When an automated differential from a hematology analyzer flags a specimen as possibly containing atypical lymphocytes, the smear should be reviewed manually since blasts and other abnormalities cannot be reliably distinguished from atypical lymphocytes in these systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/82\">",
"     82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/54/35690?source=see_link&amp;anchor=H24#H24\">",
"     \"Automated hematology instrumentation\", section on 'Leukocyte counting errors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Heterophile antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heterophile antibodies react to antigens from phylogenetically unrelated species. They agglutinate sheep red blood cells (the classic Paul-Bunnell test), horse red blood cells (used in the \"Monospot\" test), and ox and goat erythrocytes. The Monospot is a latex agglutination assay using horse erythrocytes as the substrate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. Other rapid diagnostic tests use ELISA (enzyme-linked immunosorbent assay) techniques. The sensitivity and specificity of the rapid kits approach 85 and 100 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reactive heterophile antibodies in a patient with a compatible syndrome are diagnostic of EBV infection and are therefore the diagnostic test of choice in most clinical settings in North America [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/1\">",
"     1",
"    </a>",
"    ]. No further testing for specific antibodies to EBV is warranted in such patients with a reactive heterophile antibody.",
"   </p>",
"   <p>",
"    Although they are highly specific in the appropriate clinical setting, heterophile antibodies are somewhat insensitive. The false negative rates are highest during the beginning of clinical symptoms (25 percent in the first week; 5 to 10 percent in the second week, 5 percent in the third week) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/81\">",
"     81",
"    </a>",
"    ]. In patients with a compatible syndrome, heterophile antibodies can be repeated if the patient is early in their clinical illness. More specific EBV testing can be pursued in those with more prolonged illness or in those who do not fit classic diagnostic criteria (see",
"    <a class=\"local\" href=\"#H22\">",
"     'EBV-specific antibodies'",
"    </a>",
"    below). In Europe, these EBV-specific antibodies are used routinely for the diagnosis of IM, instead of heterophile antibody assays.",
"   </p>",
"   <p>",
"    Rare false-positive heterophile tests have been reported in patients with leukemia, lymphoma, pancreatic cancer, systemic lupus erythematosus, HIV infection, and rubella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/87\">",
"     87",
"    </a>",
"    ]. In addition, heterophile antibodies can persist at low levels for up to one year after IM.",
"   </p>",
"   <p>",
"    Up to 10 percent of patients with a mononucleosis syndrome do not have an acute EBV infection as confirmed by more specific antibody testing. These patients have alternative etiologies for their mononucleosis-like illness. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'EBV-negative mononucleosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The heterophile test does not have the same specificity and sensitivity in young children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=see_link&amp;anchor=H2005184#H2005184\">",
"     \"Clinical manifestations and treatment of Epstein-Barr virus infection\", section on 'Primary EBV infection in infants and children'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     EBV-specific antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, measurement of EBV-specific antibodies is usually not necessary since the vast majority of patients are heterophile positive. However, testing for EBV-specific antibodies may be warranted in patients with suspected IM who have a negative heterophile test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/88\">",
"     88",
"    </a>",
"    ]. IgM and IgG antibodies directed against viral capsid antigen have high sensitivity and specificity for the diagnosis of IM (97 and 94 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Viral capsid antigen",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgM and IgG antibodies directed against the Epstein-Barr viral capsid antigen (VCA) are usually present at the onset of clinical illness because of the long viral incubation period. IgM levels wane approximately three months later; thus, they are a good marker of acute infection. IgG VCA antibodies persist for life and are a marker of EBV infection.",
"   </p>",
"   <p>",
"    Results of viral capsid antigen testing need to be interpreted within the appropriate clinical context. Although the presence of IgM VCA antibodies is highly suggestive of acute EBV infection, other herpesviruses (eg, CMV) can induce IgM antibodies to cell lines that express EBV antigens. In addition, during illnesses associated with intense immune activation, serologic EBV reactivation with detectable EBV IgM VCA antibodies has been described in the absence of clinical IM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of other antibodies are expressed in individuals exposed to EBV, a few of which may also be used for diagnostic purposes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3114?source=see_link\">",
"     \"Virology of Epstein-Barr virus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Nuclear antigen",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgG antibodies to EBV nuclear antigen (EBNA, a protein expressed only when the virus begins to establish latency) begin to appear 6 to 12 weeks after the onset of symptoms and persist throughout life; their presence early in the course of an illness effectively excludes acute EBV infection.",
"   </p>",
"   <p>",
"    Thus, while the presence of IgM VCA antibodies suggests the likely presence of acute EBV infection, the diagnosis is most certain in the presence of IgM VCA and the absence of IgG EBNA antibodies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Early antigen",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgG antibodies to early antigen (EA) are present at the onset of clinical illness. There are two subsets of EA IgG: anti-D and anti-R. The presence of anti-D antibodies is consistent with recent infection since titers disappear after recovery, but their absence does not exclude acute illness because the antibodies are not expressed in a significant number of patients. Anti-R antibodies are only occasionally present in IM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Serum IgA antibody",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 15 individuals with primary EBV infection, serum IgA antibodies against early lytic antigens were detected using flow cytometry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/91\">",
"     91",
"    </a>",
"    ]. Furthermore, levels of IgA antibodies rapidly declined one month after onset of acute illness, while IgM antibodies continued to be produced.",
"   </p>",
"   <p>",
"    The role that serum IgA antibodies will have in the diagnosis of IM is unclear pending further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Detection of EBV virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;EBV DNA quantification can be accomplished through polymerase chain reaction assays on blood or plasma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. One study evaluated the clinical utility of detecting EBV viremia with real-time PCR in children with primary EBV infection compared with controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/94\">",
"     94",
"    </a>",
"    ]. Twenty-one (75 percent) of the patients in the primary EBV infection group, one (4 percent) of the EBV-seronegative patients and none of the EBV-seropositive patients had detectable EBV DNA. Within the primary infection group, those with detectable virus were more likely to have lymphadenopathy, higher atypical lymphocytes counts, and higher aminotransferases than those without detectable virus. In a study of university students with acute EBV infection, severity of illness correlated with blood EBV load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/11\">",
"     11",
"    </a>",
"    ]. However, this quantitative assessment of EBV viral load is not recommend for immunocompetent patients with suspected EBV infection since it offers no therapeutic guidance.",
"   </p>",
"   <p>",
"    The use of PCR in the management of transplant recipients who develop lymphoproliferative disorders related to EBV infection is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31738?source=see_link&amp;anchor=H17288449#H17288449\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of post-transplant lymphoproliferative disorders\", section on 'Measurement of Epstein-Barr viral load'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with suspected IM based upon the history and physical examination should have a white blood cell count with differential and a heterophile test.",
"   </p>",
"   <p>",
"    If the heterophile test is positive, no further testing is necessary if the clinical scenario is compatible with typical IM. If the heterophile test is negative, but there is still a strong clinical suspicion of EBV infection, the Monospot test can be repeated since testing can be negative early in clinical illness.",
"   </p>",
"   <p>",
"    If the clinical syndrome is prolonged, or if the patient does not have a classic EBV syndrome, IgM and IgG VCA and EBNA antibodies should be measured. The presence of IgG EBNA within four weeks of symptom onset excludes acute primary EBV infection as an explanation and therefore should prompt consideration of EBV-negative causes of mononucleosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     EBV-NEGATIVE MONONUCLEOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of mononucleosis-like cases are not caused by Epstein-Barr virus (EBV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/95\">",
"     95",
"    </a>",
"    ]. Other agents that produce a similar clinical syndrome include cytomegalovirus (CMV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/46\">",
"     46",
"    </a>",
"    ], HIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/47\">",
"     47",
"    </a>",
"    ], toxoplasmosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/96\">",
"     96",
"    </a>",
"    ], human herpesvirus type 6 (HHV-6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/49\">",
"     49",
"    </a>",
"    ], hepatitis B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/97\">",
"     97",
"    </a>",
"    ], and possibly HHV-7 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Primary HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary HIV infection causes a febrile illness resembling mononucleosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/47\">",
"     47",
"    </a>",
"    ]. The most common findings are fever, sore throat, myalgias, and lymphadenopathy (",
"    <a class=\"graphic graphic_table graphicRef82487 \" href=\"mobipreview.htm?29/25/30107\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/98\">",
"     98",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18151?source=see_link\">",
"     \"Acute and early HIV infection: Pathogenesis and epidemiology\"",
"    </a>",
"    .) The following features may help to distinguish primary HIV infection from IM:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mucocutaneous ulceration is unusual in IM; its presence should heighten the suspicion for acute HIV infection.",
"     </li>",
"     <li>",
"      Rash is less common in IM (unless antibiotics have been administered), but is seen frequently in the setting of primary HIV infection within 48 to 72 hours after the onset of fever.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The heterophile test is typically negative during acute HIV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/99\">",
"     99",
"    </a>",
"    ]; false positive heterophile tests have been rarely reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/100,101\">",
"     100,101",
"    </a>",
"    ]. Atypical lymphocytes also may be present in acute HIV infection although the overall incidence of atypical lymphocytosis is lower in HIV infection and the percentage of atypical cells is usually lower than that seen with EBV.",
"   </p>",
"   <p>",
"    Patients who present with a heterophile-negative mononucleosis-like syndrome should have quantitative plasma HIV RNA and HIV antibody testing to rule out primary HIV infection since early diagnosis is important for patient management and to decrease the risk of transmission to others. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/7/43129?source=see_link&amp;anchor=H18410709#H18410709\">",
"     \"Acute and early HIV infection: Clinical manifestations and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Cytomegalovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMV causes a syndrome that is similar but often milder than EBV-associated IM (",
"    <a class=\"graphic graphic_table graphicRef78849 \" href=\"mobipreview.htm?4/23/4476\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. The illness is characterized primarily by prolonged fever, less prominent lymphadenopathy, and absent or mild pharyngitis. Hepatitis is nearly universal. The hematologic picture resembles that of EBV infection. The disease is self-limited and the great majority of patients recover with no sequelae. The diagnosis can be supported by the identification of IgM antibodies to CMV. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8597?source=see_link\">",
"     \"Diagnosis of cytomegalovirus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Toxoplasmosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxoplasmosis causes a syndrome characterized predominantly by fever and lymphadenopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/96\">",
"     96",
"    </a>",
"    ]. It rarely causes pharyngitis or abnormal liver function tests, and is not associated with the characteristic hematologic abnormalities seen with CMV and EBV infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=see_link&amp;anchor=H9#H9\">",
"     \"Toxoplasmosis in immunocompetent hosts\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Human herpesvirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic primary infection with HHV-6 or HHV-7 is uncommon in adults. However, a mononucleosis-like syndrome of varying severity with prolonged lymphadenopathy has been described in association with HHV-6 seroconversion in adults. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/1/10265?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults\", section on 'Immunocompetent hosts'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     CHRONIC OR PERSISTENT EBV INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic active Epstein-Barr virus (EBV) infection is a rare disorder, characterized by persistent infectious mononucleosis (IM)-like symptoms and prolonged active EBV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/104\">",
"     104",
"    </a>",
"    ]. Symptoms can include fever, swelling of lymph nodes, and hepatosplenomegaly along with liver function test abnormalities and cytopenias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/105\">",
"     105",
"    </a>",
"    ]. Persistent infection is best defined through detection of EBV DNA in peripheral blood at high levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/105\">",
"     105",
"    </a>",
"    ]. Treatment regimens for this illness have not been established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A common misconception is to label patients with fatigue alone as having chronic EBV based only upon positive serologic markers without any of the above abnormalities. As previously mentioned, IgG antibodies to VCA and EBNA are present for life in patients with prior EBV exposure and are not markers of active process suggesting true chronic acute EBV infection. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'EBV-specific antibodies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    EBV infection has also received a great deal of attention in past years as a possible etiologic agent for chronic fatigue syndrome (CFS). This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30825?source=see_link\">",
"     \"Clinical features and diagnosis of chronic fatigue syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary Epstein-Barr virus (EBV) infections rarely require more than supportive therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Symptomatic treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstay of treatment for individuals with infectious mononucleosis (IM) is supportive care.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    or nonsteroidal anti-inflammatory drugs are recommended for the treatment of fever, throat discomfort, and malaise. Provision of adequate fluids and nutrition is also important. It is prudent to get adequate rest, although complete bed rest is unnecessary.",
"   </p>",
"   <p>",
"    The use of corticosteroids in the treatment of EBV-induced IM has been controversial. In a multicenter, placebo-controlled study of 94 patients with acute IM, the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    reduced oropharyngeal shedding of the virus but did not affect the duration of symptoms or lead to an earlier return to school or work [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/107\">",
"     107",
"    </a>",
"    ]. A subsequent meta-analysis of seven studies found insufficient evidence to recommend steroid treatment for symptom relief; furthermore, two studies reported severe complications in patients assigned to the corticosteroid arm compared to placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/108\">",
"     108",
"    </a>",
"    ]. We do not recommend corticosteroid therapy for routine cases of IM since it is generally a self-limited illness and there are theoretical concerns about immunosuppression during clinical illness with a virus that has been causally linked to a variety of malignancies. However, corticosteroids may be considered in the management of patients with some EBV-associated complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Complications including airway obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corticosteroids, as well as emergent consultation with an otolaryngologist, are warranted in individuals with impending airway obstruction (manifested clinically by difficulty breathing or dyspnea in the recumbent position). Data on dosing and duration of corticosteroid therapy is scant. One case series described children with impending airway closure who were treated successfully with high-dose corticosteroids (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    0.25",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every six hours) but no information was given on duration of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/109\">",
"     109",
"    </a>",
"    ]. Once clinical improvement has been achieved, tapering the corticosteroid dose slowly (eg, over 7 to 14 days) is likely prudent.",
"   </p>",
"   <p>",
"    Corticosteroid therapy may be also considered in those with severe overwhelming life-threatening infection (eg, fulminant liver failure) or other complications such as severe hemolytic or aplastic anemia. Data supporting benefit of corticosteroids in these settings are less robust than what is found for the treatment of IM-related airway obstruction.",
"   </p>",
"   <p>",
"    Despite lack of evidence, one recent retrospective study of 206 patients with IM treated at a single tertiary medical center found that 45 percent received corticosteroids mainly for constitutional symptoms; only 8 percent of patients were treated based on traditional criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Antiviral treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"     Acyclovir",
"    </a>",
"    is a nucleoside analogue that inhibits permissive EBV infection through inhibition of EBV DNA polymerase but has no effect on latent infection or ability to cure the infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=see_link\">",
"     \"Acyclovir: An overview\"",
"    </a>",
"    .) Specific therapy of acute EBV infections with intravenous and oral formulations of acyclovir has been studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/107,111\">",
"     107,111",
"    </a>",
"    ]. Short-term suppression of oral viral shedding can be demonstrated, but significant clinical benefit has not been shown.",
"   </p>",
"   <p>",
"    A meta-analysis of five randomized controlled trials of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    in the treatment of acute IM, including two trials of intravenous therapy in patients with severe disease, also failed to show a clinical benefit compared to placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/112\">",
"     112",
"    </a>",
"    ]. These results are not surprising since ongoing viral replication plays a less significant role in the symptomatic phase of EBV-induced IM than the host immune responses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     RETURN TO SPORTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since infectious mononucleosis (IM) mostly affects teenagers and young adults, many of whom participate in competitive sports and other forms of exercise, a common question is when to recommend resumption of athletic activities. More than 50 percent of patients with IM develop splenic enlargement within the first two weeks of symptoms; as a result, the central issue is avoiding activities that may precipitate splenic rupture, while a secondary consideration relates to resumption of training in an athlete complaining of fatigue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Avoiding splenic rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;All athletes should refrain from sport activities during early illness. As recuperation occurs, clinicians should keep in mind that spontaneous or traumatic splenic rupture in the setting of IM appears to be most likely within 2 to 21 days after the onset of clinical symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/113\">",
"     113",
"    </a>",
"    ]. Descriptions of splenic rupture after the fourth week are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/56,114\">",
"     56,114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recommendations to resume sports are somewhat arbitrary given the lack of prospective data. Several authors recommend potential resumption of all sport activities, except for strenuous contact sports, no earlier than 21 days after illness onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/115,116\">",
"     115,116",
"    </a>",
"    ]. Others advocate a more universal four week time frame regardless of activity level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/117\">",
"     117",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A conservative synthesis of retrospective studies yields the following suggestions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/118\">",
"     118",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For athletes planning to resume non-contact sports, training can be gradually restarted starting three weeks from symptom onset. This recommendation assumes that participants avoid any activities capable of causing chest or abdominal trauma.",
"     </li>",
"     <li>",
"      For strenuous contact sports (including football, gymnastics, rugby, hockey, lacrosse, wrestling, diving, and basketball) or activities associated with increased intraabdominal pressure (such as weightlifting) that may carry a higher risk of splenic injury, we recommend waiting a minimum of four weeks after illness onset.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ways in which to document that the spleen has returned to normal size vary from practitioner to practitioner. Splenic palpation or percussion is generally unreliable in athletes with firm abdominal musculature, although experienced examiners can trust a positive finding of enlargement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/119\">",
"     119",
"    </a>",
"    ]. The safest option may be obtaining an ultrasound examination to document resolution of splenomegaly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/120,121\">",
"     120,121",
"    </a>",
"    ]. However, the use of imaging studies before a return to sports remains a debated issue due to a lack of clinical outcomes data and the cost of ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients with IM appear to have splenic enlargement that persists on serial ultrasound studies. This may be due to the occasional long-term splenomegaly seen after IM or to \"normal\" splenomegaly that may be observed in 3 to 7 percent of healthy young adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/123,124\">",
"     123,124",
"    </a>",
"    ]. Since seven weeks is among the latest descriptions of IM-related splenic rupture, clinical judgment must dictate when to allow an athlete with splenomegaly that persists beyond seven to eight weeks to resume strenuous sports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/114\">",
"     114",
"    </a>",
"    ]. Routine ultrasonography is not needed in most patients; the decision to obtain imaging should be influenced by whether the patient is returning to contact sports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;A common sense approach to resumption of training suggests that clinicians wait for resolution of objective symptoms as well as an improvement in the athlete's sense of well being. For the first few days, athletes should train at reduced levels compared to their premorbid state, increasing activities gradually as tolerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/126\">",
"     126",
"    </a>",
"    ]. Competitive athletes may not attain pre-illness levels of fitness for three or more months. The physician should be especially careful when giving recommendations to athletes who may be unduly pressured by themselves or others to resume strenuous activity too soon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of individuals with primary Epstein-Barr virus (EBV) infection recover uneventfully and develop durable immunity controlling the latent virus. Most acute symptoms resolve in one to two weeks, although fatigue and poor functional status can persist for months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/127,128\">",
"     127,128",
"    </a>",
"    ]. A prospective study of infectious mononucleosis (IM) (and other acute infections) found that 11 percent of individuals fit criteria for chronic fatigue syndrome six months after symptom onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/128\">",
"     128",
"    </a>",
"    ]. A subsequent study in adolescents noted that as many as 7 and 5 percent met that syndrome definition at 12 months and 24 months, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/129\">",
"     129",
"    </a>",
"    ]. Some studies suggest that female gender [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/43,130\">",
"     43,130",
"    </a>",
"    ] and a premorbid mood disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/130\">",
"     130",
"    </a>",
"    ] may be risk factors for persistent fatigue.",
"   </p>",
"   <p>",
"    The reason why some patients do not return to prior health is unclear, but some studies show abnormalities in mitochondrial function, as well as message levels for a variety of regulatory molecules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/131-133\">",
"     131-133",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EBV has been associated with a variety of malignancies, particularly lymphoma. Many of these infections are subclinical, but Hodgkin lymphoma has been associated with a history of infectious mononucleosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3703?source=see_link\">",
"     \"The role of Epstein-Barr virus in Hodgkin lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical manifestations and treatment of Epstein-Barr virus infection\", section on 'Malignancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present there is no commercially available vaccine to prevent Epstein-Barr virus (EBV) infection. Glycoprotein 350, a viral antigen expressed on the EBV capsid, enables entry of virus into B cells and is targeted by the immune system during natural infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/134\">",
"     134",
"    </a>",
"    ]. One phase two placebo-controlled trial evaluated a recombinant gp350 vaccine in 181 volunteers and found that although the number of cases of infectious mononucleosis was decreased in the vaccine group, gp350 did not prevent asymptomatic infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/18/31018/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25630559\">",
"    <span class=\"h2\">",
"     Return to school or work",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since EBV may be shed intermittently for months to years in people who have acquired infection, and the source of infection is rarely known in the patient who develops infectious mononucleosis, there are no restrictions regarding recently ill IM patients for returning to school or to the workplace. The decision to return to full activities should be guided by the level of fatigue and other constitutional symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/33/41489?source=see_link\">",
"       \"Patient information: Mono, the &ldquo;kissing disease&rdquo; (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/11/176?source=see_link\">",
"       \"Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infectious mononucleosis (IM) is an acute illness due to Epstein-Barr virus (EBV) infection, which occurs mainly in adolescents and young adults. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      IM is classically characterized by fever, pharyngitis, fatigue, and lymphadenopathy. Other findings can include splenomegaly and palatal petechiae. Cervical lymphadenopathy tends to involve the posterior chain of lymph nodes. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rare complications include splenic rupture and airway obstruction.",
"     </li>",
"     <li>",
"      A generalized maculopapular, urticarial, or petechial rash is occasionally seen. Rash is more common following the administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Common laboratory findings include an absolute or relative lymphocytosis, an increased proportion of atypical lymphocytes, and elevated aminotransferases. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Laboratory abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with suspected IM, based upon the history and physical examination, should have a white blood cell count with differential and a heterophile test. In addition, patients should also have a diagnostic evaluation for streptococcal infection by culture or antigen testing. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In a patient with a compatible syndrome and a negative heterophile antibody, the monospot test can be repeated since this test can be negative during the first week of clinical illness. EBV-specific antibodies (eg, viral capsid antigen IgM and IgG and early nuclear antigen antibodies) should be ordered if the patient has a repeatedly negative monospot. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of IgG EBNA, or the absence of IgG and IgM VCA, excludes acute primary EBV infection and should prompt consideration of alternative etiologies of a mononucleosis-like illness, such as cytomegalovirus (CMV), primary HIV infection, and toxoplasmosis. The most important diagnosis to exclude is primary HIV infection; this can be accomplished with both quantitative HIV RNA and HIV antibody testing. The evaluation for CMV takes on great importance in the pregnant female. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'EBV-negative mononucleosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend NOT administering",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"       acyclovir",
"      </a>",
"      for IM (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Primary EBV infections rarely require more than supportive therapy. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In individuals with impending airway obstruction, we suggest corticosteroids, as well as emergent consultation with an otolaryngologist (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For athletes planning to resume non-contact sports, training can be gradually restarted three weeks from symptom onset. For strenuous contact sports or activities associated with increased intraabdominal pressure, we suggest waiting a minimum of four weeks after illness onset (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H39\">",
"       'Return to sports'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/1\">",
"      Evans AS, Niederman JC, Cenabre LC, et al. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis 1975; 132:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/2\">",
"      Evans AS. The history of infectious mononucleosis. Am J Med Sci 1974; 267:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/3\">",
"      Sprunt TP, Evans FA. Mononucleosis leukocytosis in reaction to acute infections (infectious mononucleosis). John Hopkins Hosp Bull 1920; 31:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/4\">",
"      Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A 1968; 59:94.",
"     </a>",
"    </li>",
"    <li>",
"     Evans A, Niederman J. Epstein-Barr virus. In: Viral Infections of Human Epidemiology and Control, Evans A (Ed), Plenum Publishing, New York 1989. p.265.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/6\">",
"      Heath CW Jr, Brodsky AL, Potolsky AI. Infectious mononucleosis in a general population. Am J Epidemiol 1972; 95:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/7\">",
"      Morris MC, Edmunds WJ. The changing epidemiology of infectious mononucleosis? J Infect 2002; 45:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/8\">",
"      Aronson MD, Komaroff AL, Pass TM, et al. Heterophil antibody in adults with sore throat: frequency and clinical presentation. Ann Intern Med 1982; 96:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/9\">",
"      Nye FJ. Social class and infectious mononucleosis. J Hyg (Lond) 1973; 71:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/10\">",
"      Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 2005; 192:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/11\">",
"      Balfour HH Jr, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 2013; 207:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/12\">",
"      Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 2004; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/13\">",
"      Sawyer RN, Evans AS, Niederman JC, McCollum RW. Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis. J Infect Dis 1971; 123:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/14\">",
"      Fafi-Kremer S, Morand P, Brion JP, et al. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis 2005; 191:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/15\">",
"      Fleisher GR, Pasquariello PS, Warren WS, et al. Intrafamilial transmission of Epstein-Barr virus infections. J Pediatr 1981; 98:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/16\">",
"      Junker AK, Thomas EE, Radcliffe A, et al. Epstein-Barr virus shedding in breast milk. Am J Med Sci 1991; 302:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/17\">",
"      Kusuhara K, Takabayashi A, Ueda K, et al. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 1997; 41:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/18\">",
"      N&auml;her H, Gissmann L, Freese UK, et al. Subclinical Epstein-Barr virus infection of both the male and female genital tract--indication for sexual transmission. J Invest Dermatol 1992; 98:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/19\">",
"      Sixbey JW, Lemon SM, Pagano JS. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 1986; 2:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/20\">",
"      Israele V, Shirley P, Sixbey JW. Excretion of the Epstein-Barr virus from the genital tract of men. J Infect Dis 1991; 163:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/21\">",
"      Higgins CD, Swerdlow AJ, Macsween KF, et al. A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis 2007; 195:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/22\">",
"      Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995; 85:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/23\">",
"      Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 2005; 192:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/24\">",
"      Thorley-Lawson DA, Mann KP. Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med 1985; 162:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/25\">",
"      Paul JR, Bunnell WW. The presence of heterophile antibodies in infectious mononucleosis. Am J Med Sci 1932; 183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/26\">",
"      Paul JR, Bunnell WW. Classics in infectious diseases. The presence of heterophile antibodies in infectious mononucleosis by John R. Paul and W. W. Bunnell. American Journal of the Medical Sciences, 1932. Rev Infect Dis 1982; 4:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/27\">",
"      Corsi MM, Ruscica M, Passoni D, et al. High Th1-type cytokine serum levels in patients with infectious mononucleosis. Acta Virol 2004; 48:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/28\">",
"      Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 1987; 139:3802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/29\">",
"      Giuliano VJ, Jasin HE, Ziff M. The nature of the atypical lymphocyte in infectious mononucleosis. Clin Immunol Immunopathol 1974; 3:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/30\">",
"      Johnsen HE, Madsen M, Kristensen T, Kissmeyer-Nielsen F. Lymphocyte subpopulations in man. Expression of HLA-DR determinants on human T cells in infectious mononucleosis. Acta Pathol Microbiol Scand C 1978; 86C:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/31\">",
"      Niedobitek G, Herbst H, Young LS, et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992; 79:2520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/32\">",
"      Williams H, McAulay K, Macsween KF, et al. The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 2005; 129:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/33\">",
"      Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003; 349:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/34\">",
"      Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res 2007; 67:2382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/35\">",
"      Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006; 59:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/36\">",
"      Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 2006; 39:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/37\">",
"      Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? Expert Rev Anti Infect Ther 2006; 4:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/38\">",
"      Sokal EM, Hoppenbrouwers K, Vandermeulen C, et al. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 2007; 196:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/39\">",
"      Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med 2010; 362:1993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/40\">",
"      Hoagland RJ. Infectious mononucleosis. Prim Care 1975; 2:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/41\">",
"      Rea TD, Russo JE, Katon W, et al. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract 2001; 14:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/42\">",
"      Peter J, Ray CG. Infectious mononucleosis. Pediatr Rev 1998; 19:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/43\">",
"      Macsween KF, Higgins CD, McAulay KA, et al. Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease. Clin Infect Dis 2010; 50:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/44\">",
"      Monem SA, O'Connor PF, O'Leary TG. Peritonsillar abscess and infectious mononucleosis: an association or a different presentation of the same condition. Ir Med J 1999; 92:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/45\">",
"      Yoda K, Sata T, Kurata T, Aramaki H. Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. Arch Otolaryngol Head Neck Surg 2000; 126:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/46\">",
"      Klemola E, Von Essen R, Henle G, Henle W. Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis 1970; 121:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/47\">",
"      Gaines H, von Sydow M, Pehrson PO, Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 1988; 297:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/48\">",
"      Horwitz CA, Henle W, Henle G, et al. Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases. Am J Med 1977; 63:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/49\">",
"      Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990; 93:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/50\">",
"      Kawa-Ha K, Tanaka K, Inoue M, et al. Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. Br J Haematol 1993; 84:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/51\">",
"      Auwaerter PG. Infectious mononucleosis in middle age. JAMA 1999; 281:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/52\">",
"      Horwitz CA, Henle W, Henle G, et al. Infectious mononucleosis in patients aged 40 to 72 years: report of 27 cases, including 3 without heterophil-antibody responses. Medicine (Baltimore) 1983; 62:256.",
"     </a>",
"    </li>",
"    <li>",
"     Infectious Mononucleosis, Carter RL, Penman HG (Eds), Blackwell Scientific Publication, Oxford and Edinburgh 1969. p.47-62.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/54\">",
"      Aldrete JS. Spontaneous rupture of the spleen in patients with infectious mononucleosis. Mayo Clin Proc 1992; 67:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/55\">",
"      Gayer G, Zandman-Goddard G, Kosych E, Apter S. Spontaneous rupture of the spleen detected on CT as the initial manifestation of infectious mononucleosis. Emerg Radiol 2003; 10:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/56\">",
"      Asgari MM, Begos DG. Spontaneous splenic rupture in infectious mononucleosis: a review. Yale J Biol Med 1997; 70:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/57\">",
"      Schissel DJ, Singer D, David-Bajar K. Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. Cutis 2000; 65:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/58\">",
"      Paily R. Quinolone drug rash in a patient with infectious mononucleosis. J Dermatol 2000; 27:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/59\">",
"      LeClaire AC, Martin CA, Hoven AD. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis. Ann Pharmacother 2004; 38:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/60\">",
"      McCloskey GL, Massa MC. Cephalexin rash in infectious mononucleosis. Cutis 1997; 59:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/61\">",
"      Long CM, Kerschner JE. Parotid mass: Epstein-Barr virus and facial paralysis. Int J Pediatr Otorhinolaryngol 2001; 59:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/62\">",
"      Joki-Erkkil&auml; VP, Hietaharju A, Numminen J, et al. Multiple cranial nerve palsies as a complication of infectious mononucleosis due to inflammatory lesion in jugular foramen. Ann Otol Rhinol Laryngol 2000; 109:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/63\">",
"      Johns MM, Hogikyan ND. Simultaneous vocal fold and tongue paresis secondary to Epstein-Barr virus infection. Arch Otolaryngol Head Neck Surg 2000; 126:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/64\">",
"      Schellinger PD, Sommer C, Leith&auml;user F, et al. Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host. Ann Neurol 1999; 45:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/65\">",
"      Tselis A, Duman R, Storch GA, Lisak RP. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology 1997; 48:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/66\">",
"      Marrie RA, Wolfson C, Sturkenboom MC, et al. Multiple sclerosis and antecedent infections: a case-control study. Neurology 2000; 54:2307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/67\">",
"      Hern&aacute;n MA, Zhang SM, Lipworth L, et al. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001; 12:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/68\">",
"      Devereaux CE, Bemiller T, Brann O. Ascites and severe hepatitis complicating Epstein-Barr infection. Am J Gastroenterol 1999; 94:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/69\">",
"      Ghosh A, Ghoshal UC, Kochhar R, et al. Infectious mononucleosis hepatitis: report of two patients. Indian J Gastroenterol 1997; 16:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/70\">",
"      Chen J, Konstantinopoulos PA, Satyal S, et al. Just another simple case of infectious mononucleosis? Lancet 2003; 361:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/71\">",
"      Lei PS, Lowichik A, Allen W, Mauch TJ. Acute renal failure: unusual complication of Epstein-Barr virus-induced infectious mononucleosis. Clin Infect Dis 2000; 31:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/72\">",
"      Kitayama Y, Honda S, Sugimura H. Epstein-Barr virus-related gastric pseudolymphoma in infectious mononucleosis. Gastrointest Endosc 2000; 52:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/73\">",
"      Hudson LB, Perlman SE. Necrotizing genital ulcerations in a premenarcheal female with mononucleosis. Obstet Gynecol 1998; 92:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/74\">",
"      Avgil M, Diav-Citrin O, Shechtman S, et al. Epstein-Barr virus infection in pregnancy--a prospective controlled study. Reprod Toxicol 2008; 25:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/75\">",
"      Avgil M, Ornoy A. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol 2006; 21:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/76\">",
"      Horwitz CA, Moulds J, Henle W, et al. Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes. Blood 1977; 50:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/77\">",
"      Maquiera E, Ya&ntilde;ez S, Fern&aacute;ndez L, et al. Mononucleosis-like illness as a manifestation of carbamazepine-induced anticonvulsant hypersensitivity syndrome. Allergol Immunopathol (Madr) 1996; 24:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/78\">",
"      Lupton JR, Figueroa P, Tamjidi P, et al. An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction. Cutis 1999; 64:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/79\">",
"      Brown M, Schubert T. Phenytoin hypersensitivity hepatitis and mononucleosis syndrome. J Clin Gastroenterol 1986; 8:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/80\">",
"      Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 2007; 120:911.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/81\">",
"      Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician 2004; 70:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/82\">",
"      Brigden ML, Au S, Thompson S, et al. Infectious mononucleosis in an outpatient population: diagnostic utility of 2 automated hematology analyzers and the sensitivity and specificity of Hoagland's criteria in heterophile-positive patients. Arch Pathol Lab Med 1999; 123:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/83\">",
"      Axelrod P, Finestone AJ. Infectious mononucleosis in older adults. Am Fam Physician 1990; 42:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/84\">",
"      Seitanidis B. A comparison of the Monospot with the Paul-Bunnell test in infectious mononucleosis and other diseases. J Clin Pathol 1969; 22:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/85\">",
"      Basson V, Sharp AA. Monospot: a differential slide test for infectious mononucleosis. J Clin Pathol 1969; 22:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/86\">",
"      Linderholm M, Boman J, Juto P, Linde A. Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol 1994; 32:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/87\">",
"      Schumacher HR, Austin RM, Stass SA. False-positive serology in infectious monoucleosis. Lancet 1979; 1:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/88\">",
"      Tetrault G. Infections in heterophile-negative patients. Arch Pathol Lab Med 2001; 125:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/89\">",
"      Bruu AL, Hjetland R, Holter E, et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000; 7:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/90\">",
"      Obel N, H&oslash;ier-Madsen M, Kangro H. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS 1996; 104:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/91\">",
"      Bhaduri-McIntosh S, Landry ML, Nikiforow S, et al. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection. J Infect Dis 2007; 195:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/92\">",
"      Weinberger B, Plentz A, Weinberger KM, et al. Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCR. J Med Virol 2004; 74:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/93\">",
"      Fafi-Kremer S, Brengel-Pesce K, Bargu&egrave;s G, et al. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. J Clin Virol 2004; 30:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/94\">",
"      Pitetti RD, Laus S, Wadowsky RM. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pediatr Infect Dis J 2003; 22:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/95\">",
"      Evans AS. Infectious mononucleosis and related syndromes. Am J Med Sci 1978; 276:325.",
"     </a>",
"    </li>",
"    <li>",
"     Cameron D, MacBean LM. A clinical study of infectious mononucleosis and toxoplasmosis, Williams &amp; Wilkins, Baltimore 1973. p.18.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/97\">",
"      Thami GP, Kanwar AJ, Goyal A. Heterophil negative infectious mononucleosis like syndrome due to hepatitis B virus. J Assoc Physicians India 2000; 48:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/98\">",
"      Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 1993; 168:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/99\">",
"      Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N Engl J Med 1999; 340:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/100\">",
"      Vidrih JA, Walensky RP, Sax PE, Freedberg KA. Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection. Am J Med 2001; 111:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/101\">",
"      Walensky RP, Rosenberg ES, Ferraro MJ, et al. Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. Clin Infect Dis 2001; 33:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/102\">",
"      Klemola E, K&auml;&auml;ri&auml;inen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J 1965; 2:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/103\">",
"      Jordan MC, Rousseau W, Stewart JA, et al. Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med 1973; 79:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/104\">",
"      Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988; 157:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/105\">",
"      Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005; 80:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/106\">",
"      Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003; 187:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/107\">",
"      Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996; 174:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/108\">",
"      Candy B, Hotopf M. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev 2006; :CD004402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/109\">",
"      Wohl DL, Isaacson JE. Airway obstruction in children with infectious mononucleosis. Ear Nose Throat J 1995; 74:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/110\">",
"      Thompson SK, Doerr TD, Hengerer AS. Infectious mononucleosis and corticosteroids: management practices and outcomes. Arch Otolaryngol Head Neck Surg 2005; 131:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/111\">",
"      van der Horst C, Joncas J, Ahronheim G, et al. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991; 164:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/112\">",
"      Torre D, Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis 1999; 31:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/113\">",
"      Kinderknecht JJ. Infectious mononucleosis and the spleen. Curr Sports Med Rep 2002; 1:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/114\">",
"      Johnson MA, Cooperberg PL, Boisvert J, et al. Spontaneous splenic rupture in infectious mononucleosis: sonographic diagnosis and follow-up. AJR Am J Roentgenol 1981; 136:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/115\">",
"      Maki DG, Reich RM. Infectious mononucleosis in the athlete. Diagnosis, complications, and management. Am J Sports Med 1982; 10:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/116\">",
"      Haines JD Jr. When to resume sports after infectious mononucleosis. How soon is safe? Postgrad Med 1987; 81:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/117\">",
"      Friman G, Wessl&eacute;n L. Special feature for the Olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes. Immunol Cell Biol 2000; 78:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/118\">",
"      Auwaerter PG. Infectious mononucleosis: return to play. Clin Sports Med 2004; 23:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/119\">",
"      Tamayo SG, Rickman LS, Mathews WC, et al. Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers. J Gen Intern Med 1993; 8:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/120\">",
"      Ali J. Spontaneous rupture of the spleen in patients with infectious mononucleosis. Can J Surg 1993; 36:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/121\">",
"      Dommerby H, Stangerup SE, Stangerup M, Hancke S. Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning. J Laryngol Otol 1986; 100:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/122\">",
"      Burroughs KE. Athletes resuming activity after infectious mononucleosis. Arch Fam Med 2000; 9:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/123\">",
"      McIntyre OR, Ebaugh FG Jr. Palpable spleens in college freshmen. Ann Intern Med 1967; 66:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/124\">",
"      Hosey RG, Mattacola CG, Kriss V, et al. Ultrasound assessment of spleen size in collegiate athletes. Br J Sports Med 2006; 40:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/125\">",
"      Waninger KN, Harcke HT. Determination of safe return to play for athletes recovering from infectious mononucleosis: a review of the literature. Clin J Sport Med 2005; 15:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/126\">",
"      Noffsinger J. Physical activity considerations in children and adolescents with viral infections. Pediatr Ann 1996; 25:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/127\">",
"      Buchwald DS, Rea TD, Katon WJ, et al. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med 2000; 109:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/128\">",
"      Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/129\">",
"      Katz BZ, Shiraishi Y, Mears CJ, et al. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics 2009; 124:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/130\">",
"      Petersen I, Thomas JM, Hamilton WT, White PD. Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. QJM 2006; 99:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/131\">",
"      Vernon SD, Whistler T, Cameron B, et al. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis 2006; 6:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/132\">",
"      Vernon SD, Nicholson A, Rajeevan M, et al. Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis. Brain Res 2006; 1068:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/133\">",
"      White PD. What causes prolonged fatigue after infectious mononucleosis: and does it tell us anything about chronic fatigue syndrome? J Infect Dis 2007; 196:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/18/31018/abstract/134\">",
"      Jackman WT, Mann KA, Hoffmann HJ, Spaete RR. Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine. Vaccine 1999; 17:660.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8318 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-189.2.19.178-485ACEB782-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31018=[""].join("\n");
var outline_f30_18_31018=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H45\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25630532\">",
"      Person-to-person",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25630539\">",
"      Breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25630546\">",
"      Sexual transmission",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Classic IM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical variants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Splenomegaly and splenic rupture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Rash",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Neurologic syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EBV infection during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      LABORATORY ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Hematologic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Liver function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Hematologic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Heterophile antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      EBV-specific antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Viral capsid antigen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Nuclear antigen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Early antigen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Serum IgA antibody",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Detection of EBV virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      EBV-NEGATIVE MONONUCLEOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Primary HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Cytomegalovirus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Toxoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Human herpesvirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      CHRONIC OR PERSISTENT EBV INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Symptomatic treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Complications including airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Antiviral treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      RETURN TO SPORTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Avoiding splenic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25630559\">",
"      Return to school or work",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8318\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8318|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?1/24/1410\" title=\"picture 1\">",
"      Atypical lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/33/32272\" title=\"picture 2\">",
"      Rash in infectious mono",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8318|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/58/38828\" title=\"table 1\">",
"      Clinical manifestations of mono",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/63/26619\" title=\"table 2\">",
"      Features of mono by age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/25/30107\" title=\"table 3\">",
"      Symptoms of acute HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/23/4476\" title=\"table 4\">",
"      Symptoms CMV mononucleosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/7/43129?source=related_link\">",
"      Acute and early HIV infection: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18151?source=related_link\">",
"      Acute and early HIV infection: Pathogenesis and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=related_link\">",
"      Acyclovir: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/54/35690?source=related_link\">",
"      Automated hematology instrumentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/6/30825?source=related_link\">",
"      Clinical features and diagnosis of chronic fatigue syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=related_link\">",
"      Clinical manifestations and treatment of Epstein-Barr virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/1/10265?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=related_link\">",
"      Cytomegalovirus infection in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8597?source=related_link\">",
"      Diagnosis of cytomegalovirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31738?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of post-transplant lymphoproliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5738?source=related_link\">",
"      Evaluation of acute pharyngitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28041?source=related_link\">",
"      Overview of TORCH infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30535?source=related_link\">",
"      Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/11/176?source=related_link\">",
"      Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/33/41489?source=related_link\">",
"      Patient information: Mono, the &ldquo;kissing disease&rdquo; (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3703?source=related_link\">",
"      The role of Epstein-Barr virus in Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=related_link\">",
"      Toxoplasmosis in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3114?source=related_link\">",
"      Virology of Epstein-Barr virus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_18_31019="LAVH staging";
var content_f30_18_31019=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Staging of laparoscopic hysterectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Stage 0",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Laparoscopy done, but no additional laparoscopic procedure performed before vaginal hysterectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Stage 1",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Procedure includes laparoscopic adhesiolysis and/or excision of endometriosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Stage 2",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Either or both adnexa freed laparoscopically",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Stage 3",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Laparoscopic dissection of bladder from uterus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Stage 4",
"       </td>",
"       <td>",
"        Uterine artery transected laparoscopically",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Stage 5",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Anterior and/or posterior colpotomy or entire uterus freed laparoscopically",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Subscript 0",
"       </td>",
"       <td>",
"        Neither ovary excised laparoscopically",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Subscript 1",
"       </td>",
"       <td>",
"        One ovary excised laparoscopically",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Subscript 2",
"       </td>",
"       <td>",
"        Both ovaries excised laparoscopically",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31019=[""].join("\n");
var outline_f30_18_31019=null;
var title_f30_18_31020="Bisphos AI bone loss";
var content_f30_18_31020=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F78409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F78409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Use of bisphosphonates in women treated with AIs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Trial",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        F/U, mo",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Treatment",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Mean percentage difference in BMD between groups",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Fractures, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        LS",
"       </td>",
"       <td class=\"subtitle2\">",
"        Hip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Z-FAST",
"       </td>",
"       <td rowspan=\"3\">",
"        602",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td rowspan=\"3\">",
"        LET + ZA/D-ZA",
"       </td>",
"       <td>",
"        4.4 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        3.3 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        1.0 versus 0.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        6.7 [p&lt;0.001]",
"       </td>",
"       <td>",
"        5.2 [p&lt;0.001]",
"       </td>",
"       <td>",
"        5.6 versus 6.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        8.9 [p&lt;0.001]",
"       </td>",
"       <td>",
"        6.7 [p&lt;0.001]",
"       </td>",
"       <td>",
"        9.3 versus 11.0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        ZO-FAST",
"       </td>",
"       <td rowspan=\"2\">",
"        1065",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td rowspan=\"2\">",
"        LET + ZA/D-ZA",
"       </td>",
"       <td>",
"        5.7 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        3.6 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        9.3 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        5.4 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        5.0 versus 6.0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        SABRE",
"       </td>",
"       <td>",
"        234",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        ANA + R/Placebo",
"       </td>",
"       <td>",
"        4.0 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        2.9 [p&lt;0.0001]",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LET: letrozole; F/U: follow-up; BMD: bone mineral density; ZA: zoledronic acid; D: delayed; ANA: anastrazole; R: risedronate.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with data from:&nbsp;",
"     <br>",
"      1. Van Poznak C, Hannon RA, Mackey JR, et al. Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. J Clin Oncol 2010; 28:967.",
"      <br>",
"       2.&nbsp;Eidtmann H, de Boer R, Bundred N, et al. Efficacy of zoledronic acid in&nbsp;postmenopausal women with early breast cancer receiving adjuvent letrozole: 36-month results of the ZO-FAST Study. Ann Oncol 2010; 21:2188.",
"       <br>",
"        3. Brufsky AM, Harker WG, Beck JT, et al. Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole. Cancer 2012; 118:1192.",
"        <br>",
"         <br>",
"          Reproduced with permission from: Pant S, Shapiro CL. Aromatase inhibitor-associated bone loss. Drugs 2008; 68:2591. Copyright &copy; 2008 Adis Data Information BV.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31020=[""].join("\n");
var outline_f30_18_31020=null;
var title_f30_18_31021="Mortality and time to reperfusion in MI";
var content_f30_18_31021=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53374&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53374&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Time to thrombolysis and 35-day mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 282px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The importance of time to thrombolysis in acute myocardial infarction and the absolute reduction in 35-day mortality in a meta-analysis of over 50,000 patients. The benefit from thrombolytic therapy is greatest when it is administered within two hours of symptom onset. The survival benefit is progressively reduced as the delay in therapy increases; after two hours, the benefit from thrombolytic therapy fits a linear function (black line) in which the benefit falls by approximately 1.6 lives per 1000 patients per hour of treatment delay.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Boersma E, Maas ACP, Simoon ML. Lancet 1996; 348:771.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31021=[""].join("\n");
var outline_f30_18_31021=null;
var title_f30_18_31022="Sequential changes during fetal hypoxia";
var content_f30_18_31022=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73075&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73075&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Progression of fetal growth restriction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 317px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31022=[""].join("\n");
var outline_f30_18_31022=null;
var title_f30_18_31023="Humeral fracture infant";
var content_f30_18_31023=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left distal humerus fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 369px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rajvee Shah, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_18_31023=[""].join("\n");
var outline_f30_18_31023=null;
